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Abstract 
Stimulus control (SC) is a core component of cognitive behavioural therapy 
(CBT) for insomnia and is the single intervention for which there is most empirical 
evidence. Nonetheless, little is known about whether all of the elements within SC 
are critical to sleep improvement. This study, therefore, investigated the impact on 
sleep of the Quarter of an Hour Rule (QHR) a single, situational element considered 
central to SC for insomnia. The mechanisms of effect of SC intervention remain also 
unclear. An associated aim of the present study, therefore, was to contrast two forms 
of administration of the QHR to test aspects of the learning theory presumed to 
underlie the SC model. In addition adherence to the behavioural intervention was 
investigated and the possibility of using actigraphy to measure adherence objectively 
was explored. 
Prior to the randomised controlled trial (primary study), two preliminary studies 
were conducted. The first preliminary study aimed at determining the optimal cut-off 
to represent normalcy in sleep onset latency (SOL). The results indicated it to be 
fifteen minutes and, therefore, participants in studies two and three were asked to 
apply the QHR if they were not asleep within a quarter of an hour. Study two 
comprised three single cases and tested the feasibility of the QHR as a standalone 
therapy for insomnia. Visual inspection of the data and interrupted time series 
analyses evidenced SOL, wake after sleep onset (WASO) and sleep efficiency (S. E. ) 
improvements in two out of three participants. Their Pittsburgh Sleep Quality Index 
(PSQI) score at the end of the intervention was reduced by 50% compared to 
baseline. The participant, whose sleep was not improved, following the intervention, 
had not applied the QHR. The results of this exploratory, single case, study 
warranted further investigation of the QHR. 
In study three forty-one GP and self referred volunteers, aged 18-72 years, with 
SOL and/or WASO complaints, formed 3 randomised groups: QHRin bed, QHRout 
of bed and control. Both QHR conditions required to `read if not asleep within a 
quarter of an hour', with groups differing only with the location (in bed versus out of 
bed) where to apply the QHR. Sleep diary pre-treatment (two weeks) and post- 
treatment (three weeks), home polysomnography (PSG) (two nights pre-, two post- 
1 
treatment) and sleep related questionnaire (pre and post) data were collected. 
Adherence with the QHR was measured objectively (actigraphy + light monitoring) 
and subjectively (adherence diary). 
Following QHR treatments, statistically significant reductions in SOL (QHRout) 
and WASO (QHRin and QHRout), an increase in S. E. (QHRin and QHRout) and a 
decrease in PSQI score (QHRin and QHRout) were found. Trends also indicated 
increased total sleep time (TST). Clinically significant improvements (SOL and 
WASO S 31 minutes or reduced by 50%, PSQI : 55 or reduced by 50%) were 
obtained in 33-57% of active groups participants. Furthermore, 43% of QHRin and 
66% of QHRout participants achieved S. E. _85%. 
Magnitude of effect was greater 
for the QHRout than the QHRin and changes were achieved within the first week of 
treatment. No differences were found in PSG defined sleep variables. Nevertheless, 
subjective-objective discrepancies (i. e. differences between sleep diary and PSG 
defined sleep) were reduced following intervention. Sleep related questionnaires 
indicated fewer sleep pattern problems, less cognitive and somatic arousal and less 
cognitive activity (sleep effort, problem solving and sensory engagement) following 
QHR interventions. Participants tended to adhere in categorical terms (either 
adhering most times (majority) or not adhering at all). Adherence was adequate 
indicating that the QHR is well tolerated and accepted. Importantly, the combination 
of actigraphy and light provided a tool to measure adherence objectively. 
The QHR, a single instruction administered in the form of brief therapy, was 
found to improve subjectively reported sleep both statistically and clinically. The 
finding that both QHRin and QHRout were efficacious for WASO sheds doubt on 
the argument that for difficulties maintaining sleep, the QHR component works 
solely via conditioning principles. However it is possible that re-conditioning effects 
apply not only to external (environmental) factors as posited by SC theory but, also, 
to internal (cognitive) factors. The finding that sub-ob discrepancies decreased 
following QHR intervention is discussed in terms of levels of arousal and stimuli 
engagement at the time of falling asleep and during PSG defined sleep. Further 
research is warranted. 
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CHAPTER 1 
Introduction 
4 
1.1 Overview 
This chapter presents an overview of insomnia, its classifications, characteristics 
and epidemiology. Insomnia assessment and diagnostic issues are also considered 
with a view to what questions each of these methods can help to answer. Thereafter 
the three main perspectives of insomnia and some theoretical models within which it 
is possible to understand the emergence, maintenance and exacerbation of insomnia 
are outlined and evidence supporting and / or disconfirming these perspectives and 
models are presented. By taking into account the psychological and behavioural 
factors presumed to be involved in insomnia, a rationale for the use of psychological 
treatments is proposed. Psychological interventions for insomnia are briefly outlined 
and treatment outcome studies are critically reviewed so as to highlight what is still 
to be done. Furthermore, variables moderating treatment efficacy are discussed and a 
call for investigation of adherence to treatment is made. Drawing on the models and 
current limitations in insomnia treatment research, and the recent guidelines on 
insomnia, it is proposed that the investigation of one single component of the 
behavioural treatment for insomnia stimulus control, namely the quarter of an hour 
rule (QHR), can be employed not only to mitigate sleep difficulties but, importantly, 
to shed light on mechanisms of effects and the minimum dose needed to achieve 
therapeutic gains. In addition, employing only one single element permits a closer 
13 
look at adherence and to the testing of an objective methodology to measure and 
monitor adherence and its effects on therapy outcomes. 
1.2 Insomnia 
Lay-person definitions of insomnia include "not being able to sleep well", 
"taking ages to fall asleep", "spending hours awake during the night" and, as a 
result, `feeling very tired during the day with difficulties concentrating", `feeling 
lethargic and with snappy moods". The self-labelled `insomniacs' will probably go 
on to say that they would love to have a good night's sleep, that they have tried 
everything (but nothing worked), that they don't want drugs or that drugs are not 
working anymore. Some will remember how easy it was to sleep once, and how good 
it feels when they have the occasional good night. 
Insomnia is so widespread that most people have an idea of what insomnia is, 
although the `insomnia ingredients' vary according to personal (one's own or 
someone else's) experiences. But what is insomnia really? Perhaps, as proposed by 
Espie (1991,2002) the best way to start answering this question is to understand 
what normal sleep is and what regulates it. 
1.2.1 Basic Facts about Sleep 
Sleep is not a unitary state: while the observer can only see the two opposite 
states, that is wakefulness and sleep, the individual experiences different types of 
sleep such as deep and light sleep and dreaming. Research has corroborated the 
subjective experience of sleep as a non-unitary state by the measuring of the 
electrical currents of the brain. 
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The first division of sleep is that of non-rapid eye movement (NREM) sleep and 
REM sleep. As illustrated in figure 1, NREM sleep is further subdivided into four 
distinct stages. 
Figure 1: An example of EEG traces during NREM and REM stages 
Stage 1 
Stage 2_L, ý ýýýrVlff ý'ý 
Slow Waves 
(stages 3& 4) 
r ýtNyw, ý/y, vM 
REM sleep 
Stage 1 is a very light sleep characterised by a relatively low-voltage and mixed 
frequency activity where theta rhythm (3 to 7 cycles per second - cps) and vertex 
sharps are common. Stage 2 represents light sleep as well and the EEG shows a 
pattern of relatively low voltage with mixed frequency activity. Two specific EEG 
patterns enable the distinction of stage 2 from stage 1: the sleep spindles (12-14 cps, 
with a duration of 0.5 to 1.5 seconds) and k-complex (a well delineated sharp wave 
of duration exceeding 0.5 seconds which is immediately followed by a positive 
component and stands out from the ongoing background activity). Each epoch (30 
seconds) in stage 2 comprises up to 20% of delta waves (delta waves have high 
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voltage, i. e. amplitudes greater than 75 millivolts, and there are maximum 2 for cps). 
Deep sleep is seen in stage 3 and 4. Stage 3 is defined by the presence of delta waves 
in a percentage between 20 and 50 per each epoch of EEG recording. Stage 4, 
finally, is characterised by delta waves in more than 50% of the epoch. REM sleep is 
characterized by EEG activation: relatively low voltage, mixed frequency (typical of 
relaxed wakefulness) at the scalp level coupled to rapid eye movement and motor 
atonia (i. e. loss of muscle tone). Detailed guidelines and criteria for staging sleep are 
provided by the standard sleep staging manual (Rechtschaffen and Kales, 1968). 
Sleep is, then, a highly organised activity and it follows a cyclic pattern. A normal 
adult enters sleep via NREM stages (from 1 to 4); this sequence is then reversed from 
stage 4 to 2 leading to the first REM episode. This first cycle of sleep takes about 70 
to 120 minutes and on average, during one night, four to five of these cycles happen. 
In Table 1 generalisations about sleep in normal and primary insomnia adults are 
provided. These PSG values for sleep continuity and sleep architecture measures 
were estimated by Smith, Nowakowski, Soeffing, Orff and Perlis (2003) from 
literature. 
Table 1- Average PSG Sleep variables for Healthy Normal Sleepers and 
Primary Insomnia 
can Measures .'i le onto ujý 
SOL 10 (minutes) 56 (minutes) 
WASO 10 (minutes) 45 (minutes) 
TST 420 (minutes) 352 (minutes) 
SE >90% 79% 
Wake 5% 11% 
Stage 1 5% 10% 
Stage 2 60% 56% 
Stage 3&4 15% 12% 
Stage REM 15% 22% 
The question is: what regulates sleep? 
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In the 1970s Borbely and his colleagues in Zurich, began the exploration of a two- 
factor theory of the regulation of sleep based on experimental work with both 
animals and humans, which was then formulated in 1984 (Daan, Beersma and 
Borbely, 1984). In brief, they proposed that two `opponent processes' regulate sleep: 
on one hand a homeostatic sleep drive, which is constantly active, promotes and 
maintains sleep (the longer one is without sleep the greater the sleep debt and as a 
consequence the drive to sleep); on the other hand wakefulness is fostered by a 
biological clock (regulated by a circadian timer), active during the day and inactive 
at night which acts as a kind of arousal system (Carskadon and Dement, 1981; 
Dement and Vaughan, 1999). In addition environmental and social factors influence 
sleep (e. g. shift work) (Webb, 1988). 
An important point was made by Espie (2002): normal sleep is a `passive' state 
that does not require effort, the 'good' sleeper falls asleep automatically without 
forcefully trying, in fact without trying at all. 
Having discussed normal sleep, its regulation and `passivity' it is easier to define 
and understand insomnia. 
1.2.2 Definition and Classification of Insomnia 
Broadly speaking insomnia refers to difficulty initiating and/or maintaining sleep. 
A more specific set of sleep disorders, all of which have in common a complaint of 
insomnia, has been provided by classification systems such as the Diagnostic and 
Statistical Manual of Mental Disorders (DSM) and the International Classification of 
Sleep Disorders (ICSD). Insomnia can be broadly subdivided into two categories: 
primary insomnia (i. e. independent, no comorbid symptoms) and secondary insomnia 
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(i. e. insomnia is instigated by other sleep, psychiatric or medical conditions). It is 
noteworthy that determining causality is often difficult (Smith, Smith, Nowakosky 
and Perlis, 2003) and that a diagnosis of primary insomnia is often made by 
exclusion (Morin, 1993). 
Insomnia is also characterized by its duration: in the DSM insomnia is defined as 
`acute' if it lasts for less than a month and it is accompanied by specific events 
precipitating the sleep problems (e. g. pain, bereavement). Insomnia is, instead, 
considered `chronic' when the symptoms last longer than one month despite the 
stressor having been resolved or the person having adjusted to it. According to the 
ICSD-R, instead, insomnia is considered chronic if it lasts for at least six months. 
Typically if the individual presents with secondary insomnia the treatment will 
focus on the disorder (for example depression) deemed to give rise to the insomnia 
symptoms. In instances of acute insomnia the treatment choice, if treatment is 
provided, is pharmacotherapy. When the individual presents with primary insomnia 
symptoms, instead, behavioural interventions for insomnia are provided, if available, 
as either standalone treatment or in addition to pharmacotherapy. 
The present research investigates psychological interventions for insomnia, hence 
attention will focus on insomnia when it is chronic and a primary disorder. 
In short, primary insomnia is defined by DSM-IV as a complaint of initiating 
and/or maintaining sleep or non-restorative sleep lasting for at least one month 
associated to decreased functioning during the day (e. g. lack of concentration, 
tiredness, decreased productivity) (American Psychiatric Association, 2000). Table 
2, here below, provides the DSM-IV diagnostic criteria for primary insomnia. 
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Table 2- DSM-IV - Diagnostic Criteria for 307.42 Primary Insomnia 
A. The predominant complaint is difficulty initiating or maintaining 
sleep or non-restorative sleep, for at least one month. 
B. The sleep disturbance (or associated daytime fatigue) causes 
clinically significant distress or impairment in social, occupational, 
or other important areas of functioning. 
C. The sleep disturbance does not occur exclusively during the course 
of narcolepsy, breathing related sleep disorder, circadian rhythm 
sleep disorder, or a parasomnia. 
D. The disturbance does not occur exclusively during the course of 
another mental disorder (e. g. major depressive disorder, 
generalised anxiety disorder, a delirium). 
E. The disturbance is not due to the direct physiological effects of 
a substance (e. g. a drug of abuse, a medication) or a general 
medical condition. 
Primary insomnia as defined by the DSM-IV subsumes to a number of insomnia 
categories in the ICSD. The category most closely resembling the DSM-IV definition 
of primary insomnia is that of psychophysiologic insomnia. According to the ICSD- 
R (American Sleep Disorder Association, 1997) psychophysiologic insomnia is a 
disorder of somatized tension and learned sleep-preventing associations resulting in a 
complaint of insomnia and associated decreased functioning during wakefulness 
(table 3 reports diagnostic criteria). 
It should be noted that this definition, as compared to that of primary insomnia, is 
more tied up with the underpinning of the disorder (i. e. how insomnia started and it is 
maintained). Somatized tension refers to somatic hyperarousal, either perceived or 
objectively measured. Learned sleep-preventing associations refer to either internal 
cognitions (mainly worry about the inability to sleep) or external stimuli (conditioned 
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association of sleeplessness with situations and behaviours related to sleep such as 
lying in bed) both provoking pre-sleep arousal. The patient's focused attention on 
sleep is of paramount importance in psychophysiologic insomnia. 
Table 3- ICSD-R - Diagnostic Criteria: Psychophysiologic Insomnia 307.42-0 
a. A complaint of insomnia is present and is combined with a complaint of 
decreased functioning during wakefulness. 
b. Indication of learned sleep-preventing associations are found and include the 
following: 
1. Trying too hard to sleep, suggested by an inability to fall asleep when 
desired, but ease to fall asleep during other relatively monotonous 
pursuits, such as watching television or reading. 
2. Conditioned arousal to bedroom or sleep-related activities, indicated by 
sleeping poorly at home but sleeping better away from the home or 
when not carrying out bedtime routines. 
c. There is evidence that the patient has increased somatized tension (e. g. 
agitation, muscle tension, or increased vasoconstriction) 
d. Polysomnographic monitoring demonstrates all of the following: 
1. An increased sleep latency 
2. Reduced sleep efficiency 
3. An increased number and duration of awakenings 
e. No other medical or mental disorders accounts for the sleep disturbance. 
f. Other sleep disorders can coexist with the insomnia, e. g. inadequate sleep 
hygiene, obstructive sleep apnoea syndrome, etc. 
Minimal criteria: A+B 
The ICSD-R has recently been revised and a new version has been published 
(ICSD-2, American Academy of Sleep Medicine, 2005). This new version, informed 
by current research and guidelines, incorporates changes with regard to sleep 
disorders. In particular psychophysiologic insomnia, is renamed psychophysiological 
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insomnia in the ICSD-2 and described as a complaint of primary insomnia with the 
essential features of heightened arousal and sleep preventing associations (appendix 
1 presents the revised criteria). It is noteworthy that although the characteristics 
pertaining to psychophysiological insomnia have hardly changed from one version to 
the next, in the latest version cognitive activity (in the form of intrusive, ruminative 
presleep cognitions, often related to the inability to sleep and its consequences) are 
explicitly mentioned. 
Having clearly defined primary insomnia (as per DSM-IV) and 
psychophysiological insomnia (as per ICSD-R, ICSD-2), attention can be turned to 
the epidemiology of insomnia worldwide. 
1.2.3 Epidemiology of Insomnia 
The prevalence of primary insomnia in the adult population, as evidenced by 
epidemiologic surveys, is around 10-15 % increasing to around 20 % in older adults 
with a 'women to men' ratio of roughly 3: 2 (Ancoli-Israel and Roth, 1999; Foley, 
Monjan, Brown, Simonsick, Wallace et al, 1995; Ford and Kamerow, 1989; Gallup 
Organisation, 1995; Morgan, 2003; Ohayon, 2002). Although there are variations in 
percentage of insomnia incidence, it is a worldwide complaint (Cirignotta, Mondini, 
Zucconi, Lenzi and Lugaresi, 1985; Gislason and Almqvist, 1987; Kim, Uchiyama, 
Okawa, Liu and Ogihara, 2000; Leger, Guilleminault, Dreyfus, Delahaye and 
Paillard, 2000; McGhie and Russell, 1962; Ohahion and Partinen, 2002, Ohahion and 
Hong, 2002). For example, an epidemiological survey of the French population 
found that 29% of the respondents had insomnia symptoms at least three times per 
week during the previous month (Leger et al, 2000). Cirignotta and colleagues 
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(1985) found it in around 15% of the population of San Marino. Similarly a survey of 
the South Korean general population found insomnia symptoms at least three times 
per week in 17% of those surveyed (Ohahion and Hong, 2002) and the overall 
prevalence of insomnia in the Japanese general population has been reported as 21 % 
(Kim, Uchiyama, Okawa, Lin and Oshihara, 2000). A survey carried out in the UK 
evidenced that sleep problems are by far the most'common mental health complaint 
(Singleton, Bumpstead, O'Brien, Lee, Meltzer, 2001) and primary insomnia is the 
most common of all sleep complaints (Bixler, Kales, Soldatos, Kales, and Healy, 
1979). It is noteworthy that around 2% of the general population meet criteria for 
psychophysiological insomnia (American Academy of Sleep Medicine, 2005). 
Insomnia is often dismissed as less of a serious problem (Simon and vonKorff, 
1997) and often ignored at the clinical level despite being a considerable public 
health problem which is reported by around 20% of patients seen in general practice 
(Shocat, Umphress, Israel and Ancoli-Israel, 1999) and being associated with 
increased economic costs both in health care and industry (Simon et al, 1997). 
Indeed, insomnia is a contributing factor to reduced productivity, absenteeism, and 
accidents and, once established, it is difficult to extinguish (Brassington, King and 
Bliwise, 2000; Katz and McHorney, 1998; Mendelson, 1995; Roth and Ancoli-Israel, 
1999). 
In sum, primary insomnia is a persistent, common and difficult to treat condition 
associated with reduced daytime functioning, distress and sizeable economic costs. 
In addition insomnia has been found in two meta-analyses to be a key risk factor in 
the first episode and recurrence of depression (Cole and Dendukuri, 2003; Riemann 
and Voderholzer, 2003). It seems, therefore, important to understand what 
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mechanisms underlie the development and maintenance of insomnia and effective 
ways of treating it. First of all, however, ways of assessing insomnia and treatment 
outcomes need to be discussed. 
1.3 Assessment of Insomnia and Monitoring Treatment Efficacy 
The main methods for measuring sleep are subjective measures, in the form of 
retrospective and prospective self-reports and objective measures in the form of 
actigraphy and polysomnography (PSG). Each of these will be briefly described and 
evaluated so as to outline their strengths and weaknesses. 
Typically, the sleep data collected by means of prospective self-reports and 
objective measures are i) sleep onset latency (SOL) that is the time taken to fall 
asleep at the beginning of the night; ii) wake after sleep onset (WASO) that is the 
total time spent awake during the night after sleep onset; iii) total time in bed (TIB) 
that is the amount of time spent in bed; iv) total sleep time (TST, TST=TIB - 
[SOL+WASO]) that is the amount of time actually spent asleep while in bed, v) sleep 
efficiency (S. E., S. E. =[TST/TTB]*100) that is the percentage of time spent asleep 
while in bed, and vi) number and length of arousals (only objective data). It should 
be noted that WASO can comprise all awakenings including early morning 
awakenings or it can be subdivided into WASO during the night and `early 
wakening' that is the amount of time from the last wakening in the morning until 
rising. 
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1.3.1 Subjective Measures 
The two most commonly used self-report measures of sleep are sleep 
questionnaires (retrospective self reports) and sleep diaries (prospective self-reports). 
1.3.1.1 Sleep Questionnaires 
Sleep questionnaires have sufficient diagnostic sensitivity in discriminating 
between normal and poor sleepers and they provide an easy, quick and inexpensive 
way to measure sleep patterns. They are, therefore, particularly in use where a large 
number of people are to be screened or surveyed, although they are also used as pre- 
and post- treatment measures of the individual's perception of their sleep quality and 
quantity. For example The Pittsburgh Sleep Quality Index (PSQI: Buysse, Reynolds, 
Monk, Berman, and Kupfer; 1989) was expressly designed for this latter purpose 
(Smith, Nowakowski, et al, 2003). 
One important limitation of sleep questionnaires is their validity: they usually 
require the individual to provide estimates in terms of average which are most likely 
influenced by the particular mood of the individual at the time of completion and the 
most salient or recent experience of sleep (e. g. the particularly bad night). In 
addition, an average figure raises validity issues given that in insomnia night-to-night 
variability is high and, importantly, a feature of insomnia: most researchers and 
clinicians will have come across questionnaires with replies such as "it varies" or "5 
minutes to 4 hours", to the questionnaire item: `average time to fall asleep in the last 
month'. 
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In sum, sleep questionnaires provide a quick, convenient and inexpensive tool to 
measure sleep but have the disadvantage of being based on estimates drawn from 
memory of a number of past nights and of giving one global figure for each sleep 
variable under scrutiny. Sleep diaries, critically outlined below, partly avoid these 
pitfalls. 
1.3.1.2 Sleep Diary 
This measurement is the standard of practice for behavioural sleep medicine. 
Unlike sleep questionnaires, the sleep diary is completed each morning upon 
awakening for a given number of days so that sleep can be sampled across time. 
Therefore, although sleep measures are taken retrospectively (i. e. the previous night), 
they are applied prospectively in that they are gathered for a number of (future) 
consecutive nights. Similarly to retrospective sleep measures the individual is 
required to estimate variables such as `time to fall a sleep' and `duration of 
wakenings during the night'. However, sleep diaries require such estimates to only 
one time point (the previous night) hence the response biases (e. g. using averages) 
discussed above are avoided. Of course sleep diaries collect subjective judgements of 
sleep and, therefore, are not as precise as objective measures (section 1.3.2 here 
below). Nonetheless a very important feature of subjective measures is that, unlike 
PSG or actigraphy, they enable the gathering of information about the perception 
both of sleep disturbance (i. e. the complaint) and of recovery following treatment. 
An issue with the diary is adherence to the instruction `fill it in every morning': 
people might fill the diary in later on during the day or even worse a few days later. 
Another issue with sleep diaries, worth addressing especially for research purposes, 
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relates to standardisation: although there is a general agreement across sleep 
laboratories regarding the sleep parameters to be gathered, a standardised sleep diary 
is not in use and this can result in variations in the characterisation of sleep 
continuity across studies. These problems could be resolved by employing simple 
ways to store the daily sleep diary entries (e. g. I-pod type) and by agreeing on a 
minimal standard form, both in terms of sleep parameters to be collected and 
wording of questions, to be used across all sleep laboratories. 
As it has been shown in the preceding discussion the sleep diary is an inexpensive 
tool for measuring sleep continuity and sleep quality variables night after night. The 
fact that it relies on the individual's report of the previous night is a weakness but 
also a major strength of sleep diaries. On one hand the reported values are not free of 
the memory biases typical of retrospective measures but on the other hand sleep 
diaries capture the subjective perception of the sleep difficulties. Given that the 
essential feature of insomnia is the individual's complaint of poor sleep (minimum 
three days per week) and its consequences during the day, it can be argued that the 
sleep diary is the most valid tool to measure this feature of insomnia and it is, 
therefore, not surprising that it is standard practice in behavioural sleep medicine. 
Sleep diaries measure sleep continuity and collect the individual's perception of 
being either asleep or awake. As already mentioned, the subjective report of sleep 
argues against a unitary sleep state and the different `layers' of sleep can be 
monitored via PSG, an objective measurement of sleep and wakefulness. 
26 
1.3.2 Objective Measures of Sleep 
In this section polysomnography and actigraphy will be described and critically 
evaluated. 
1.3.2.1 Polysomnography 
Polysomnography (PSG) permits researchers and clinicians to measure sleep 
objectively, to obtain an exact temporal (second-by-second) resolution of sleep, to 
have direct and quantitative measures of brain and muscle activity and to 
differentiate sleep into substates (stages 1,2,3,4 and REM) which are not detectable 
with other sleep measurements (Smith, Nowakowski et al, 2003). 
Three measures are sufficient for monitoring and scoring sleep: 
electroencephalography (EEG) in particular the recording of brain wave activity 
from central and occipital areas of the scalp, electrooculography (EOG) which 
measures a differential of electrical potential, generated by each eye movement, 
between the cornea and the retina; and electromyography (I3MG), which monitors 
muscle tone and is generally recorded at the chin site. These electrical currents can 
be represented continuously and plotted over time and their combination permits the 
detection and categorization of sleep stages and wakefulness. In order to obtain 
reliable PSG data the electrodes need to be placed accurately: the 10-20 International 
System (Jasper, 1958) is the most commonly used system for electrode attachment. 
The PSG data are divided into sleep stages employing criteria for staging normal 
human sleep provided in the Rechtschaffen and Kales' (1968) manual (section 1.2.1 
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and figure 1 give explanation and example of sleep stages, and figure 15a shows a 
PSG recording device). 
An important issue is that PSG recording usually takes place in sleep laboratories 
and several studies have noted that PSG sleep differences between poor and normal 
sleepers are at best modest (Means, Edinger, Glenn and Fins, 2003; Sugarman, Stem 
and Walsh, 1985). It could be argued that in laboratory settings the conditioned cues 
for wakefulness typical of the poor sleeper's bedroom are absent. Additionally the 
laboratory setting may provide a pre-bed routine that obviates to sleep-disruptive 
habits and the novelty might distract the individual from the usual pattern of 
worrying in bed. The fact that poor sleep is expected can paradoxically promote a 
good night's sleep by removing sleep anxiety performance. The opposite is true for 
the normal sleeper: habitual cues for sleep are absent, the usual pre-bed routine is 
disrupted and they might question their ability to sleep in a novel environment. 
In other words, it can be argued that a short series of sleep recordings conducted 
in laboratory settings might not be representative of individuals' typical sleep. For 
example, Edinger and colleagues conducted a series of PSG studies where PSG 
recordings were conducted both at participants' homes and in laboratory settings. 
One study showed that individuals, regardless of their sleep status, acclimatise more 
readily to PSG recording when in their home as compared to the laboratory setting 
and that PSG recording at home enabled capture of the relatively high night-to-night 
variability typical of people with insomnia (Edinger, Fins, Sullivan, Marsh, Dailey, 
Hope, Young, Shaw, Carlson and Vasilas, 1997). In a subsequent study Edinger and 
colleagues found that people with insomnia who had a bed partner showed sleep 
differences with regard to normal sleepers only when PSGs were recorded at home, 
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once again suggesting that home PSG is a suitable option if capturing `typical' sleep 
patterns is important (Edinger, Glenn, Bastian, Marsh, Daile, Hope, Young, Shaw 
and Meeks, 2001). 
It seems, therefore, worthwhile to measure PSG sleep at home as this increases 
ecological validity in comparison with laboratory based trials. Simple to use, non- 
intrusive, relatively cheap, portable EEG systems have been recently devised which 
make it feasible to conduct home PSG so as to monitor objective sleep changes 
following insomnia interventions whilst the individuals sleep in the `reality' of their 
own usual sleep environment. 
It is noteworthy that subjective measures of sleep and PSG sleep are very often 
mismatched in both young adults and the elderly (Carskadon, Dement, Mitler, 
Guilleminault, Zarcone and Spiegel, 1976; Mercer, Bootzin and Lacks, 2002; 
Schramm, Hohagen, Backhaus, Lis and Berger, 1995; Webb and Schneider-Helmert, 
1988). In order to explain such discrepancies, Borkovec (1979) suggested that when 
an overly active reticular system (which governs arousal) is present or a 
neurotransmitter-dependant sleep system fails to switch on then PSG confirms 
insomnia. In contrast, when reported insomnia is not confirmed by PSG defined 
sleep the individual has an overly active cognitive processing of anxiety-laden 
thoughts. It could be argued that, in the latter case, sleep staging does not capture 
features of insomnia such as alertness. Alertness in the form of EEG fast activity can 
be detected by performing power spectral analysis to the PSG recorded night (Perlis, 
Smith, Orff, Andrews and Gill, 2001). 
Interestingly, several studies highlighted that despite positive treatment effects 
being evidenced by sleep diary data, there were only very small treatment effects or 
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none at all if PSG data were considered (e. g. ' Morin, Kowatch, Barry and Walton, 
1993; Engle-Friedman, Bootzin, Hazlewood and Tsao, 1992; Morin, Stone, Trinkle, 
Mercer and Remsberg, 1993; Schramm et al, 1995). 
Another important point, related to the difference between subjective and 
objective measures of sleep, could be made by taking into account Espie's (1991) 
observation that the subjective complaint normally incorporates an element of 
dissatisfaction with sleep quality variables such as `not feeling refreshed in the 
morning', or `sleep was of very poor quality'. Such complaints are not invalidated by 
an absence of EEG evidence of sleep pattern disruption: indeed not being sensitive to 
sleep quality variables weakens the role of PSG as a measurement criterion. 
1.3.2.2 Actigraphy 
Actigraphy measures movement and its absence i. e. this measurement, rather than 
measuring sleep directly, infers sleep by the absence of movement (Sadeh and 
Acebo, 2002). The movement detector, a small piezoelectric accelerometer that 
generates voltages when there is movement, is housed in a wristwatch-like device. 
The detected movement is translated into digital counts accumulated across epoch 
intervals, whose length can range from 2 seconds to 15 minutes, and stored in the 
internal memory of the watch. The epoch data collected are transferred to a computer 
that has the set up and the reader interface and each epoch is evaluated for whether it 
represents sleep or wakefulness. 
Given that actigraphy is a proxy measure of sleep its validity as a measurement of 
sleep variables is inferior when compared to that of sleep diary and PSG. Indeed a 
problem with actigraphy is validity: good agreement (r=0.94) between actigraphy 
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and PSG for epoch by epoch sleep has been found in normal sleepers (Jean-Louis, 
Kripke, Cole, Assmus and Langer, 2001), but epoch by epoch wake have lower 
validity most probably because people, especially poor sleepers, tend to lie still in an 
attempt to fall asleep. In addition, the discrepancy is much higher when the sleep of 
people with insomnia is assessed (Chambers, 1994; Hauri and Wisbey, 1992). 
Furthermore, it has been shown that there are gender and age differences in actigraph 
estimates of sleep (for a review see Sadeh and Acebo, 2002). It could be argued that 
such variability decreases the usefulness of actigraphy when the focus of research is 
sleep. Kushida, Chang, Gadkary, Guilleminault, Carrillo, and Dement, (2001) 
compared PSG, actigraphy and sleep diary measures for one night in one hundred 
people with sleep difficulties. They found that the accuracy of actigraphy declines as 
sleep diminishes: actigraphy was excellent in detecting sleep (sensitivity = 0.92) but 
its ability to detect wakefulness (specificity= 0.48) was rather poor and the ability to 
detect both sleep and wakefulness (accuracy = 0.78) was low. Pollack, Tryon, 
Nagaraja and Dzwonczyk (2001) investigated the ability of actigraphy to predict 
PSG defined sleep and wakefulness and argued that actigraphy is not an accurate 
sleep-wake detector, although it may be useful as a measure of rest/activity. In 
particular, Sadeh and Acebo (2002, p120) cautioned that "actigraphy is not the best 
method if interest is in the precise duration of sleep onset" because the largest 
discrepancies between actigraphy and PSG measures are typically around sleep-wake 
and wake-sleep transitions. 
It is important to note that actigraphs can collect other measures in addition to 
movement: this can be very useful if actigraphy is employed for collecting data other 
than sleep. For example one model (Actiwatch-L by Cambridge Neurotechnology, 
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figure 22 in section 6.3.3.5a for an example of actiwatch) incorporates an integral 
light sensor that monitors light intensity range measured from 0 to 50,000 lux. In this 
way, both movement and light are detected and stored. A secondary aim of the 
present research is the exploration of the impact of adherence on insomnia treatment 
outcomes: this extra feature of actigraphy can be exploited to objectively monitor 
adherence to a behavioural instruction asking participants to read (study 3, ch. 5). 
In sum, there is not an absolute `gold standard measure' of sleep. While sleep 
questionnaires are an important tool to quickly gather information regarding the 
perception of sleep problems, sleep diaries provide nightly information regarding the 
perception of sleep continuity and, very importantly, the subjective complaint. PSG 
measures objective sleep continuity and sleep architecture and enables power 
spectral analysis. However, given that PSG recordings are costly and time consuming 
they are not really feasible as a measurement of many consecutive nights. For this 
reason actigraphy is employed when the measurement of sleep over time is to be 
collected objectively; even though it presents the important problem of validity 
discussed above. 
It can be concluded that subjective and objective measures of sleep might be 
complementary and, most importantly, the questions one is trying to answer and the 
issues and hypotheses under investigation (e. g. endorsed beliefs about sleep, EEG 
activity during sleep) should inform which are the best to use. 
The next section introduces insomnia aetiological systems and related research. 
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1.4 Theoretical Perspectives on Insomnia 
The aim of this section is to critically outline the major perspectives on insomnia 
(i. e. physiological, behavioural and cognitive) and related research. In addition 
'purist' models within a given perspective and models integrating different 
perspectives are discussed. 
Whilst there is limited information regarding mechanisms underlying 
pathophysiology and genetic or heritability factors in insomnia (Richardson and 
Roth, 2001; Yves, Morin, Cervena, Carlander, Beset and Billiard, 2003), most 
insomnia models agree on the hypothesis that insomnia is a disorder of arousal: the 
person complaining of insomnia has a level of arousal inhibiting sleep onset at 
bedtime and/or during the night. The debate regarding the origin (physiological, 
psychological and/or environmental) of such hyperarousal is, however, ongoing. 
1.4.1 Physiological Perspective of Insomnia 
This perspective proposes that physiological arousal and sleep are incompatible 
and that individuals with chronic insomnia experience sleep difficulties because of a 
high level of physiological arousal either in general or around bedtime and during the 
night. 
In the nervous system arousal can be maintained by a failure of central nervous 
system (CNS) processes to promote sleep (homeostatic sleep drive) and/or to inhibit 
wakefulness (biological clock) (Daan et al, 1984). There is evidence of heightened 
cortical arousal during the sleep of people with insomnia. For example, Merica, Blois 
and Gaillard's (1998) PSG study found increased beta power (beta waves are 
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characteristic of alertness) in their insomnia group as compared to the control group. 
Similar results were obtained by Perlis, Kehr, Smith, Andrew, Orff and Giles (2001): 
high frequency EEG activity during the light sleep stages (stages 1 and 2) was 
increased in individuals with primary insomnia as compared both to controls and 
individuals with insomnia secondary to major depression. 
High levels of autonomic activity associated with tension and problems in 
physiological relaxation (e. g. muscle tension, respiration rate) can be another form of 
arousal that, less directly, inhibits sleep. For example Monroe (1967) conducted an 
important study with 16 normal and 16 poor sleepers and found that poor sleepers 
exhibited heightened autonomic arousal both during and prior to sleep (evidenced by 
higher body temperature, body movements per hour, vasoconstriction per minute, 
perspiration rate and skin conductance). Other studies, however, did not find 
differences between normal and poor sleepers in autonomic variables (for a review 
see Bootzin and Nicassio, 1978; Borkovec, 1982). More recently, Bonnet and 
colleagues assessed physiological arousal employing a measure of oxygen 
consumption (V02) and found that the insomnia group, as compared to controls, 
displayed higher metabolic rate (autonomic arousal) both during the day and at night 
(Bonnet and Arand, 1995,1997; Bonnet, McNulty and Arand, 1993). A limitation of 
these studies is that physical fitness and caloric intake greatly influence body oxygen 
consumption, hence the observed differences could have been due, for example, to 
the insomnia group being less physically fit than the control group. 
In sum, although there are findings that physiological hyperarousal (autonomic 
and/or cortical) correlates with insomnia, research has not unequivocally supported 
the physiological perspective. It is noteworthy that this perspective informs on the 
34 
interaction between insomnia and arousal but lacks explanatory power regarding the 
development and exacerbation of insomnia. Although research evidence of 
physiological arousal is often used to provide support for aspects of some theoretical 
models of insomnia, a formal model of insomnia within the physiological perspective 
has not been proposed. 
The behavioural perspective, discussed in the next section, attempts to provide an 
analysis of the maintenance and exacerbation of insomnia. 
1.4.2 Environmental/Behavioural Perspective of Insomnia 
According to the behavioural perspective, acute insomnia might be precipitated by 
a number of psychosocial events but chronic insomnia has its source in the 
environment. The source of the individual's recurrent difficulties with sleep is not 
considered to be physiological or psychological in origin, rather the individual's 
arousal is caused by situation and temporal factors or the interaction between the 
individual and their environment. 
This perspective posits that the environment may elicit arousal responses by either 
failing to predict sleep at the right time for sleeping or predicting wakefulness at the 
wrong times. It is suggested that sleep disruptive habits (e. g. extending the time spent 
in bed, napping) and conditioned responses (e. g. lying in bed elicits wakefulness 
rather than sleep) interfere with sleep drive and serve as environmental inhibitors of 
sleep (Bootzin and Epstein, 2000; Edinger and Wohlgemuth, 1999; Morin, Savard 
and Blais, 2000; Spielman, Saskin and Thorpy, 1987). 
However, results from the couple of studies investigating, directly or indirectly, 
conditioning in insomnia call into question the conceptual basis of the behavioural 
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perspective of insomnia. Kazarian, Howe and Csapo (1979) found support for the 
hypothesis that poor sleepers engage in sleep incompatible behaviour (both in the 
form of overt behaviour such as reading and covert such as thinking). However, two 
other studies found that normal sleepers, similarly to poor sleepers, engaged in sleep 
incompatible activity in the bedroom and that the two groups did not differ in pre- 
sleep activities (Harvey, 2000a; Haynes, Adams, West, Kamens and Safranek, 1982). 
The findings that poor and normal sleepers endorse similar behaviour at bedtime do 
not automatically rule out the role of conditioning in insomnia: it could be, for 
example, that the concept of `preparedness' applies to poor sleepers but not to 
normal sleepers with regard to sleep incompatible behaviours and sleep. In learning 
theory, the concept of `preparedness' refers to the observation that depending on the 
organism's make-up and social modelling, the organism is prepared (predisposed) to 
learn some associations more readily than others (Seligman, 1971; Hygge and 
Ohman, 1978). Learned taste aversion studies, for example, suggest that there is a 
biological preparedness to learn certain relations more readily than others and similar 
effects occur in operant learning with some responses more readily strengthened by 
some reinforcers than others (Bolles, 1970; Shettleworth, 1972; Bernstein, 1978). As 
discussed in section 1.4.2.2, predisposition is one of the three main factors theorised 
to play a major role in insomnia (Spielman et al, 1987). Additional research, perhaps 
employing prospective rather than retrospective measures, is much warranted to 
validate this hypothesis. 
Two behavioural models of insomnia (stimulus control and the 3 factor model of 
insomnia) have gained extreme popularity. Perhaps, especially with regard to 
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stimulus control, this is mainly due to the positive outcomes repeatedly obtained with 
stimulus control therapy for insomnia and sleep restriction. 
1.4.2.1 Stimulus Control (Bootzin. 1972. Bootzin and Nicassio. 1978) 
Bootzin (1972) conceptualised sleep and insomnia in terms of learning theory and 
developed stimulus control therapy for insomnia. Stimulus control is based on 
operant conditioning concepts: stimuli can elicit a number of responses depending on 
the conditioning history. Stimulus control can be defined as the degree to which an 
antecedent stimulus (or class of stimuli) determines the probability that the organism 
gives the conditioned response i. e. the antecedent stimulus has some control over that 
particular response. Briefly, applying stimulus control concepts to sleep, falling 
asleep (operant) is emitted so as to produce sleep (reinforcement) and stimuli 
associated with sleep become discriminative stimuli for the occurrence of sleep 
(Bootzin and Nicassio, 1978). Stimuli associated with sleep can be temporal (i. e. 
bedtime) and/ or environmental (i. e. bedroom). 
Fig 2 -Operant Analysis of Sleep 
Stimuli signalling reinforcement , 
Operant Reinforcer 
Bed 
Pillow 
Brushing teeth Falling asleep 
p, Sleep 
In normal sleet) stimuli such as one's bed are associated to sleep 
As shown in figure 2, this model proposes that in normal sleep the bedroom 
environment provides stimuli signalling sleep and such stimuli elicit falling asleep. 
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Bootzin and colleagues proposed that in the case of insomnia the discriminative 
stimuli for sleep are not established (e. g. lack of association sleep-bedroom) or 
stimuli for activities that are not compatible with sleep (e. g. television) are present. 
Situational triggers (sleep-preventing activities such as watching TV, reading, 
problem solving and bed aversion) may elicit arousal responses by becoming a cue 
for wakefulness or by failing to predict sleep. Espie (2002) suggested that poor 
stimulus control can inhibit bedtime de-arousal responses that in turn disrupt both the 
homeostatic sleep drive and the wakefulness-sleep circadian cycle. 
Evidence for this model is provided by the success of the therapy intervention 
(section 1.7.2) derived by the stimulus control analysis of insomnia rather than by 
testing directly the conditioning aspects theorised to be responsible for insomnia. As 
critically presented in sections 1.6.2 and 1.7.2, many studies found that stimulus 
control therapy for insomnia markedly decreased SOL and WASO by 50 to 80% as 
compared to pre-treatment values and this findings have been taken as evidence for 
the plausibility of this model. Notwithstanding its efficacy, the mechanisms by which 
stimulus control achieves its effects are unclear and it cannot be ruled out that the 
therapy works for reasons other than re-establishing stimulus control. This point has 
been emphasised by Salkovskis (2002) who argued that treatment evidence does not 
shed light on the underlying mechanisms of effect. Indeed, as already discussed in 
the previous section, only a few studies have investigated pre-bed activities in normal 
and poor sleepers and no differences have been observed. Contrary to conventional 
wisdom (ICSD-R), it has, recently, been reported that people with insomnia sleep 
worse when they are away from home and it has been argued that this finding runs 
contrary to the hypothesis of conditioning to the bedroom environment (Vallieres, 
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Belanger, Bastien, Espie, Morin, 2005). However, it could also be argued that, in the 
case of insomnia, falling asleep is not under the stimulus control of any bedroom 
environment (either one's own or a hotel room), which coupled to other factors (e. g. 
drinking more, uncomfortable mattress) increases the sleep problem. It could also be 
that any bedroom environment sustains wakefulness, rather than falling asleep, in 
people with insomnia. 
This model explains how insomnia is maintained and exacerbated but it lacks 
explanatory power with regards to the emergence of insomnia. The Spielman model, 
to which attention is now turned, while emphasising conditioning as the main factor 
maintaining insomnia, attempts to explain the emergence of insomnia. 
1.4.2.2 The Three Factor Model of Insomnia (Spielman, Caruso, and Glovinsky 
198_7 
Departing from an exclusively environmental/behavioural framework Spielman, 
Caruso and Glovinsky (1987) proposed a stress diathesis model of insomnia with an 
additional behavioural component. In brief, this model hypothesises that insomnia 
occurs acutely in relation to both trait and state (predisposing and precipitating) 
factors. In its early stages maintaining factors are developed and if not extinguished 
such maintaining factors will give rise to chronic insomnia. 
Figure 3 shows the factors responsible for the emergence, exacerbation and 
maintenance of insomnia over time. The individual may be predisposed to develop 
insomnia due to trait characteristics such as personality characteristics, physiological 
arousal (Perlis, Giles, Mendelson and Bootzin, 1997; Kales and Kales, 1984; 
Stepanski, 2000) and genetic predisposition (Bastien and Morin, 2000). However, 
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precipitating events (e. g. situational stress, bereavement, pain) need to occur for the 
individual to experience acute insomnia, and factors adopted in an attempt to cope 
with insomnia symptoms (e. g. napping, extending the sleep opportunity window) are 
proposed to play a major role in chronic insomnia. 
Fig. 3- The Three Factor Model of Insomnia (Spielman et al, 1987) 
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Similarly to the stimulus control model, the three factor model is hased on operant 
conditioning and does not take into account the possibility that classical conditioning 
plays a role in the maintenance of insomnia. 
As already mentioned, both the stimulus control and the three factor models derive 
evidence from the efficacy of behavioural treatment of insomnia. However, their 
central tenets have never been tested empirically. 
Neither of these models of insomnia nor the behavioural perspective in general, 
take cognition into consideration, yet a common complaint of people with insomnia 
is that of 'an overactive mind' during the night. Attention is, therefore. now turned to 
a perspective addressing this reported feature of insomnia. 
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13 Perpetuating 
1.4.3 Cognitive Perspective on Insomnia 
According to the cognitive perspective of insomnia cognitive and/or emotional 
hyperarousal predisposes, precipitates and maintains insomnia. In brief, mental 
alertness (e. g. thinking, planning) may interfere with sleep and, sleeping difficulties 
can become a source of cognition with consequent effects upon self-perception: the 
individual ruminates about not sleeping and its consequences. Cognitive arousal, 
therefore, can manifest itself not only in the form of planning/thinking at night but 
also in the form of rumination, the individual's beliefs about their insomnia and/or 
the attribution of negative daytime events to insomnia (Espie, 1991; Harvey, 2002a, 
Morin, 1993). This preoccupation with sleep becomes a source of cognitive arousal 
and consequently exacerbates insomnia in a continuous negative loop where faulty 
cognitions about sleep (e. g. amount of sleep needed, effects of sleep loss) fuel worry 
and worry jeopardises sleep (Espie, 2002; Morin, 1993). 
Research findings lend support to this perspective: people with insomnia were 
found to complain of cognitive arousal (e. g. inability to `switch off their mind') more 
than of physiological arousal (Nicassio, Mendlowitz, Fussel and Petras, 1985) and of 
higher levels of presleep rumination as compared to normal sleepers (Espie, Brooks 
and Lindsay, 1989; Harvey, 2000c; Lichstein and Rosenthal, 1980). For example 
Lichstein and Rosenthal (1980) found that 55% of their 296 people with insomnia 
sample, regarded their sleep problems as arising from cognitive arousal and only 5% 
as arising from somatic arousal. Espie and collaborators found that two thirds (42 
people) of their sample regarded cognitive intrusion as an important source of their 
sleep problems (Espie, Lindsay, Brooks, Hood and Turvey, 1989). These findings 
have been replicated by Harvey (2000b). Nicassio et al (1985) found, in their sample 
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comprising both college students and adults with sleep problems, that the correlation 
between pre-sleep cognitive arousal and sleep onset latencies was higher than that 
with pre-sleep somatic arousal. However, Sanavio (1988) found hardly any 
correlation (0.09) between measures of pre-sleep cognitions and self-reported SOL. 
It is noteworthy that poor sleepers' cognitive activity at bedtime is generally 
emotionally-laden: poor sleepers typically report more negative thoughts regarding 
their sleep and its impact on their lives than controls (e. g. Espie, 1991; Edinger, Fins 
et al, 2000; Kuisk, Bertelson and Walsh, 1989). Bedtime is a period during which 
competing external stimulation is minimal and it is not, therefore, surprising that it 
becomes the time for focusing upon problems. It has been proposed (Kales and 
Kales, 1984) that people with insomnia internalise stress during the day which then 
re-emerges at sleep time. Indeed, Nelson and Harvey (2003) explored the amount 
(employing a press-holder counter device) and content of pre-sleep imagery and 
found that poor sleepers, as compared to normal sleepers, reported fewer images. 
However, unlike those of normal sleepers, such images were unpleasant (and related 
to topics such as intimate relationships and sleep); furthermore, SOL and amount of 
negative images were positively correlated. 
In addition, research findings, employing self-report questionnaires (e. g. Edinger 
et al, 2000; Harvey, 2000b; Morin, 1993) or audiotape recordings of pre-sleep 
thoughts (Wicklow and Espie, 2000) suggest that insomniacs hold greater 
dysfunctional beliefs and attitudes about sleep than normal sleepers (e. g. `I need 8 
hours of sleep to function well the next day'). Indeed people with insomnia 
experience anxiety about being able to sleep (sleep performance anxiety): they try to 
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control the `deviant' performance via coping efforts which might actually have the 
opposite effect of increasing SOL and WASO. 
Another line of evidence for a cognitive model has been provided by studies 
where emotional and cognitive arousals have been manipulated (DeValck, Cluydts 
and Pirrera, 2004; Gross and Borkovec, 1982). For example, Gross and Borkovec 
(1982) found that individuals who were told they had to give a speech (manipulation 
of sleep cognition) had nap onset latencies almost twice as long than those who were 
not told so. In contrast, however, Haynes, Adams and Franzen (1981) found that a 
pre-sleep arithmetic mental task shortened SOL in people with insomnia. Although 
this finding suggests that mentation does not impact on sleep, it can also be argued 
that the fairly simple task employed by Haynes and colleagues inhibited self- 
generated and emotionally-laden mental activity, hence enabling cognitive de- 
arousal. 
Cognition and affect, therefore, seem to interact in insomnia and it is possible that 
failure to find associations between sleep and cognitive arousal in some studies may 
have depended on the type of cognitions (and whether they were affect-laden) under 
examination. 
It is important to consider that reinforcement contingencies are not always 
negative: thinking and planning can be enjoyable and valued by the individual and if 
this is the case avoiding mentation in bed might be difficult. In addition a distinction 
between difficulty sleeping because of thinking and thinking because of wakefulness 
must be made: taking into account that research has not always found an association 
between sleep latency and cognitive alertness it has been suggested that cognitive 
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arousal may be epiphenomenal to wakefulness (Espie, 1991; Morin, 1993, Perlis, 
Giles, Mendelson, Bootzin and Wyatt, 1997). 
Nevertheless a sizeable amount of evidence for cognitive arousal in insomnia has 
been gathered and it should be noted that this perspective, as compared to the 
physiological and behavioural ones, has provoked a lot of research, most probably 
fuelled by patients' reports of `a racing mind' and the popularity of cognitive theories 
and therapies for psychopathologies and psychological distress in general. 
In the next section a cognitive model of insomnia that acknowledges and gives 
equal weight to (faulty) cognition both at night and during the day is presented. 
1.4.3.1 Cognitive Model of the Maintenance of Insomnia (Harvey. 2002a) 
Harvey's (2002a) cognitive model of insomnia draws on contemporary 
experimental cognitive approaches to psychopathologies in general and anxiety 
disorder in particular. This model argues that selective attention and the processes 
hindering the automatic corrections of distortion of perception typically seen in 
anxiety disorders maintain insomnia. 
According to this model (depicted in figure 4) insomnia is fuelled by worry and 
rumination about sleep and the daytime consequences of little sleep. This negatively 
valenced cognitive activity triggers autonomic arousal. The `fight or flight' state 
produces selective attention towards threat-cues related to the initiation of sleep and 
the individual monitors body sensations and environmental stimuli (Neitzer-Semler 
and Harvey, 2004). In turn, monitoring internal and external events that could disrupt 
sleep increases both cognitive and physiologic arousal so that the individual is more 
likely to find evidence of arousal, which reinforces monitoring behaviour. In 
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addition, selective attention and monitoring the consequences of poor sleep can lead 
to detecting daytime deficits and to distorted perception of the causes of such 
deficits. This process ultimately leads to the endorsement of counterproductive safety 
behaviour (e. g. avoiding demanding work and social activities), which. in turn. 
increases worry regarding lack of sleep (Harvey, 2002a). 
Fig. 4- Cognitive Model of the Maintenance of Insomnia (Harvey, 2(N)2a) 
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A key point of this model is that insomnia is maintained by cognitive processes 
and not by deficits in the sleep/wake cycle. This model makes a novel cont 1-1 hilt ion to 
the cognitive perspective in that it introduces the concepts of selective attention, 
distorted perception and safety behaviours and, very importantly it places equal 
weight upon cognitive activity at night and during the day. 
Research findings supporting the concept of negatively toned cognitive activity at 
bedtime has been reviewed in the preceding section and lends support to this model. 
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With regard to selective attention to the environment, Harvey and Schmidt (2000) 
found that clock monitoring increased SOL in both normal and poor sleepers. While 
this finding is evidence that looking at the clock impacts negatively on SOL, it does 
not `prove' that clock monitoring is a typical behaviour engaged by people with 
insomnia. From a conditioning perspective, on the other hand, it could be argued that 
clock monitoring is a sleep-incompatible behaviour hence not eliciting falling asleep. 
More recently Neitzer-Semler and Harvey (2004) found that people with insomnia, 
as compared to normal sleepers, reported more monitoring for sleep related threat- 
cues, negative thinking and the endorsement of safety behaviours. 
Although clinicians and sleep researchers alike have experience of people with 
insomnia reporting `shying away' from "demanding and social" activities because 
they think they will not be able to cope due to lack of sleep, a systematic 
investigation of such social avoidance has yet to come. Nonetheless this is an 
important issue because research have highlighted that maintaining appropriate levels 
of physical activities (e. g. recreation, domestic maintenance, walking) affords 
protection against insomnia (Morgan, 2003). 
This model has implications for insomnia therapy: instead of focusing directly on 
increasing amount of sleep and decreasing SOL and WASO, therapy should aim at i) 
decreasing selective attention and monitoring for sleep related threat cues; ii) 
correcting distorted perceptions about lack of sleep and its consequences and iii) 
eliminating the endorsement of safety behaviours. 
None of the models discussed in the previous sections stand alone as a 
comprehensive theoretical model of the emergence, exacerbation and maintenance of 
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insomnia: each explains part of the empirical findings regarding physiological, 
behavioural and cognitive relation with insomnia. These frameworks are obviously 
not mutually exclusive and, as the next section highlights, some sleep scholars have 
proposed models of insomnia integrating the physiological, environmental and 
cognitive perspectives. 
1.4.4 Integrative Models of Insomnia 
Several integrative models of insomnia have been put forward over the past 
decades and furthered insight into factors likely to be implicated in the maintenance 
and exacerbation of insomnia. In this section, however, only four integrative models 
will be critically appraised. Kales and Kales' (1984) model has been selected because 
it incorporates psychodynamic concepts and explicitly points out secondary gains 
which may hinder the person's desire to overcome insomnia. Morin's (1993) model 
takes into account individual and environmental factors and argues that the 
consequences of insomnia can become the cause in a bi-directional loop. Perlis et 
al's (1997) model introduces the concept of classical conditioning in insomnia and 
provides a rationale of how this can activate cortical arousal producing enhanced 
sensory and information processing in the quiet hours of sleep. Espie's (2002) model 
stands out because, differently from the general consensus that insomnia is linked to 
hyperarousal, it proposes that mechanisms inhibiting de-arousal are responsible for 
the inability to fall asleep. 
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1.4.4.1 Insomnia as a Psychobehavioural Disorder (Kales and Kales. 1984) 
Kales and Kales (1984), building on their experience of evaluating and treating 
individuals with insomnia, proposed that insomnia is a psychobehavioural disorder 
(characterised by excessive somatic symptomatology despite being functional in 
nature) and as such it is best understood by using the biopsychosocial model of 
illness. Similarly to other psychobehavioural disorders, insomnia affects and is 
affected by a number of facets of the person's life: personality factors, the illness 
itself, the family, the physician-patient interaction and society. 
Supported by research evidence and strongly rooted in psychodynamic theories, 
Kales and Kales proposed that a tendency to internalise emotions and to have certain 
vulnerabilities rooted in childhood (i. e. emotional deprivation in childhood leading 
them to a feeling of inadequacy, insecurity and dependency in adulthood) can cause 
the emergence and maintenance of insomnia. It is therefore understandable that the 
insomniac may develop feelings of entitlement and expect to be nurtured and cared 
for by others (Healy, Kales, Monroe et al, 1981 as cited in Kales and Kales, 1984; 
Coursey, Buchsbaum and Frankel, 1975; Kales, Kales and Bixler, 1976). 
In other words the internalisation of psychological conflicts is a source of chronic 
emotional arousal, which produces physiological activation, which in turn causes 
insomnia. In support of their model, Kales and Kales (1984) cited two studies 
involving more than 500 participants employing the Minnesota Multiphasic 
Personality Inventory. It was found that the predominant personality characteristic of 
people with insomnia, as compared to controls, was a strong tendency to internalise 
psychological conflicts rather then to express them openly. It can be argued that 
internalisation of conflicts gives rise to constant worry and frustration and, 
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interestingly, people with insomnia scored higher than normal sleepers in personality 
factors related to trait worry (Dorsey and Bootzin, 1997). In addition, Kales and 
Kales (1984) proposed that the initial sleep difficulty can give rise to a fear of 
sleeplessness as well as an expectation of poor sleep, both contributing to further 
emotional and psychological arousal and consequently maintenance and exacerbation 
of insomnia. 
An important point often overlooked is that insomnia symptoms can generate 
secondary gains such as sympathy and attention (Kales et al, 1976). The social 
environment may contribute to the persistence of insomnia by providing benefits that 
hinder willingness to rehabilitation. In this way, insomnia itself may have a 
reinforcing effect by offering the individual a way to manipulate their environment 
and avoid unwanted aspects of daily life. 
1.4.4.2 An Integrative Model of Insomnia (Morin. 1993) 
In 1993 Morin, putting together research findings and clinical experience, 
proposed an integrative model of insomnia based on social learning theory, in 
particular the stimulus-organism-response-consequence model (see Haynes and 
O'Brien, 1990). Morin (1993) reasoned that the main mediating feature of insomnia 
must be hyperarousal because arousal regulates the balance between wakefulness and 
sleep and excessive arousal is incompatible with sleep. Depending on the individual, 
hyperarousal can manifest itself in the motoric, cognitive-affective and /or 
physiological (both central and/or autonomic systems) domains. 
In addition sleeplessness can exacerbate hyperarousal in a vicious loop. A variety 
of stimulus conditions (e. g. associations about bedtime routines and worry about not 
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being able of falling asleep) can elevate arousal above a critical threshold and 
interrupt the natural sequence of relaxation, drowsiness and falling asleep. Morin 
suggested that people prone to insomnia might be more prone to conditioning. As 
proposed in section 1.4.2, people with insomnia might display a biological 
preparedness to learn certain associations but this hypothesis has not been 
empirically tested. Furthermore events during the day may influence the inability to 
sleep: internalisation of psychological conflicts, as proposed by Kales and Kales in 
1984, may fuel arousal at bedtime and strengthen the underlying conditioning 
process. 
Typical responses to sleeplessness include worry over sleep loss, rumination 
about daytime events, muscle tension and restlessness. In addition the person tries 
harder to fall asleep which increases performance anxiety. Next day consequences 
(perceived or real) involve fatigue, mood disturbances and performance impairments 
and these, in turns, fuels the memory of the bad night and can, over time, produce a 
sense of helplessness. In order to cope with insomnia people develop maladaptive 
behaviours such as napping which, while temporarily minimising sleep loss, 
overtime interfere with the synchronising effect of regular sleep-wake rhythm. 
Similarly to the three factor model (Spielman et al, 1987), Morin's (1993) model 
proposes that chronic insomnia is generally preceded by situational insomnia, 
brought on by stressful life events, that failed to improve once stressors disappeared. 
This model highlights that the consequences of insomnia can become the causes 
and vice-versa: there is a bi-directional influence among these controlling variables 
(figure 5). This is a strength of Morin's model in that it has explanatory power of the 
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persistence of insomnia complaints and of the fact that insomnia is unlikely to remit 
spontaneously. 
Fig. 5- An Integrative Model of Insomnia (Morin, 1993) 
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There is evidence (albeit not unequivocal) for the components of this model. In 
previous sections evidence for cognitive, emotional and physiological arousal in 
insomnia have been discussed and causality has been questioned. The hypothesis that 
people with insomnia, as compared to controls, endorse dysfunctional cognitions 
regarding sleep and consequences of lack of sleep has been evaluated and many 
examples of research findings supporting this hypothesis have been provided. It has 
also been pointed out that there is scarce direct testing of the hypothesis that people 
with insomnia endorse more maladaptive behaviour than normal sleepers. Finally, 
although most insomnia patients complain of daily deficits (Morin and Espie, 2003) 
objective evaluation of daily functioning has found only mild impairments (Riedel 
and Lichstein, 2000). 
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Morin points out that this theoretical framework has several implications for the 
management of chronic insomnia. First, learned behavioural and cognitive responses 
play a major role in maintaining insomnia, thus, treatment should focus on 
maladaptive sleep habits and dysfunctional sleep cognitions. Given that teaching to 
control sleep might exacerbate performance anxiety and, consequently, ability to 
sleep, this model posits training people with insomnia to control temporal, 
contextual, behavioural and cognitive factors that facilitate sleep rather than to 
control sleep itself. 
1.4.4.3 The NeurocoQnitive Model of Insomnia (Perlis et al. 1997) 
The neurocognitive model (Perlis et al, 1997) can be viewed as an extension of 
the behavioural model proposed by Spielman et al (1987). As illustrated in figure 6, 
this model acknowledges that cognitive factors might be mediating the occurrence 
and severity of insomnia in its acute phase and that cognitive activity might extend 
wakefulness. However, it argues that chronic insomnia is a `reversible' central 
nervous system disorder due to operant and classical conditioning (Perlis, Smith and 
Pegeon, 2005) and that dysfunctional beliefs and worry are epiphenomena to (that is 
a by-product of) insomnia rather than a cause of insomnia. As discussed previously 
this possibility has been raised by other researchers (e. g. Morin, 1993, Espie, 2002). 
Perlis and colleagues reasoned that wakefulness in bed might elicit arousal and 
that the continuing pairing of bed environment and wakefulness might be classically 
conditioning the individual to be aroused by the bedroom itself. Such conditioned 
arousal might perpetuate insomnia even when sleep incompatible or maladaptive 
behaviours (e. g. watching TV in bed, staying in bed for long periods) are removed. 
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Fig. 6: The Neurocognitive Model of Insomnia (Perlis et al, 1997) 
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The neurocognitive model took its lead from previous work (e. g. Mendelson et al, 
1986) on the perception of being awake while actually being asleep according to 
EEG sleep staging. It argues that cortical arousal is the result of classical 
conditioning and it is observable in people with primary insomnia as a high- 
frequency EEG activity (such as Beta activity, 14-45 Hertz) prior to falling asleep 
and during NREM sleep. Beta activity allows for higher levels of sensory and 
information processing making the individual more sensitive to environmental 
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stimuli. Being more sensitive to stimuli interferes with the ability to `let go of the 
surrounding' and initiate sleep and can, hence, explain longer SOL. 
Likewise increased information processing during PSG-defined sleep is proposed 
to interfere with the person's ability to distinguish sleep from wakefulness and, 
therefore, can help in explaining the individual's complaint of hardly having slept all 
night despite PSG evidence of sleep. 
Fast EEG activity studies lend support to this model. Indeed, studies have shown 
that Beta EEG is elevated in people with insomnia as compared to normal sleepers 
(Freedman, 1986; Lamarche and Ogilvie, 1997; Merica et al, 1998; Merica and 
Gaillard, 1992; Perlis, Smith, Orff et al, 2001), it is positively associated with sleep 
state misperception (degree of discrepancy between subjective and objective 
measures of sleep) (Mercer et al, 2002), and varies with successful CBT treatment 
for insomnia (Krystal, Edinger, Wohlgemuth and Marsh, 2002). In addition Beta 
activity has been found to be negatively associated to perception of sleep quality 
(Hall, Buysse, Nowell, Nofzinger, Houck et al, 2000; Nofzinger, Price, Metzer, 
Buysse, Villemagne et al, 2000; Perlis, Merica et al, 2001). It is important to note 
that the evidence that increased high frequency activity appeared to be in the Beta 
and Gamma bands of the EEG suggests that the primary source potential for the 
signal is EEG (i. e. cortical arousal), rather than EMG (i. e. somatic arousal) which 
supports the suggestion that cortical and somatic arousals are distinct phenomena. 
Although the findings from these studies reveal cortical arousal the possibility that it 
is a consequence of cognitive arousal (e. g. being more alert because of scanning the 
environment for events threatening sleep) rather than being classically conditioned 
cannot be ruled out. 
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1.4.4.4 Psychobiological Inhibition Model of Insomnia (Espie. 2002) 
The models of insomnia discussed in the previous sections focus on hyperarousal. 
Espie (2002), by contrast, proposed that insomnia is associated to the individual's 
inability to de-arouse. His psychobiological inhibition model examined insomnia 
from a different angle than the one traditionally taken. Rather than considering 
insomnia as the result of hyperarousal and its sleep inhibiting effects (inhibition of 
the `falling asleep' system), Espie conceptualised insomnia as the malfunction of 
mechanisms and processes inhibiting wakefulness (inhibition of the 'wake-off' 
system). According to this model, and typical of neurobiological systems, good sleep 
is the natural state for the individual with both functional plasticity (accommodating 
night-to-night variations) and automaticity. Espie (2002) proposed automaticity of 
`sleep homeostasis' and `circadian timing' (for details see Dijk and Czeisler, 1995) to 
be the controlling feature of good sleep. Importantly, the concept of automaticity 
encapsulates the idea that good sleep is a `passive' state that does not require effort. 
As depicted in figure 7, good sleep is maintained by four interacting components: 
sleep-stimulus control, physiological de-arousal, cognitive de-arousal and daytime 
facilitation. In normal sleep both physiological and mental cues of sleep readiness are 
accurately interpreted and cues in the home environment reinforce cognitive and 
physiological de-arousal so that the individual enters sleep effortlessly. In insomnia, 
instead, cognitive phenomena (preoccupation with sleep, intention to sleep and effort 
to sleep) inhibit such de-arousal processes and make sleep difficult both at the 
beginning and during the night (for a formal conceptualisation of the attention- 
intention-effort pathway to insomnia see Espie, Broomfield, MacMahon, Macphee 
and Taylor; 2006). 
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This model helps explain the transition from acute to chronic insomnia: attempts 
to re-gain normal sleep (e. g. focussing on ways to sleep well, going to tied earlier if 
the night before was bad) are likely to give rise to homeostatic dysregulation, 
circadian timing problems and conditioned arousal. 
Perlis et al (2005) pointed out that considering hyper-arousal and de-arousal as 
two separate concepts enables us to define insomnia more clearly and to search for 
its neurobiological basis. In addition such differentiation permits to better understand 
mechanisms of effect in insomnia treatment programmes. Empirical research on the 
distinction of these two concepts is, therefore, warranted. 
This model suggests that the efficacy of multicomponent cognitive-behavioural 
therapies (CBT) (outlined and discussed in the next session) may rely on the de- 
activation of inhibitory mechanisms of de arousal. Sleep hygiene might remove some 
potential inhibitors of physiological de-arousal. Sleep scheduling (temporal 
instruction of stimulus control therapy and sleep restriction), re-adjusts the balance 
between the homeostatic sleep drive and the biological clock. and might also de- 
activate inhibition processes of cognitive de-arousal. In other words, when falling 
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asleep is difficult, giving up trying to sleep enables to decrease mental effort and 
consequently to fall asleep. Performing an activity rather than lying in bed awake is 
likely to shift cognition from sleep related concerns to the activity itself. Relaxation 
techniques are likely to facilitate both cognitive and physiological de-arousal. 
Addressing, challenging, and substituting dysfunctional sleep related thoughts is 
likely to decrease worry about not sleeping and its consequences permitting cognitive 
de-arousal. 
The theoretical concepts and related evidence for the development. maintenance 
and exacerbation of insomnia inform insomnia therapy to which attention is now 
turned. 
1.5 Therapeutic Approaches to the Treatment of Insomnia 
In this section the principal therapies for insomnia (table 4), informed hý one or 
the integration of the perspectives discussed in the preceding section, are briefly 
outlined. 
Table 4- Insomnia Therapy according to Underlying Perspective 
Therapy Perspectives: Physiological Behavioural Cognitive 
Pharmacotherapy 
Sleep Hygiene v tý 
Progressive Muscle Relaxation v 
Diaphragmatic Breathing V 
Biofeedback Assisted Relaxation V 
Stimulus Control v 
Sleep Restriction V 
Paradoxical Intention V 
Imagery v 
Suppression v 
Cognitive Restructuring 
CBT vVv 
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Given that the experiments devised and carried out in the present research relate 
to stimulus control therapy, in addition to being presented here, stimulus control is 
explained in details and critically appraised in subsequent sections. 
1.5.1 Treatments Related to the Physiological Perspective 
1.5.1.1 Pharmacotherapy 
Pharmacotherapy derives from the physiological perspective and it is the most 
popular approach for treating insomnia patients in primary care (Dement, 1994 as 
cited in Edinger and Wohlgemuth, 1999). It is noteworthy that Greater Glasgow 
remains amongst the highest prescribing areas in Scotland per head of weighted 
population during 1999 according to ISD Primary Care Unit statistics. Although 
pharmacotherapy has been shown to produce short-term sleep improvements, there is 
little evidence of its long-term efficacy (Kramer, 2000) and prolonged use of 
hypnotics is not recommended due to risks of dependence, sedative side effects, 
misuse and associated morbidity (Russell and Lader, 1992). 
Perlis, Pigeon and Riemann (2006, submitted) summarised the findings of four 
meta-analyses on the use of pharmacotherapy (hypnotics and off label treatment with 
sedating antidepressant) and concluded that there is no firm evidence of the efficacy 
of pharmacotherapy for the treatment of persistent insomnia. Furthermore, they 
warned that, in the elderly, treatment benefits are outweighed by the risks. Their 
summary is in agreement with the NIH Statement produced in 2005 regarding 
treatment of insomnia (National Institute of Health, 2005). 
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Kripke (2000) argued that prescription should be limited to short courses and 
substituted by cognitive behavioural treatment (CBT). Indeed, more recently NICE 
(2004) recommended GPs to consider non-medicine as the first line of insomnia 
treatment and to prescribe hypnotic drugs only in the most severe cases of insomnia 
and only for short periods. Importantly, a pragmatic randomised controlled trial 
evidenced the efficacy and cost effectiveness of CBT for insomnia (CBT-I) in 
primary care patients presenting with a history of long term hypnotic drug use 
(Morgan, Dixon, Mathers, Thompson and Tomeny, 2003). Similarly to Morin, 
Colecchi, Ling, and Sood's (1995) results, Morgan et al's (2003) study showed that 
CBT-I facilitated hypnotic drug use decrease. Another important finding of Morgan 
et al's (2003) study was that following CBT-I, participants' sleep and quality of life 
were improved as compared to participants who continued with their usual treatment 
(i. e. hypnotic drugs). 
Given that research findings and guidelines suggest that pharmacotherapy for 
persistent insomnia is not the best line of treatment (Kramer, 2000), it is not 
surprising that a variety of behavioural and cognitive therapies for insomnia have 
been devised. 
1.5.1.2 Sleep Hygiene 
Sleep hygiene is typically regarded as a behavioural strategy which, being 
educational in nature, sits well within a cognitive framework. Nonetheless, its aim is 
to ensure that agents heightening physiological arousal are avoided in the hours 
before bedtime and during sleep. In fact, sleep hygiene most often involves providing 
the patient with a list of behaviour (e. g. ingesting too much caffeine, smoking, 
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alcohol consumption) that may influence sleep quantity and quality. Although sleep 
hygiene is very popular, research findings evidenced that it is not efficacious as a 
standalone insomnia treatment (Morin, Culbert and Schwartz, 1994). 
1.5.1.3 Relaxation 
A number of relaxation techniques have been devised, each targeting a particular 
physiological system. The rationale being that a person with physiological arousal 
will find it difficult to fall asleep, hence if relaxation is induced sleep will follow. For 
example `progressive muscle relaxation' aims at decreasing muscle tension (Haynes, 
Woodward, Moran and Alexander, 1974). Diaphragmatic breathing aims at moving 
the patient from thorax to abdomen breathing (i. e. deeper and slower). Biofeedback 
assisted relaxation aims at inducing muscle relaxation by frontalis EMG biofeedback 
(see Bootzin and Nicassio, 1978 for a review). It should be noted that the efficacy of 
relaxation in improving sleep does not lend support, per se, to the physiological 
framework. Indeed research found that sleep improvements following relaxation 
were not coupled to post treatment changes on physiological measures (e. g. heart 
rate, respiration) (Hauri, 1981; Borkovec, Grayson, O'Brien, Weerts, 1979). 
1.5.2 Treatments related to the behavioural perspective 
1.5.2.1 Sleep restriction 
As discussed previously, poor sleepers tend to extend the sleep window 
opportunity (going to bed earlier and staying in bed longer, especially if the night 
before was a bad night) in an effort to provide more opportunity to sleep: this 
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strategy, however, is likely to result in fragmented and poor quality sleep. Spielman 
and colleagues (1987), drawing on the idea that homeostatic sleep drive and accurate 
circadian timing regulate sleep and that the individual's coping strategies disrupt 
these process, devised a therapy named 'sleep restriction'. 
Sleep restriction aims at increasing S. E. by restricting the amount of time spent in 
bed (so as to approximate it to the actual time spent asleep) and at regularising sleep 
patterns by going to bed and getting up at the same time each day. Once S. E. is 
improved (i. e. S. E. >_85%) the time in bed is extended by 15 minutes per night per 
week until the patient's S. E. starts to decline again. Morin (2005) proposed that sleep 
restriction improves sleep continuity due to a mild sleep deprivation and a reduction 
of sleep performance anxiety. Morin et al's (1994) meta-analysis found sleep 
restriction to improve both SOL and WASO. 
1.5.2.2 Stimulus Control Therapy for Insomnia 
By applying the conditioning conceptualisation of insomnia already discussed 
(section 1.4.2.1) a stimulus control therapy for insomnia was devised (Bootzin, 1972; 
Bootzin and Nicassio, 1978). Given that stimulus control is the most efficacious 
single therapy for insomnia, and the present research focus on one of its elements, 
the stimulus control treatment and associated efficacy studies are discussed in details 
in section 1.7. In brief the stimulus control package aims at bringing the act of 
falling asleep quickly under the stimulus control of the bedroom environment by 
training the person with insomnia to re-associate temporal (bedtime) and 
environmental (bedroom) cues for sleep with rapid sleep onset. 
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Before turning attention to cognitive therapies for insomnia it should be noted that 
sleep restriction and stimulus control are most often used together: for example, 
Espie and colleagues call this combination `sleep scheduling' (e. g. Espie, Inglis, 
Tessier and Harvey, 2001) in their CBT intervention. 
1.5.3 Cognitive Treatments for Insomnia 
As discussed in previous sections there is ample evidence that individuals with 
insomnia report heightened cognitive arousal at bedtime. The basic premise of 
cognitive therapy is that appraisal of sleeplessness can trigger negative cognitions, 
emotions and beliefs about lack of sleep and its consequences that are incompatible 
with sleep. A number of cognitive treatments for insomnia aiming to produce sleep 
by altering faulty beliefs and attitudes about sleep have been devised. For example 
`paradoxical intention' aims at increasing the chance of falling asleep quickly by 
obviating the performance anxiety that develops because of trying to control sleep. It 
directs the individual to try at any cost not to fall asleep: it is a "let it be attitude" and 
it is the only cognitive technique that does not directly try to decrease cognitive 
activity. `Imagery', in contrast, attempts to distract the individual from thinking 
about sleep related topics. `Suppression' aims at blocking out the thought content 
itself. Cognitive restructuring teaches the individual to rationally re-appraise their 
thought contents and to de-catastrophise the consequences of a bad night's sleep. 
These techniques might all be cognitive but they focus upon different solutions to the 
mental problem and represent variants of a cognitive model of insomnia. 
Interestingly, given the amount of research and related theoretical debate regarding 
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the importance of cognition in insomnia, the majority of therapeutic intervention and 
outcome studies are not based solely on cognitive therapy. 
1.5.4 Multifaceted Cognitive Behavioural Therapy 
The different interventions described so far are obviously not incompatible with 
each other. Indeed they can be combined and in recent years treatment packages, 
each including several single therapies for insomnia, have become the standard 
practice (Morin, 2005). Cognitive Behaviour Therapy (CBT) for insomnia typically 
includes stimulus control, sleep restriction, cognitive restructuring and sleep hygiene. 
The CBT package might also include other single therapies such as relaxation, 
paradoxical intention and imagery. 
In sum, a number of psychological therapies for insomnia have been devised and 
in recent years insomnia therapy has typically been delivered in a multicomponent 
package (CBT). Having briefly outlined the principal insomnia therapies it is 
important to turn attention to evidence of treatment efficacy. Meta-analytic reviews 
pertaining to behavioural and psychological therapies for insomnia permit evaluation 
of treatments across studies and to identify therapies standing out as most 
efficacious. 
1.6 Treatment Outcome Evidence 
This section presents a summary of the evidence currently available in support of 
non-pharmacological interventions for insomnia. Findings from meta-analyses are 
summarised and discussed and a brief overview of recent clinical trials is provided 
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taking into account issues of clinical significance and long-term impact. Firstly, 
meta-analytic procedures are briefly explained. 
1.6.1 Meta-Analytic Procedures 
Meta-analytic procedures are an important tool as they permit the systematic 
evaluation of treatment outcome across multiple studies. Statistics such as t tests or F 
tests are not appropriate for such comparisons as the values obtained with these tests 
are partially a function of the sample size. In other words, studies with equivalent 
differences between treatment and control conditions can have very different t and F 
values depending on the sample sizes. In contrast, estimates of effect size provide a 
standard metric for assessing treatment effectiveness across multiple trials because 
they are not influenced by sample sizes. The most common estimate of effect size is 
Cohen's d (Cohen, 1988). Cohen's d is a measure of effect that may be thought of as 
determining how many standard deviations separate the means of two groups. Cohen 
(1988) hesitantly defined an effect size of 0.20 as a small effect, 0.50 as a medium 
effect and 0.80 as a large effect and acknowledged the danger of using terms such as 
`small', `medium' and `large' out of context ("there is a certain risk in offering 
conventional operational definitions for those terms for use in power analysis in as 
diverse a field of inquiry as behavioural science", p. 25). 
1.6.2 Meta-Analytic Findings 
Outcomes of studies evaluating non-pharmacological interventions for insomnia 
have been summarised in six meta-analyses (Irwin, Cole and Nicassio, 2006; Morin 
et al, 1994; Montgomery and Dennis, 2004; Murtagh and Greenwood 1995; Pallesen, 
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Nordhus and Kvale, 1998; Smith, Perlis, Park, Smith, Pennington, et at, 2002). In 
figure 8 the effect sizes reported by each of these meta-analyses are reported. 
Fig: 8- Effect Sizes for Sleep Parameters Obtained with 
Psychological Interventions as reported in 5 Meta-Analyses 
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In 1994, Morin et al reviewed 59 studies (involving more than 2000 participants) 
on the psychological treatment of insomnia so as to assess the size of changes 
occurring with CBT. With regard to SOL the effect size was 0.88 (i. e. on average the 
treated person was 0.88 standard deviation better than the untreated people) and the 
average treated individual was falling asleep faster than 81(/(- of those who did not 
receive treatment. With regard to WASO the effect size was 0.65 and the treated 
person had WASO shorter than 74% of those who did not receive treatment. TST 
effect size was found to be 0.42. The absolute values of improvement rate were 27.7 
minutes for SOL (43% improvement), 32.7 minutes for WASO (46% improvement) 
and 28.5 minutes for TST (8c/c improvement). Only the effects for SO L and WASO 
were statistically significant. The modest improvement in TST might be due to the 
initial impact of stimulus control and sleep restriction. Finally comparison of various 
treatment modalities showed that stimulus control and sleep restriction (although 
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the authors advised to be caution regarding the latter therapy as only a few studies 
were available) were the most effective single therapies for both SOL (improvement 
of 32 minutes) and WASO (improvement of 40 minutes) while sleep hygiene was not 
effective as standalone therapy. 
Murtagh and Greenwood's (1995) meta-analysis evaluated 66 studies (involving 
about 1500 participants) so as to assess the size of changes occurring with CBT on 
three variables: SOL, number of wakenings after sleep onset (NoA) and TST. These 
authors made the decision to include unpublished manuscripts they could get hold of. 
They reasoned that, typically, only studies reporting significance are published and 
this (unwritten) publishing policy might lead to effect sizes being inflated. However, 
they found effect sizes to be similar to those found by Morin et al (1994): 0.87 for 
SOL, 0.63 for NoA and 0.49 for TST. The absolute values of improvement rate were 
24 minutes for SOL (39% improvement), -1.2 for NoA (73% improvement) and 32 
minutes for TST (9% improvement). Stimulus control global effect size was higher 
than that of any other therapy and SOL improvement was 32 minutes. Similarly to 
Morin et al's (1994) meta-analysis findings, stimulus control appeared to provide 
the greatest improvement in general. 
These two meta-analyses also examined follow-up data: the improvements 
obtained were maintained and for certain variables (SOL and TST) changes from 
baseline values actually increased. 
In 1998 Pallesen et al evaluated the outcome of thirteen studies examining the 
effects of CBT-I in the older population. Significant effects were found for SOL 
(effect size was 0.41), NoA (effect size 0.25), WASO (effect size 0.61) and TST 
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(effect size 0.15). The effect sizes were higher at follow-ups. It was, therefore, 
concluded that CBT-I is also indicated in the older population. 
By contrast, Montgomery and Dennis' (2004) summary of outcomes for CBT-I in 
the older population provided by six studies yielded positive results only for WASO 
and TST. They found that CBT had a modest impact on WASO (decrease of 22 
minutes) and on TST (increase of 14.6 minutes) and practically no effect on SOL. 
They concluded that CBT-I is indicated for WASO in the older population. 
In 2006 Irwin and colleagues carried out a further meta-analysis evaluating the 
impact of behavioural interventions for insomnia in older adults. Evaluation of 23 
randomised controlled trials showed significant effects on sleep quality (effect size of 
0.76), SOL (effect size of 0.52) and WASO (effect size of 0.64). Behavioural 
therapies (stimulus control and sleep restriction) effect sizes were found to be in the 
region of 0.91 for sleep quality, 0.59 for SOL and 0.82 for WASO. 
Finally, Smith and colleagues in 2002 published a comparative meta-analysis of 
pharmacotherapy and behavioural therapies for chronic insomnia. With regard to the 
impact of behavioural therapies on sleep the following effect sizes and absolute 
changes were found. The effect size for both SOL and WASO was 1.0, for TST was 
0.46 and for sleep quality rating was 1.44. Behavioural therapies fared better than 
pharmacotherapy for all values but TST. However, this outcome might be due to 
sleep restriction curtailing amount of sleep. Absolute values of improvement rate 
were 23.3 minutes (43% improvement) for SOL, 38.4 minutes (55.9% improvement) 
for WASO, 19.6 minutes (5.9% improvement) for TST and 0.96 (28.4% 
improvement) for sleep quality ratings. 
67 
In sum, the data from these meta-analyses show that cognitive/behavioural 
treatments for insomnia produce reliable and robust changes in a number of sleep 
continuity parameters and that these improvement hold at follow-ups. It is important 
to note that stimulus control was found to produce equivalent (or better) outcomes 
than multicomponent CBT and other single therapies for insomnia. 
1.6.3 Clinical studies 
Clinical trials have evidenced that CBT is clinically effective for persistent 
insomnia presenting in general practice (Espie, Inglis and Harvey, 2001; Morgan, 
Thompson, Dixon, Tomeny and Mathers, 2003), therapeutic gains are maintained at 
follow up and CBT can provide a cost effective alternative to pharmacotherapy in the 
treatment of insomnia (Morgan, Dixon, Mathers, Thompson and Tomeny, 2004). 
Taking into account these findings it is not surprising that Espie (1999) argued that 
cognitive-behavioural treatment therapies might be the treatment of choice for 
chronic primary insomnia rather than pharmacotherapy. 
It is noteworthy that, although the majority of people treated improve their sleep, 
only a small percentage of them (around 25 %) return within the normal sleep 
parameters. The majority still experience some (albeit less severe) sleep problems 
(Espie, Inglis, Tessier and Harvey, 2001; Morin, Colecchi, Stone, Sood and Brink, 
1999). 
1.6.4 Is CBT the Treatment of Choice? 
The meta-analyses and clinical studies discussed above provide convergent 
evidence regarding the efficacy and effectiveness of CBT-I in reducing sleep 
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continuity parameters. A review conducted by the Standards of Practice Committee 
of the AASM (Chesson, Ferber, Fry, Grigg-Damberger, Hartse et al, 1999; Morin, 
Hauri, Espie, Spielman, Buysse and Bootzin, 1999) reached similar conclusions, 
albeit a note of caution was stated because none of the published studies was 
awarded `A level'. `A level' methodology requires a placebo control while non- 
pharmacological studies of insomnia typically have a waiting-list control group. 
Indeed, only a few studies have used attention-placebo conditions (e. g. Lichstein, 
Riedel, Wilson et at, 2001; Backhaus, Hohagen, Voderholzer, Riemann, 2001) while 
majority of clinical trials have used waiting list control groups. Without a placebo 
control it is difficult to attribute, unequivocally, treatment effects to any specific 
elements of the therapy itself (e. g. relaxation, re-conditioning) rather than to factors 
such as the measurement process (e. g. self-monitoring) or factors such as social 
desirability (Crowne and Marlow, 1960), therapist attention or patient's expectation. 
It is noteworthy that stimulus control was the only therapy being warranted a full 
Grade B recommendation. In addition it should be noted that effect sizes for SOL 
and WASO reported for stimulus control have ranged between 0.70 and 1.16 while 
for CBT from 0.92 to 1.05 (Morin et at, 1994; Murtagh et al, 1995) and that best 
outcomes from CBT have been found when stimulus control (and sleep restriction) 
were part of the package. 
1.6.5 Considerations Regarding Treatment Outcome Findings 
To conclude this section the following main points are to be considered. 
First, although CBT has become in recent years the standard non pharmacological 
therapy for insomnia, stimulus control has yielded strong effects as evidenced by the 
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meta-analytic reviews just discussed. Significantly, the Standards of Practice 
Committee of the AASM (1999) recommended stimulus control as the gold standard 
treatment for insomnia. 
Second, despite ample evidence supporting the efficacy of psychological and 
behavioural treatments for insomnia, there is still scarce information regarding the 
specificity of these treatment modalities and the active mechanisms responsible for 
sleep improvements (Morin, Bastien and Savard, 2003). Not surprisingly, given that 
stimulus control for insomnia fared better than other single therapies, one such 
investigation found that the most critical ingredients associated with long-term sleep 
improvements were stimulus control and sleep restriction (Harvey, Inglis and Espie, 
2002). 
It seems, therefore, timely to investigate what the critical components of CBT are 
and, furthermore, what elements of each single therapy are essential. One way to 
carry out such investigation is by a dismantling strategy to isolate individual 
components (Currie, Wilson, Pontefract and deLaplante, 2000). 
An important pitfall in insomnia research is the dose-response curve. While it has 
been amply investigated in pharmacological research this has not been the case with 
regard to psychological treatment. That is, behavioural therapists have generally 
failed to explore what "dose" of CBT is needed to achieve minimally acceptable 
sleep improvement (Edinger and Means, 2005). Lichstein and Riedel (1994), after 
performing a review of treatments of insomnia, pointed out that there appears to be 
wide potential for brief interventions and limited therapist participation. For 
example, Edinger and Sampson (2003) have found that 2 sessions of CBT produced 
significant improvements in insomnia symptoms. More recently, Edinger and 
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colleagues have explored the dose-response effects of behaviour therapy for 
insomnia. They assessed the optimal dose of CBT for treating WASO by 
administering it in 1,2,4 and 8 bi-weekly sessions and found that the 1 and 4 session 
protocols had greater efficacy than the other two conditions. Specifically a 50% 
reduction WASO in 58% of participants was achieved by the 4 session condition, in 
44% of participants by the 1 session condition and only 23% in the 8 session 
condition (Edinger, Wohlgemuth, Radtke and Marsh, 2004). This is a much needed 
and welcomed line of research: it helps in establishing the optimum dose of therapy 
required to achieve a given level of improvement and providing intervention 
guidelines accordingly. 
Whilst significant progress has been made, the field is not, as yet, at a point where 
the patients can be offered a maximally effective psychological treatment. This is 
indicated by the significant percentage (20-30%) of patients who do not improve 
following CBT and by the average overall improvement (see the six meta-analyses 
just reviewed) among those who do respond being only around 40 to 60%. Although 
this degree of change is statistically significant, it is not enough to convincingly 
move the average patient into a state where they could be classified as, and they 
would call themselves, normal sleepers. 
Given these premises it seems very important to examine systematically from first 
principles (almost at a microscopic level) the single components of individual 
therapies that are delivered as part of the multicomponent package CBT-I. This has 
theoretical and more pragmatic values. Testing one element at a time helps to shed 
light on the theoretical underpinning of the therapy (why it works). Likewise 
examining single elements of insomnia packages would enable the extraction of the 
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essential and most therapeutic ingredients and ultimately enable the provision of 
optimum service while containing health costs. 
Stimulus control appears to be a good candidate for a detailed examination of 
single elements. Not only has it been favoured by outcome findings and been 
recommended as the gold standard therapy for insomnia; it is also easy to administer 
and positive outcomes are typically obtained in a few weeks. 
1.7 Stimulus Control: a Detailed Description and Critical Appraisal 
This section is in three parts. First, the six elements comprising stimulus control 
are analysed so as to assess what the theoretical bases underpinning these elements 
are. Second, previous research on stimulus control therapy for insomnia is outlined 
and evaluated. Third, by taking into consideration both theory and research evidence, 
the element of stimulus control therapy deemed to epitomise stimulus control is 
identified. 
1.7.1 Stimulus Control Therapy: its Elements 
As already discussed stimulus control therapy is based on learning theory, in 
particular operant conditioning and stimulus control (section 1.4.2.1). Briefly, 
stimulus control theory holds that in chronic insomnia, sleep incompatible behaviour 
diminishes or extinguishes the discriminative properties for sleep of the bedroom 
environment. 
The aim of therapy, therefore, is for the patient to be in their bed only when asleep 
so that the bedroom environment acquires discriminative properties eliciting the 
physiological response and attitude consistent with a discriminative stimulus. In 
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other words, the bedroom environment (discriminative stimulus) would signal the 
imminence of sleep (reinforcer) and the person should follow asleep quickly 
(operant). Subsequent sleep experiences will reinforce this process. 
It is important to note that stimulus control therapy for insomnia comprises both 
elements of strict stimulus control and elements of temporal harmonisation of the 
sleep-wake schedule. In particular, by inspecting table 5, it becomes apparent that 
instructions 2,3, and 4 are situational in that they aim at ensuring that the bed is used 
only for sleep and that the patient does not spend time in bed awake. The other 
instructions (1,5 and 6) are temporal in nature: they ensure a stable sleep-wake 
rhythm. 
Table 5- Components of the Stimulus Control Therapy for Insomnia 
1. Lie down intending to sleep ONLY when you are sleepy. 
2. Do not use your bed for anything except sleep: that is do not read, watch TV, eat or 
worry in bed. Sexual activity is the only exception to this rule. On such occasion the 
instructions are to be followed afterward, when you intend to sleep. 
3. If you find yourself unable to fall asleep, get up and go to another room. Stay up as long 
as you wish and then return to the bedroom to sleep. Although we do not want you to 
watch the clock, we want you to get out of bed if you do not fall asleep immediately. 
Remember that the goal is to associate your bed with falling asleep quickly. If you are 
in bed more than about 10-15 minutes without falling asleep and have not gotten up, 
you are not following this instruction, 
4. If you still cannot fall asleep, repeat step 3. Do this as often as it is necessary throughout 
the night. 
5. Set your alarm and get up at the same time every morning irrespective of how much 
sleep you got during the night. This will help your body acquire a consistent sleep 
rhythm. 
6. Do not nap during the day. 
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It could be argued that while situational elements sit well within a stimulus 
control framework, temporal elements do not. This suggests that the mechanism of 
effects of at least half of the stimulus control package for insomnia is likely to be due 
to factors other than those of operant learning theory. This reasoning restricts the 
choice of the best candidate to synthesise stimulus control to only two elements: 
`using the bed only for sleeping' (instruction 2) and `getting out of bed if not asleep 
quickly' (instruction 3 and 4). Both instructions aim at the same target: `be in bed 
only when asleep'. In this way the association between bedroom and sleep is created 
and strengthened while associations between bedroom and wakefulness avoided. 
However, it is felt that instruction 2 does not explicitly tell the patient what to do if, 
once intending to sleep, sleep does not come. Instruction 3, by contrast, prescribes 
what to do (i. e. go to another room) if not asleep: in so doing it automatically 
prevents sleep-incompatible activities being performed in bed and ensures that the 
bed is used only for sleeping. The instruction "If you find yourself unable to fall 
asleep, get up and go to another room" can be proposed, therefore, as the element of 
stimulus control that better encapsulates the stimulus control essence. 
It should be noted that instruction 3 requires the person to get out of bed if not 
asleep within 10-15 minutes. However, as pointed out by Espie (1991) this 10-15 
minutes limit is arbitrary. Indeed, in his first application of stimulus control to 
insomnia Bootzin (1972) left this rule vague: `if unable to sleep get up' so as to avoid 
the patient initiating a habit of clock watching. Espie and colleagues (Espie et al, 
1989) used a 20 minutes period for initial sleep latency because in their clinical 
experience only few successfully treated people achieved post-treatment sleep onset 
latency of ten minutes. They argued that ten minutes might be too strict a threshold 
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when compared to the sleep pattern of normal sleepers for whom taking ten minutes 
to fall asleep might not be considered problematic. 
As shown in figure 9, the amount of time lying awake in bed prior to "getting up 
and going to another room" varies from study to study (a few minutes to 25 minutes 
range). 
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Figure: 9- Time frame for the Stimulus Control instruction 
'get up and go to another room' 
A few 10 15-20 20 20-25 20-30 
Minutes 
A few minutes/reasonable time: Bootzin, 1972; Toler, 1978: Norton et al, 1979: Haynes et al, 1975 
10 minutes: Bootzin et al, 1991: Bootzin et al, 2000: Lacks, et al, 1983a: Lacks et al. 19836: 
Puder et al, 1983; Turner et al, 1979ä. b: Zwart et al, 1979: 
15-20 minutes: Bootzin et al, 2000: Morin et al, 1988: Morin et al. 1990: Morin et al. 
1994: Morin, Colecchi et al, 1999: Morin, Hauri et al, 1999. 
20 minutes: Morin et al, 1995: Sanavio et al, 1990: Espie et al, 1989; Espie et al, 1999 
20-25 minutes: Jacob et al, 1993 
20-30 minutes: Hoelscher et al, 1988 
Ultimately the aim of therapy is to move the patient to normalcy: it is, therefore, 
important to explore the length of normal sleepers' SOL so as to determine the 
optimum timeframe for this stimulus control instruction. The average PSG measured 
SOL for normal young adults is around 10 minutes (see table 1 p. 4), but it seems 
important to examine SOL also in terms of sensitivity and specificity so as to 
establish what duration best represents SOL in normal sleep. This issue is addressed 
in the first study of the present research (chapter 3). 
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1.7.2 Stimulus Control Therapy: Outcome Studies 
Bootzin (1972) first used stimulus control in a single case study and within three 
weeks of stimulus control treatment the number of times the patient had to get out of 
his bed at sleep onset were dramatically reduced. Importantly, as depicted in figure 
10, improvement was maintained at six weeks follow up and confirmed by the 
individual's wife. The improvement was very encouraging and warranted more 
systematic and controlled research. 
Fig. 10 - Frequency of nightly rising during treatment and 
follow-up (Bootzin, 1972) 
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Bootzin (1975) (as reported in Bootzin and Nicassio's review, 1978) allocated a 
sample of 66 participants, with severe and persistent insomnia, to: stimulus control, 
relaxation, self-relaxation placebo or waiting list control groups. Participants self- 
reported severe insomnia although the length of insomnia was not stated. Stimulus 
control reduced SOL by 67 minutes, while relaxation reduced it by 30 minutes. In 
addition 57% of those receiving stimulus control averaged less than 25 minutes to 
fall asleep as compared to 29% of those in the relaxation group and 22% of those in 
the two untreated groups. 
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Following these first two insomnia treatment studies employing stimulus control 
many investigations have shown that stimulus control is effective in reducing SOL 
and WASO and increasing TST. 
For example, Haynes et al's (1975) found stimulus control therapy to be 
associated with shorter SOL (average reduction of 40 minutes) in all four single 
cases by the end of treatment. There were also improvements for all four participants 
in terms of TST and feeling rested after sleep, and three of them reported fewer 
wakenings. In addition, in three out of four cases, improvements were maintained at 
a nine-month follow up (telephone contact). In view of previous findings that poor 
and normal sleepers engage in similar sleep-incompatible behaviours in the pre-bed 
period (Haynes, Follingstad and McGowan, 1974), they proposed that stimulus 
control increases sleep continuity by conditioning low levels of physiological arousal 
to bedroom stimuli. Reading, talking working in bed may increase arousal and thus 
make sleep more difficult. It is important to note that their design ABAB (baseline, 
stimulus control, back to baseline, stimulus control) did not show a reversal effect 
after the first treatment phase; it could, however, be argued that rather than a return 
to baseline it represented a maintenance phase. Therefore the re-introduction of 
stimulus control treatment in the following phase was of little experimental value 
(Espie, 1991). 
Lawrence and Tokarz (1976, as reported in Bootzin and Nicassio, 1978) recruited 
a student population with moderate SOL and assigned them to individual stimulus 
control, small group stimulus control, progressive relaxation training or 
desensitisation placebo. Both stimulus control groups reduced mean SOL to less than 
20 minutes and improvement was considerably better than relaxation (75% vs 30% 
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improvement SOL improvement at post-treatment). Unfortunately no follow-up data 
is available. 
Hughes and Hughes (1978) assigned 36 media recruited people with insomnia for 
at least 4 months to one of four groups: stimulus control, relaxation, EMG feedback 
or pseudo-feedback. Two weeks baseline and two weeks post-treatment sleep diary 
were collected. A drawback of this study is that treatment length varied considerably 
from eight weeks for EMG feedback, to four weeks for relaxation and to only two 
weeks for stimulus control. All groups improved and no differences were found in 
efficacy among treatments. Interestingly stimulus control produced SOL 
improvements very rapidly (two weeks). Similarly to other researchers they proposed 
that the equivalence in treatment outcome might be due to a cognitively mediated 
process common to all treatments. Follow-up data suggested that results were 
maintained but, unfortunately, given that data was available for only 33% of 
participants (12 out of 36), it was impossible to differentiate between treatments. 
Turner and Asher's (1979b) treatment study employed a multiple baseline design 
with six severe insomniacs. After one-week baseline, three participants received 
eight weeks of stimulus control and the other three participants four weeks of quasi- 
desensitisation placebo treatment followed by four weeks of stimulus control. The 
placebo treatment had little impact on SOL, while stimulus control reduced SOL in 
both when treatment lasted eight and four weeks. Interestingly the authors reported 
that five out of the six participants achieved SOL shorter than thirty minutes within 
four weeks of stimulus control therapy. The sleep diary data were corroborated by 
reports of spouses or roommates. Turner and Asher also collected participants' 
suggestions regarding stimulus control efficacy. All six individuals suggested that 
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stimulus control worked by "breaking up lying in bed and thinking"; in other words 
it provided a way of controlling bedtime cognitions by simply getting out of bed. 
These comments suggest that stimulus control decreases anxiety regarding 
sleeplessness. 
Turner and Ascher (1979a) devised a well controlled comparative study and 
showed that stimulus control, similarly to progressive muscle relaxation and 
paradoxical intention, improved the sleep of severe insomniacs while control 
conditions (desensitisation placebo and waiting-list) did not. Each group comprised 
ten media recruited participants who received four weekly therapy sessions following 
a baseline week. All three active groups reduced SOL (from more than an hour to 
less than thirty minutes) and number of awakenings after four weeks of therapy. 
Stimulus control was not found to be superior to relaxation or paradoxical intention 
but it produced the greatest absolute SOL reduction. Three shortcomings to this study 
should be noted. First there was no follow-up and it could be that gains might have 
been kept differentially across treatments. Second, there was no indication of what 
point in treatment therapeutic effects started to emerge. Third uncontrolled use of 
sleep medication was allowed: both increment and reduction of sleep medication 
might have contributed to the post-treatment results. 
Lacks, Bertelson, Gans and Kunkel (1983a) replicated Turner and Asher's 
(1979a) study and they also investigated the interaction between insomnia severity 
and treatment. Sixty-four media and GPs recruited participants divided, upon 
completion of one week sleep diary, into three groups: mild (SOL 15-44 minutes), 
moderate (SOL 45-75 minutes) and severe (SOL 76-152 minutes) insomnia and 
randomly allocated within groups to each of the treatments. Participants received 
79 
therapy for four weekly sessions in small groups. Differently from Turner and 
Ascher's (1979a) study, SOL measures showed that stimulus control outcomes were 
considerably superior not only to no-treatment and placebo, but also to paradoxical 
intention and relaxation at each assessment point after week one. They also found a 
modest positive correlation between insomnia severity and degree of improvement 
and they concluded that stimulus control is the most effective treatment choice 
regardless of insomnia severity. 
Lacks, Bertelson, Sugerman and Kunkel (1983b) compared the effect of stimulus 
control with quasi desensitisation placebo on WASO. Fifteen participants, all 
presenting with sleep maintenance insomnia (average 75 minutes), were recruited via 
media advertisements and letters to GPs. After one week baseline they were given 
treatment in small groups during (four weekly sessions of 60-90 minutes). WASO 
was reduced from 60 to 25 minutes in the stimulus control group and from 88 to 51 
minutes in the placebo group (note that both groups reduced WASO by thirty-five 
minutes). The two treatments did not differ from one another and both treatments 
maintained these gains at three months follow-up. Two important points can be made 
from this study: first that stimulus control is efficacious in reducing WASO as well 
as SOL and number of awakenings. Second the quasi-desensitisation placebo 
treatment may actually have an active component: specifically the mental rehearsal 
of pre-bedtime routine and imagery is likely to preclude intrusive cognitions and in 
this way facilitating returning to sleep. 
The studies reviewed so far assessed stimulus control efficacy in students and 
adults. Anderson and colleagues tested stimulus control efficacy in improving sleep 
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in older adults. Stimulus control improved WASO and S. E. but not SOL in their 
group of older adults (Anderson, Zendell, Rosa, Rubinstein, Herrera et al, 1988). 
Sanavio et al (1990) allocated 40 insomniacs to one of four experimental 
(cognitive, biofeedback, stimulus control coupled to relaxation and no treatment) 
groups. Each group received six intervention sessions. The three active groups all 
reduced both SOL and WASO as compared to no improvements in the control group. 
However, only cognitive therapy resulted in an increase in TST. These authors 
provided three years follow up data (23 participants out of 30 provided data) showing 
that further reductions in both SOL and WASO were achieved for all three active 
treatments. In particular WASO was reduced from roughly an hour at baseline to 
about 15 minutes three years after the six weeks treatment. 
Puder, Lacks, Bertelson and Storandt (1983) found that stimulus control was 
efficacious in improving SOL in older adults when a clinical psychologist 
administered therapy in small groups in four weekly sessions. A cohort of sixteen 
older adults was assigned to either immediate or delayed (following ten weeks 
baseline) stimulus control. Both groups, once stimulus control was administered, 
reduced their sleep latency by around fifty per cent and such reduction was 
maintained at two months follow-up. 
Stimulus control efficacy in reducing sleep difficulties in `older' people (average 
age 57) was also investigated by Morin and Azrin (1987). Twenty-seven media 
recruited people meeting criteria for insomnia were randomly allocated to stimulus 
control, imagery training and no treatment control. Following one-week baseline 
participants attended four weekly one-hour therapy sessions conducted in small 
groups. The stimulus control group achieved a statistically significant reduction of 
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WASO (by 65%) as compared to the other two groups. At 12-months follow up, 
however, stimulus control and imagery displayed almost identical WASO (around 25 
minutes). They argued that psychological therapy for insomnia is indicated to 
decrease WASO in older adults too. 
Morin and Azrin (1988) conducted another study, similar to that of the previous 
year with regard to number of participant and treatments, collecting data both via 
sleep diary and a switch-activated clock to record, objectively, WASO and SOL. 
Both active treatments, but not the waiting-list control group, reduced WASO and 
stimulus control produced an increase in TST of 65 minutes on average. Therapeutic 
gains were maintained at 12 months follow-up. SOL data were also reported and 
showed improvement both at the end of treatment and at follow-up for stimulus 
control (56,40 and 23 minutes respectively), at a lesser extent for imagery training 
(38,26,25) but, interestingly, also for the waiting list control (52,31). 
Espie, Lindsay et al (1989) recruited eighty-four GPs referred outpatient adults, 
seventy participants were allocated to either stimulus control, relaxation, paradoxical 
intention, desensitisation placebo or no treatment. The remaining fourteen were 
allocated to a tailored intervention. Sleep diaries, incorporating both measures of 
sleep quantity and quality, were completed for, two weeks baseline and eight weeks 
intervention. It is noteworthy that the stimulus control group almost halved SOL 
during the first week of treatment and by the eighth week SOL was 31 minutes (pre 
to post change of 62%). In line with Lacks et al's (1983a) findings stimulus control 
produced significant improvements in short time. By the end of the eighth week 
paradoxical intention reduced SOL to 36 minutes (51% pre to post change). In 
contrast, relaxation effects were similar to placebo. With regard to sleep quality, 
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while relaxation produced improvements both in terms of perceived restedness upon 
wakening in the morning and sleep enjoyment, stimulus control produced no 
measurable impact upon these variables. To summarize, stimulus control produced 
quick and effective improvements in SOL, and the treatment achieved clinical 
significance: indeed every patient improved, two-thirds reduced SOL by greater than 
half and a higher percentage of participants had sleep onset latencies of 30 minutes 
or less at follow-up. As pointed out by the authors the instruction to go to bed only 
when sleepy/tired might have guaranteed, per se, shorter SOL. 
It is noteworthy that the efficacy of stimulus control in improving sleep has been 
typically tested by employing only subjective measures (sleep diary). To the author's 
knowledge only two studies looked at subjective and objective sleep improvements 
following stimulus control. In Anderson et al's (1988) study stimulus control 
improved subjective estimates of WASO and S. E but S. E. was the only PSG sleep 
parameter improved. Similarly, Engle-Friedman et al (1992) found that stimulus 
control improved subjectively measured sleep parameters and was the most effective 
condition in improving sleep when compared to relaxation and control. However 
such subjective changes were not corroborated by polysomnographic data. It should 
be noted that lack of PSG changes following CBT-I treatments are not uncommon 
(Krystal, Edinger, Wohlgemuth, and Michaels, 2002). 
The studies reviewed so far highlight that stimulus control is efficacious in 
reducing estimates of SOL, WASO and NoA per night and, in general, it has yielded 
greater therapeutic effects when compared to other treatments. Furthermore 
therapeutic effects have generally been achieved very rapidly (Espie, Lindsay et al, 
1989; Hughes and Hughes, 1978). In addition it has been found to be efficacious 
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with both young and older populations and to maintain therapeutic effects at follow- 
ups. 
The mechanisms of effects of stimulus control are, however, less clear and 
participants' comments on the possible ways in which this therapy works are 
suggestive of `breaking a pattern of lying in bed thinking', 'being able of stop 
thinking by getting out of bed'. In addition the findings of four studies cast doubts on 
the stimulus paradigm by either using only some instructions or by using a paradigm 
that seems to run counter to the whole conditioning aspect. 
Tokarz and Lawrence (1974) (as reviewed in Bootzin and Nicassio, 1978) 
separated temporal components aimed at regularising the sleeping pattern according 
to the constraints of time (sleep scheduling) and stimulus components aimed at 
making the bedroom environment function as a discriminative stimulus for falling 
asleep (e. g. not watching TV in bed) of stimulus control. Results showed these two 
factors to yield equivalent efficacy in reducing SOL (from 50 minutes at baseline to 
around 10 at post-treatment) in their student sample when therapy was delivered in 
small groups once a week over four weeks. This is an important finding as it suggests 
that only half of the stimulus control instructions (either temporal or situational 
instructions) are sufficient to produce remarkable improvements. It is, therefore, 
surprising, that only a couple of studies have been carried out to replicate and explain 
these findings especially given that stimulus control is the core of CBT, the most 
delivered insomnia therapy in the last 25 years. 
Another important study with regard to the mechanisms of effect of stimulus 
control was carried out by Zwart and Lisman in 1979. They assigned 47 
undergraduate students, all reporting SOL greater than 30 minutes, to five different 
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conditions: the `whole stimulus control' package, `only temporal control' 
instructions, `non-contingent control' (that is getting out of bed a fixed number of 
times at fixed intervals), `countercontrol' (that is sit up in bed and do something if 
unable to sleep within 10 minutes) and `waiting list'. Each group, other than the 
waiting list one, met 4 times on a weekly basis for 30 minutes. Figure 11 shows SOL 
at baseline and at the end of treatment (4 weeks) for the five conditions: interestingly 
the whole stimulus control package, temporal control instructions and countercontrol 
instructions form three parallel lines suggesting equivalence of improvement 
(confirmed by statistical analyses). 
Fig. 11 -Mean SOL for Groups at Baseline and End of Treatment 
(Zwart and Lis man, 1979) 
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In line with Tokarz and Laurence's (1974) findings, `temporal control' 
instructions were effective and sufficient to decrease insomnia symptoms. This 
finding made the authors suggest that stimulus control may function both for 
reconditioning of responses to the environment but also via improved harmonisation 
of the circadian cycle. Of particular importance was the finding that `counter control 
instructions' were as effective as the stimulus control package. This finding shed 
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doubts on an environmental conditioning paradigm. Zwart and Lisman suggested that 
counter control ensured disruption of bedtime as cues for mental arousal. In other 
words `doing something' acts as a distractor: the person who cannot sleep is 
occupied and does not focus on lying there not sleeping. 
Alperson and Biglan (1979) investigated the efficacy of self-administered (in the 
form of manual with minimal therapist contact) treatment of insomnia. After two 
weeks baseline, twenty two media-recruited insomniacs aged less than fifty-five 
years old, were assigned to one of three groups: relaxation and stimulus control, 
relaxation and `counter-control' or self-monitored. A further group, comprising 
seven insomniacs aged over fifty-five received relaxation plus stimulus control. It 
was found that both the stimulus control and the counter-control groups decreased 
sleep latency significantly better than the self-monitor group, and, similarly to Zwart 
and Lisman's (1979) findings there were no differences between the stimulus control 
and the counter control groups. However it is not possible to rule out the possibility 
that the procedure most impacting on SOL reduction was relaxation (which was 
taught in both conditions). It is worth noticing that the older group responded 
significantly less well than the younger one. This latter finding could be due to 
stimulus control being less efficacious with older adults. However, given that other 
studies have shown stimulus control to improve sleep in this population (e. g. Morin 
and Azrin, 1987,1988; Puder et al, 1983), this explanation seems unlikely. Different 
outcomes between the studies could be due to delivery modality: self-administered 
therapy might work less well than therapist led administration with older 
participants. It could also be that older participants found it difficult getting out of 
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bed (e. g. mobility issues, cold) and gave up adhering to some components of 
stimulus control. 
Indeed, when counter-stimulus control was administered to older adults, a 
statistically significant reduction in WASO was obtained (Davies, Lacks, Storandt 
and Bertelson, 1986). 
In sum these four studies, in line with the stimulus control studies discussed 
previously, evidenced the efficacy of stimulus control. In addition, and very 
importantly, Tokarz and Lawrence's (1974) and Zwart and Lisman's (1979) studies 
also highlighted that stimulus control may function via at least two separate 
mechanisms: a stimulus control paradigm (situational components of stimulus 
control) and an `improved harmonisation of the individual's circadian cycle' 
(temporal instructions) rather than solely via reconditioning of responses to the 
environment (Espie, 1991, p. 55). Furthermore, the findings that counter-stimulus 
control instructions improved sleep call into question the conceptual basis of 
stimulus control. Should the mechanism of effects be the strengthening of an 
association between bedroom environment and sleep, then asking people to stay in 
bed awake (and perform activities in bed) should weaken even further such 
association. Taking this point into consideration it could be argued that counter- 
stimulus control produced sleep improvements because of its temporal instructions. 
1.7.3 `Get up and go to another room if not asleep': a feasible therapy? 
The stimulus control studies discussed in the previous section evidenced the 
efficacy of stimulus control therapy for insomnia: importantly, stimulus control has 
been consistently found to be as efficacious as other therapies or to produce stronger 
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effects. Just as importantly, such effects emerged after only one or two weeks of 
therapy. However, participants' comments suggested that positive outcomes might 
not be due only to bringing back falling asleep under the stimulus control of the 
bedroom. Three studies (Alperson and Biglan, 1979; Davies et al, 1986; Zwart and 
Lisman, 1979) showed that both the original stimulus control and counter-stimulus 
control improved sleep. These findings would suggest caution about considering 
conditioning as the only mechanism underpinning stimulus control efficacy. 
In section 1.7.1 it has also been argued that stimulus control therapy for insomnia 
comprises two different sets of instructions: one set aiming at re-establishing 
temporal harmonisation of the sleep-wake schedule and the other one aiming at 
bringing falling asleep under the stimulus control of the bedroom (situational 
elements). Indeed, two studies evidenced that therapeutic effects can be obtained 
when only situational or only temporal instructions are delivered (Tokarz and 
Lawrence, 1974; Zwart and Lisman, 1979). 
The results of these four studies, coupled to the findings that both poor and 
normal sleepers endorsed similar sleep incompatible behaviours at bedtime (e. g. 
Harvey, 2000a; Haynes et al, 1982), highlight the importance of carrying out further 
research on the situational aspect of stimulus control. As already mentioned, it is 
surprising that this line of investigation has not been pursued and it seems timely to 
address this. 
Given that situational elements of stimulus control have been shown to produce 
sleep improvements and that the instruction `If you find yourself unable to fall 
asleep, get up and go to another room' seemed to epitomise the essence of stimulus 
control theory (section 1.7.1), it seems reasonable to propose a simplified stimulus 
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control therapy comprising only this instruction and to test its efficacy in improving 
sleep. 
Before concluding this chapter it is important to highlight moderating variables, 
that is variables that can influence treatment outcomes. 
1.8 Treatment Response and Moderating Variables 
Meta-analyses have evidenced that behavioural therapies for insomnia improve 
sleep in around 70-80% of treated individuals - that is around 20-30% of people 
undergo insomnia treatment without benefiting from it. This finding raises an 
important question: what factors inhibit or moderate negatively sleep improvements 
in some of the treated individuals? 
Chambers (1992) suggested that non-adherence might be the single greatest 
drawback to the success of behavioural treatment for insomnia, and attention is now 
turned to this moderating variable. Thereafter therapy credibility and expectancy of 
improvement are discussed. Finally the importance of the individual's readiness to 
change is highlighted. 
1.8.1 Treatment Adherence 
In the provision of health, the term adherence refers to the implementation of 
medical and treatment advice (Spilker, 1991) and it has been highlighted that non- 
adherence with treatment instructions can mask treatment effects (Frangakis and 
Baker, 2001). 
Sleep researchers are becoming increasingly aware that adherence is an extremely 
important construct in therapeutic interventions (Bouchard, Bastien and Morin, 
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2003; Buysse, 2003; Harvey et al, 2002; Morgan Thompson et al, 2003; Riedel and 
Lichstein, 2001; Vincent and Hameed, 2003), yet very little systematic research on 
its impact on therapeutic gains have been carried out and no standardized 
methodology for measuring adherence exists. 
The few times adherence has been measured, measurement has relied on 
subjective (mainly examination of sleep diaries) or important others' reports (Morin, 
Colecchi et al 1999; Bouchard et al, 2003). For example, Bouchard and colleagues 
(2003) used sleep diaries to measure adherence during 8 weeks CBT treatment. 
Seven daily criteria reflecting stimulus control and sleep restriction were extracted 
from the sleep diaries and rated. It was found that participants complied with at least 
6 criteria each day. Harvey et al (2002) asked patients (both responders and non- 
responders to treatment) to rate their use of the behavioural treatment components of 
CBT-I 1 year after treatment was completed. Although the component sleep 
scheduling (a combination of stimulus control and sleep restriction) was used by less 
than 50% of patients at one year follow-up, it was found to be the strongest and most 
consistent predictor of SOL and WASO reduction. 
The possibility that stimulus control could present a challenge in terms of 
adherence has also been evidenced by Schramm and colleagues. Their insomnia 
sample was asked, at the end of therapy, about their use of CBT modules and 
responses showed that stimulus control was rarely practised (Schramm et al, 1995). 
Similarly, Chambers (1992) found that only about 30%, of a sample of 103 insomnia 
patients, strictly followed treatment recommendations. In contrast, Riedel and 
Lichstein (2001) found, in their sample of older adults, that adherence to sleep 
restriction instructions was `reasonably good'; interestingly, consistency in sleep 
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schedule predicted sleep improvements at post-treatment while degree of bedtime 
reduction did not. 
These studies investigated adherence to CBT and, therefore, do not permit 
assessment of whether participants applied all components of stimulus control. In 
this regard it has been suggested that the instruction `get out of bed if unable to 
sleep', particularly when elderly people are involved, can be difficult to comply with 
(Bootzin and Epstein, 2000). Indeed, Lichstein and Morin (2000) argued that the 
component of stimulus control `get out of your bed if not asleep in 20 minutes' is 
particularly difficult to be followed by older adults because of mobility issues and the 
reluctance to leave the bed during winter months: non adherence with this instruction 
might help explain findings that stimulus control for insomnia is less efficacious with 
older adults. 
As already mentioned these studies relied either on adherence being inferred by 
sleep diary entries or on retrospective (end of studies and follow-ups) estimates of 
adherence. This can be misleading as reports of adherence can be affected by the 
researcher's expectation or the participant's desire to conform or please the therapist 
raising the possibility that conclusions on the effects and active therapeutic 
ingredients of an intervention could be compromised (Buysse, 2003). 
One instrument, namely actigraphy, already used in sleep studies, could lend itself 
to monitoring adherence objectively. Carney, Lajos and Waters (2003) proposed that 
using actigraphy to verify adherence to treatment instructions could be very 
important. In their elegant study they found that participants who were told that 
actiwatches would provide information on application of sleep instructions (bed and 
wake time) adhered more than those who were not informed that the 'watch' would 
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verify their adherence. A pitfall of this study is that sleep schedule was to be 
followed only for 2 nights; it is therefore possible that the undergraduates complied 
with instructions only because of the short time they were required to do so. In 
addition the group was composed of normal sleepers. It might be that poor sleepers 
would find it more difficult to follow instructions. Nonetheless, this study 
highlighted an objective method to evaluate adherence which is worth pursuing. In 
study two and three of the present research the possibility to use actigraphy to 
measure adherence objectively is explored. 
It is important to pay attention to two other factors, namely credibility of 
treatment and expectancy of improvement following treatment, because they can 
impact on treatment outcomes (Kazdin, 1979). For example, if the individual does 
not believe that therapy will help improve sleep, they might be less likely to adhere 
to the treatment modality. 
1.8.2 Credibility and Expectancy 
Assessing credibility of treatment and expectancy of positive treatment outcomes 
enables the investigators to check that these two variables are not responsible for any 
differences in observed outcome between the compared conditions. Expectancy and 
credibility have been found to be influenced by the amount of information given and 
the kind of language used (Kazdin and Krouse, 1983), and to correlate with therapy 
outcome (Chambless, Tran and Glass, 1997; Borkovec and Costello, 1993). Riedel 
and Lichstein (2001) found that some of their patients did not adhere to spending less 
time in bed (sleep restriction) because this seemed counterintuitive to what one ought 
to do when having insomnia. 
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1.8.3 Other Moderating Variables 
It can be argued that independently of the efficacy of a given treatment, the 
individual must be ready (that is motivated and willing) to learn and apply therapy 
instructions (Edinger and Means, 2005). In other words, if the individual is not 
"ready to change", even the most efficacious treatments will not produce positive 
therapeutic outcomes. As suggested by Morin and Espie (2003) the 'stages of 
change' model put forward by Prochaska, DiClemente and Norcross (1992) is a 
useful tool to assess readiness and motivation to change (figure 12). It is noteworthy 
that Morgan et al's (2003) study highlighted that higher expectations of change 
predicted better treatment outcomes. 
Fig. 12 - Assessment of Readiness to Implement Insomnia Therapy using 
the Process of Change Model 
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For example, secondary gains (e. g. sympathy, relief from demanding tasks) might 
influence readiness to change (Kales and Kales, 1984). 
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1.9 Summary of the Introduction 
The preceding sections critically reviewed the literature pertaining to insomnia, its 
non-pharmacological treatment and variables that can hinder treatment efficacy. 
Several distinct findings can be extracted from the literature. 
First, although there is empirical evidence supporting the physiological, 
behavioural and cognitive perspectives of insomnia none seems to be exhaustive. 
Single factor theories are attractive for their simplicity but recent research suggests 
that insomnia is multi-dimensional in that physiological, psychological, behavioural 
and social domains interacts in the emergence, maintenance and exacerbation of 
insomnia. 
Second, in the last 20 years CBT-I, which comprises several single therapies, has 
been the most popular non-pharmacological treatment for insomnia and behavioural 
sleep medicine is continually providing further evidence of its efficacy. Nonetheless 
its mode of action is less clear, in other words we know it works but we don't quite 
know what the mechanisms of effect are. Furthermore, whether all CBT-I 
components are essential to positive treatment outcomes is unknown. 
Third, meta-analyses have highlighted that stimulus control for insomnia is the 
most efficacious single component therapy for insomnia. It is also the only therapy 
recognised as the golden standard treatment for insomnia by the American Academy 
of Sleep Medicine and a core component of CBT packages. Nonetheless, its 
mechanisms of effect are unclear. Despite stimulus control being based on the notion 
that in insomnia falling asleep is not under the stimulus control of the bedroom 
(because sleep incompatible behaviours are in the bedroom and/or sleep inducing 
stimuli are not established), research findings raised doubts about this hypothesis. 
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Two studies on pre-sleep activities failed to find differences between normal and 
poor sleepers, hence suggesting that behaviour incompatible with sleep might not 
play, per se, an essential role. Furthermore, a counter-stimulus control paradigm, 
requiring participants to spend time awake sitting up in bed, was found to improve 
sleep. This finding argues against situational conditioning. In addition, participants' 
comments suggested that stimulus control breaks a pattern of lying awake in bed 
thinking. Finally, a detailed examination of the elements of stimulus control 
highlighted that it comprises both situational (aiming at re-establishing good stimulus 
control) and temporal instructions (aiming at re-harmonising sleep and wakefulness). 
Fourth, although research has consistently found stimulus control to improve 
sleep, most studies relied only on subjective estimates of sleep. Indeed, the two 
studies employing objective measurements (PSG) of sleep failed to find changes in 
the sleep parameters under investigation. 
Fifth, it has been shown that, although insomnia treatments produce sleep 
improvements in around 70-80% of the population, not everyone responds to 
treatment. The possibility that this is in part due to non-adherence has been raised but 
systematic research on adherence and its impact on treatment outcomes is lacking. 
Furthermore, in the few instances in which adherence has been investigated, its 
measurement was provided by retrospective and subjective tools (e. g. sleep diary, 
participants' comments). This finding highlighted the importance of measuring 
adherence systematically and objectively. 
The next chapter details the present research, which comprises three studies 
designed to investigate the issues just highlighted above. 
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Chapter 2 
Overview of the Present Research 
2.1 Rationale 
The literature reviewed in the previous chapter highlighted that CBT is an 
efficacious treatment for insomnia comprising several discrete therapies each of 
which, in turn, encompasses several elements. The fact that it is multicomponent 
makes it difficult to assess if all its components are critical to therapeutic gains and to 
identify mechanisms of treatment effect. The assessment of what elements are 
critical to positive outcomes is important because of the need to provide cost- 
effective care. Understanding the mechanisms of effect underpinning insomnia 
treatment is also important because it may help to shed light on factors that maintain 
and/or exacerbate insomnia. This, in turn, could lead to possible ways of preventing 
acute insomnia from becoming chronic, and so maximise the effectiveness of 
insomnia treatment packages. 
However, most research on insomnia therapy has been `macroscopic' in nature 
focussing on the efficacy and effectiveness of complex multicomponent packages, 
with a tendency, if anything, to add modules rather than striving to obtain maximum 
effect with minimum intervention. It seems important, therefore, to address this issue 
by looking not just at single therapies within CBT but also `microscopically' at 
single elements of these therapies. A good analogy would be: having built a fine 
house it is as if we have neglected to pay sufficient attention to what its foundations 
and cornerstones are. The present research was devised to look into this matter. 
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Having evaluated the literature (chapter one), stimulus control for insomnia 
emerged as a core component of CBT, the most efficacious single therapy and the 
only therapy recognised as the gold standard treatment for insomnia by the American 
Academy of Sleep Medicine. Notwithstanding its efficacy, previous research 
findings cast doubts on whether all its elements are critical to positive outcomes and 
on the mechanisms of effect of stimulus control. For this reason stimulus control 
was examined in more detail. Analysis of its six component parts suggested that the 
instruction `if you are not asleep within a reasonable time get up and go to another 
room and return to bed only when sleepy again' captures the essence of learning 
theory posited to underlie stimulus control therapy and, in this sense, may be a 
cornerstone element worth of close examination. 
Interestingly, the duration of waking time before applying this instruction was 
found to be somewhat arbitrary in that it varied from study to study. If this 
instruction is to return the individual into the normal range then what constitutes 
normalcy with regard to SOL needs to be clear and study one was devised to address 
this issue. 
Furthermore, findings that poor and normal sleepers endorse similar sleep 
incompatible behaviours at bedtime questioned conditioning as the sole mechanism 
underpinning stimulus control. This possibility was strengthened by findings that a 
counter-stimulus control paradigm produced positive outcomes. 
The literature review also highlighted that the impact of stimulus control on PSG 
defined sleep seeming largely unknown. It should be appreciated that it is only in the 
past 10-15 years that PSG measures have started to be employed in efficacy studies 
and that results are equivocal: some studies have evidenced PSG defined sleep 
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improvements while other studies have not (for a review see Stepanski, 2000). The 
majority of outcome studies employing PSG are CBT trials perhaps because most 
single therapy studies were carried out in the 1970s and early 1980s when, due to 
technology constraints, PSG recording was more cumbersome than nowadays. One 
stimulus control study employing PSG measures found only S. E. improvements 
(Anderson et al, 1988). It seems, therefore, important to attempt to address the need 
for objective data on sleep changes following therapy. In particular, given that 
stimulus control for insomnia attempts to condition falling asleep to the bedroom 
environment, home PSG seems a more logical choice than PSG recorded in 
laboratory settings. 
In addition, examination of previous research revealed that not everyone responds 
to insomnia treatment. Several researchers have argued that poor treatment response 
is likely to be related to adherence, yet adherence has been rarely investigated. In 
addition the few studies that examined adherence have done so subjectively or have 
inferred it from sleep diary entries. It was reasoned that in the case of a single 
element therapy, whose implementation requires overt behaviour (i. e. get up and 
read), actigraphy could be employed to measure adherence objectively. 
The present research, therefore, represents an investigation into the impact of a 
single element therapy, named the Quarter of an Hour Rule (QHR), on subjective and 
objective (PSG) sleep in people presenting with insomnia in primary care or self- 
referred as having insomnia. Additionally, whether conditioning to the bedroom 
environment is the sole mechanism of effect of stimulus control therapy for insomnia 
was explored. Finally, the relationship between treatment outcome and adherence 
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and, importantly, the feasibility of employing actigraphy to measure adherence 
objectively were examined. 
2.2 Aims 
The principal aim of the present research was to examine the impact of the QHR 
on sleep parameters of individuals with psychophysiological insomnia. Both 
subjective (sleep diaries) and objective measures (home PSGs) of sleep were 
gathered. The second aim was to investigate its mechanisms of effect. The third 
objective was to explore the relationship between therapy outcomes and adherence 
and the feasibility of employing actigraphy to measure adherence objectively. 
This research comprises three studies. Two preliminary studies were completed to 
inform the randomised controlled experimental trial (study three). The first aim of 
study one (chapter three) was to determine what constitutes normalcy with regard to 
SOL so as to have a `reasoned' duration of time to wait before applying the QHR. 
The results of study one informed the second and the third studies. 
Prior to conducting a randomised controlled experimental study, it was deemed 
important to carry out a few single case studies to test if the QHR would impact on 
sleep. The first aim of study two (chapter four) was, therefore, to assess the effect of 
the QHR on subjective and objective sleep of three individuals presenting with 
insomnia. In particular, the validity of home portable EEG equipment, whose set up 
could be performed by the participants themselves, was tested. Another aim of study 
two was to investigate adherence to the QHR both subjectively via adherence diaries 
and objectively using actigraphy. The results of this explorative study informed on 
the feasibility of the QHR as a standalone therapy. Data gathered from study two also 
99 
enabled optimal calibration of study three methodology with regards to objective 
measurements of sleep and adherence. 
The first aim of the randomised controlled experimental trial (study three, chapter 
five) was to investigate the impact of the QHR on subjective and objective sleep of 
GP referred and self-referred people with insomnia. The second aim was to explore 
possible mechanisms of effect of the QHR by requiring to apply the QHR in two 
different locations out of bed (QHRout) and in bed (QHRin). In addition, a battery of 
sleep related questionnaires measuring sleep related behaviours, cognitions and 
arousability were administered. As in study two, another aim of this research was to 
investigate the impact of adherence on treatment effects. Adherence with the QHR 
treatments was measured daily subjectively, via an adherence diary, and objectively 
by means of actigraphs incorporating a light detector. 
Each of these studies are described and discussed in the following chapters. 
2.3 Ethical Approval and Ethical Issues 
Ethical approval for the present research and two amendments to the original 
approved protocol were granted by the Greater Glasgow NHS Primary Care Trust. 
Copies of the original and the amendments were forwarded to the University Ethics 
Committee as is standard practice (appendix 2). 
It should be noted that based on prior work in this area (e. g. Bootzin, 1972; Zwart 
and Lisman, 1979; Davies at al, 1986) it was assumed that the QHR intervention 
would be either beneficial or would carry no adverse effects. 
With regard to home PSG, the procedure was well tolerated and minimal 
discomfort was reported. Participants were given a mobile telephone contact number 
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so as to have access to the researcher during the PSG nights. Participants were 
encouraged to contact the researcher if they had questions or problems related to the 
PSG recording equipment or if emergencies requiring the removal of PSG equipment 
arose. Only one participant phoned, soon after the researcher left her home, as she 
thought she might have switched the EEG recording equipment off. 
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CHAPTER 3- Study One 
A Cross-Sectional Comparison of Sleep Behaviour in 
Normal and Poor Sleepers 
This study was carried out so as to assess normal and poor sleepers' SOL with the 
aim of determining the duration of SOL in normal sleep. In addition, the portion of 
the sleep opportunity window that should be considered in calculating TIB was also 
explored with the aim of wording the sleep diary so as to best capture sleep 
continuity variables. The findings of this study informed methodology for study two 
and study three (chapters four and five respectively) with regard to component 
therapy (called the QHR). 
3.1 Rationale 
Research typically focuses on the `abnormal' and on therapies to decrease 
'disease'. Ideally, however, the ultimate goal of therapy is not just to achieve 
symptom control but also to return the individual to normalcy. It seems very 
important, therefore, also to study normal sleep behaviour to inform both theory and 
treatment. 
In the present context, decisions concerning the amount of time to wait before 
applying the instruction `get up and go to another room' (table 5, instruction 3 
section 1.7.1) would be somewhat arbitrary without data on what latency constitutes 
SOL in normal sleep. Whereas to the author's knowledge what constitutes normal 
subjective SOL has never been formally assessed in its own right, such data can be 
inferred from the literature comparing normal and poor sleepers. For example, Means 
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et al (2003) reported normal sleepers' SOL of 12 minutes and Wohlgemuth, Edinger, 
Fins and Sullivan (1999) of 23 minutes. 
Likewise, it is also important to standardise research and clinical practice by 
employing a `reasoned' definition of sleep efficiency. Sleep diaries routinely used in 
research include sleep continuity variables (e. g. SOL, WASO), however, sleep 
behaviour at bedtime and in the morning is not always measured in a uniform 
manner. For example, it is possible to measure TIB in several ways: TIB can be 
defined as the time elapsed from `intention to sleep' to `woke up' (i. e. the narrowest 
sleep window opportunity), or it can be calculated as the time between `retiring to 
bed' to `out of bed' (i. e. the widest sleep opportunity). Providing TIB is measured 
consistently (i. e. it is measured identically across conditions and at the considered 
time points) this does not represent an issue within each single study. However when 
studies carried out by different researchers are compared, the way in which TIB is 
measured might be in part responsible for differences in treatment outcomes. 
Importantly, if the sequences of behaviour, at sleep time (Ti) and in the morning 
upon awakening (T2) (fig. 13), differ between normal and poor sleepers then when 
calculating TIB T1 and/or T2 would acquire importance for theory (potentially 
helping explaining some aspects of insomnia) and, consequently, for therapy. 
Fig. 13: Sequence of Behaviour at Sleep Time and in the Morning 
Out of bed 
Retiring 
to bed 
SLEEP &WAS O 
Intention SOL Woke up 
to sleep 
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3.2 Aims and Hypotheses 
The first aim of this study was to investigate the duration of subjective SOL that is 
typical of normal sleep. In particular what duration would be the best cut-off to 
include normal sleepers and to exclude poor sleepers (sensitivity/specificity) was 
examined. 
The second aim was to investigate sleep behaviour at bedtime and in the morning 
in normal and poor sleepers. Based on the stimulus control argument that in insomnia 
sleep incompatible behaviours are present, it was hypothesised that poor and normal 
sleepers would differ with regard to the periods of time spent awake in bed, both at 
bedtime pre-sleep and in the morning after wakening. The first prediction was that 
Ti would be greater for poor sleepers than normal sleepers. The second prediction 
was that T2 would be greater for poor sleepers than normal sleepers. 
In addition, information regarding reasons for waking up in the morning and 
behaviour endorsed when sleep did not come easily was collected. 
3.3 Methods 
3.3.1 Design 
This was a cross sectional comparison to examine sleep behaviour in normal and 
poor sleepers. The areas of interest regarded the sleep pattern at SOL, Ti and T2 
(measured in minutes). There was one between subjects factor of `Group' with two 
levels (normal sleeper and poor sleeper). 
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3.3.2 Participants 
One hundred potential participants were approached. These were acquaintances and/ 
or colleagues of the researcher, with English as their first language, aged 20 to 60 
years. Fourteen individuals decided not to participate and six participants did not 
return the forms. A total of eighty volunteers took part in the survey (45 females and 
35 males). The majority was employed either full or part time (77%), while a small 
percentage was retired (9%) or in full time university education (14%). They all self- 
reported as free from psychological or neurological disorders. To analyse the data in 
relation to sleep problems, participants were divided into two groups according to 
their total score in the PSQI (Buysse et al, 1989). Demographic and PSQI 
characteristics are reported in table 6 (section 3.4.1). 
3.3.3 Materials and Apparatus 
3.3.3.1 Diary 
Sleep parameters were gathered by means of sleep diaries (adapted from Morin 
and Espie's (2003) sleep diary), which participants completed each morning upon 
rising for one week (appendix 3). Via the sleep diary, daily information on 'sleep 
continuity' such as SOL, WASO, which indicated and / or confirmed the disorder 
(i. e. insomnia) were gathered. The sleep diary is routinely used to gather sleep- 
continuity measures in sleep research (Espie, 1991; Morin, 1993). 
The sleep diary, however, can also be used to gather sleep behaviour information 
such as pre-bed routine. This investigation concentrated on sleep behaviour at night 
(when retiring to bed) and in the morning by explicitly differentiating the 'retiring to 
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bed' from `intention to sleep' times and `wake up' from `out of bed' times (fig. 14 in 
section 3.1). Additionally, the diary included three questions so as to gather 
information about: i) endorsed behaviour when `sleep does not come easily' at sleep 
onset, ii) endorsed behaviour when `sleep does not come easily' during the night and 
iii) reasons for waking up in the morning. 
Similar to Monk, Buysse, Rose, Hall and Kupfer's (2000) study, information 
regarding restedness and alertness on awakening was collected. Participants judged 
their quality of sleep, restedness and alertness in the morning on a rating scale (0= 
not at all, .., 4=very much). 
3.3.3.2 Sleep Questionnaire 
The Pittsburgh Sleep Quality Index (PSQI: Buysse et al, 1989) is a 
retrospective self-rated questionnaire comprising 19 items assessing the individual's 
sleeping habits and sleep quality during the past month (appendix 4). The PSQI 
produces seven component scores (each producing a score between 0 and 3), the sum 
of which provide a global index of sleep quality. A score above 5 on the global index 
(score ranging from 0-21) identifies significant sleep disturbance with high 
sensitivity and specificity (Buysse et al, 1989; Backhaus, Junghanns, Broocks, 
Riemann and Hohagen, 2002). Test-retest reliability for the PSQI global score, over a 
one-month period, was found to be 0.85 in the original study (Buysse et al, 1989) and 
Carpenter and Andrykowski (1998) reported good internal consistency in a mixed 
sample of medical patients with normal and poor sleep (Cronbach's a=0.80). 
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3.3.4 Data Processing 
The primary sleep diary variables were `Duration of SOL', Ti and T2 as previously 
defined. In order to validate the cross sectional investigation, however, the sleep 
parameters indicating a disorder of insomnia were first studied. 
Data were analysed using a statistical package (SPSS for Windows version 11.5). 
3.3.5 Procedure 
Potential participants were informed that the study investigated whether people 
who sleep well act differently from those who do not sleep well both during typical 
nights and when sleep does not come so easily. People, who expressed an interest in 
participating, were told that they were required to fill in a sleep questionnaire (PSQI) 
and, thereafter, to complete sleep diary every morning for one week. Both the PSQI 
and the sleep diary were to be forwarded to the researcher in the provided envelope 
at the end of the week. As the diary and the PSQI did not have an ID number, they 
were stapled together. 
The PSQI takes around 10 minutes to complete and the sleep diary around 5 
minutes per day, thus requiring around 45 minutes of participants' time to complete 
the investigation. 
3.4 Results 
3.4.1 Participant Characteristics 
Table 6 presents information regarding number of participants in each group, their 
gender, age, and the mean and standard deviation (SD) for PSQI total scores. 
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Table 6- Summary Data for the normal sleeper and the poor sleeper Croups 
---------------------------------------------------------------------------------- - - ---------- 
Normal sleeper 
- 
Poor sleeper 
---- -- 
Total 
Participants il) l NO 
Female/Male 29/21 16/ 14 45/35 
Age band: 
(20-30 years) 22 10 32 
(31-40 years) 13 9 22 
(41-50 years) 8 6 14 
(51-60 years) 7 5 12 
PSQI total score (SD) 2.5 (1.0) 10.0(1.9) 
As expected, given that the normal and poor sleeper groups were formed by 
splitting the participants into two groups depending on their PSQI score (Buysse et 
al, 1989), an independent t-test confirmed that the 2 groups differed significantly in 
terms of their quality of sleep level Jt(78)= -23.53, p=O. OOOl J. There were no 
significant differences in age group Ix2(3)=O. 90, p=0.821 or gender IX2( 1 )=O. 16. 
p=0.68 J. 
3.4.2 Sleep Continuity and Sleep Quality Data 
Sleep continuity variables are generally used to confirm sleep status initially. 
As shown in table 7, diary sleep data demonstrated differences between normal 
and poor sleepers. In order to assess if these differences were statistically significant 
separate Mann-Whitney U tests were conducted on SOL, WASO and TST with 
group (normal sleeper vs. poor sleeper) as the between subjects factor. The choice of 
a non-parametric test was nude because visual inspection o1' the data suggc"ted that 
the scores were not normally distributed. This was confirmed by examination of 
kurtosis and skewness (values higher than 1.9). 
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Table 7- Mean and SI) for Sleep (bntinuit) (in minu(es) and Sleep Quality 
(0-4) for the Normal Sleeper and Poor Sleeper Groups 
Normal Sleeper (N=50) Poor Sleeper (N=30) 
SOL 9.38(7.69) 47.22(31) 
WASO 8.72(8.87) 53.73(58) 
TST 442(43) 342(85) 
TIB Intention to sleep' to 'wok en up') 460(43) 444(66) 
TI ('retiring to bed' to 'intention to sleep ) 14(14) 17(14) 
T2 'waken up' to 'out of bed' ) 29(20) 57(42) 
Quality of Sleep 3.04(0.48) 1.60(0.72) 
Restedness 2.91(0.50) 1.58(0.63) 
Alertness 2.91(0.59) 1.79(0.80) 
Mann Whitney analyses revealed that there were highly significant differences 
with regard to SOL (U=101.000, N1=50, N, =30, P= 0.0001 two tailed), WASO IU= 
219.50, Ni=50. N2=30, P= 0.0001 two tailed) and TST (U=182.000. Ni=50. Ný=30, 
P= 0.0001 two tailed). Specifically, participants in the poor sleeper group took 
longer to fall asleep, were awake for longer during the night and slept less than 
normal sleepers. These results, therefore, confirmed the initial differentiation of the 
two groups on the basis of their PSQI scores. 
Each morning participants reported the quality of the previous night's sleep, and 
their level of alertness and restedness upon awakening. Examination of' able 7 
indicates that ratings of quality of sleep, restedness and alertness on final waking of 
normal sleepers differed from those of the poor sleeper group. The data net criteria 
for parametric tests and independent t-tests confirmed that normal sleepers reported 
better quality of sleep, felt more rested and alert upon awakening than poor sleepers 
[t(78)= 10.70, p<0.00I; t(78)=10.30, p<0.001; t(78)=7.12, p<O. 00I respectivelyl. 
Interestingly, on occasions when normal sleepers could not fall asleep easily they 
tended to 'just lie there waiting for sleep' (84% of times). Although poor sleepers 
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reported `lying there' as their most endorsed behaviour when they could not sleep 
(66%), they often reported `watching TV' and/or `reading a book' and/or `listening 
to the radio' and/or `thinking about how to sleep'. 
3.4.3 Upper Limit of Sleep Onset for Normal Sleepers 
To establish the upper limit of normal sleep behaviour at sleep onset, data from 
the normal sleeper group were examined in terms of sensitivity and specificity. 
Sensitivity refers to the probability that a person having a given characteristic will be 
correctly identified as having such characteristic. Specificity is the probability that a 
person without that characteristic will be properly classified as not having it. 
Analysis of sensitivity and specificity data indicated that SOL of 5 minutes 
correctly identified only 38% (19 individuals) of normal sleepers and correctly 
excluded 100% (30 individuals) of poor sleepers, SOL of 10 minutes correctly 
identified 72% (36 individuals) of normal sleepers and correctly excluded 90% (27 
individuals) of poor sleepers, SOL of 15 minutes correctly identified 92% (46 
individuals) of normal sleepers and correctly excluded 86.7% (26 individuals) of 
poor sleeper and SOL of 20 minutes correctly identified 92% (46 individuals) of 
normal sleepers and correctly excluded 76.7% (23 individuals) of poor sleepers. 
As depicted in figure 14, these results indicate that a SOL of 15 minutes is the best 
cut-off to include normal sleepers and exclude poor sleepers. 
In light of these findings, it seems plausible to consider a quarter of an hour as the 
upper limit of normal sleep behaviour at sleep onset and, to specify such time when 
instruction 3 of stimulus control is delivered (table 3, section 1.7.1). 
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Fig. 14: Box and Whiskers Plot indicating that a quarter of an hour is 
the best cut-off for normal sleep onset behaviour 
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3.4.4 Sleep Behaviour at Bedtime and in the Morning 
Data for TI and T2 were also not normally distributed hence non-parametric 
statistical analyses were carried out. Separate Mann-Whitney U tests were conducted 
on these variables. There was no significant difference between the two groups for 
TI (U=656.500, N1=50, N, =30, P=0.35 n. s. ) indicating that the amount of time spent 
in bed prior to switching off the light with the intention to sleep, did not differ 
between normal and poor sleepers. 
In contrast, there was a significant difference between the two groups with regard 
to T2 (U=443.500, N1=50, N2=30, P=0.002 two tailed) suggesting that the aniotint of 
time spent lying in bed once awake in the morning was greater for poor sleepers. 
This finding highlighted the importance of considering this portion of sleep 
opportunity window when calculating TIB. 
3.4.5 Reasons for Waking Up in the Morning 
With regard to reasons given for waking up, normal sleepers reported using some 
form of wake up call (e. g. an alarm clock, their partner or flatmate) on 70% of 
weekdays, and 38% of weekends. They `just woke up' on 16% and because of noise 
on 14% of weekdays and 50% and 12% respectively of week-ends. Poor sleepers, by 
contrast, indicated that they woke up on majority of days (76%) because of light, 
noise, or `for no reason' and attempted to sleep again till the time to get up for work 
or their daily activities both on weekdays and weekends. 
3.5 Discussion 
In this section results obtained in the survey will be discussed with particular 
attention to the design of study two (exploratory single case study, chapter 4) and 
study three (experimental study, chapter 5). 
3.5.1 Summary of the Results 
The first aim of this cross sectional study was to assess the duration of SOL typical 
of normal sleep behaviour. Results indicated that 15 minutes was the best cut-off to 
discriminate normal SOL. The second aim was to investigate whether or not sleep 
behaviour at bedtime and in the morning differed between normal and poor sleepers. 
The first prediction, that the amount of time spent in bed before switching off the 
light with the intention to sleep would be greater for poor sleepers compared to 
normal sleepers, was not supported. The second prediction, that poor sleepers would 
spend a longer time in bed in the mornings than normal sleepers, was supported. 
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Finally, descriptive information regarding reasons for waking up in the morning 
and behaviour endorsed when sleep did not come easily was collected. This 
information suggests that normal sleepers during weekdays tended to use a form of 
`wake up' call in order to get up in the morning while poor sleepers tended to wake 
up for no apparent reasons or because of noise. Additionally, in the few occasions 
when normal sleepers could not fall asleep easily they tended to lie in bed waiting for 
sleep to come while poor sleepers tended to endorse a variety of behaviour (e. g. lie in 
bed, watching TV, read, get a juice). 
3.5.2 - Interpretation of the Results 
Importantly for insomnia therapy instructions, this study highlighted that 15 
minutes provides the best sensitivity-specificity cut-off to discriminate normal SOL 
from SOL of poor sleepers. For example, as already pointed out in the introduction, 
the amount of time to wait before applying the stimulus control instruction 'get out 
of your bed and go to another room' is rather arbitrary varying from a few minutes 
(Haynes et al, 1975) to 20-30 minutes (Hoelscher et al, 1988). The present finding 
suggests that 15 minutes may be the most appropriate amount of time to return the 
poor sleeper to normalcy. 
The first prediction, that the amount of time spent in bed before switching off the 
light with the intention to sleep would be greater for poor sleepers as compared to 
normal sleepers, was not supported. However, on reflection, this finding may not be 
surprising, given that some previous research has shown that poor and normal 
sleepers endorse similar pre-sleep activities (Haynes et al, 1982). In poor sleepers, 
considering TIB from the intention to sleep could result in heightened arousal due to 
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the pairing of being in bed with being awake and frustrated/worried. Accordingly 
from a learning theory perspective, any time spent awake should be avoided so as to 
re-establish appropriate stimulus control. 
The present results seem to suggest that both normal and poor sleepers do spend a 
similar amount of time in bed prior to attempting to sleep. However, it could be 
speculated that the reason for spending time awake in bed prior to attempting to sleep 
differed depending on the group. In particular it might be that normal sleepers decide 
to switch off the light so as to sleep when they feel sleepy, while poor sleepers might 
make such decision on the basis of external cues (e. g. clock, partner) rather than to 
internal cues for sleep. This possibility has been raised in a recent paper on the 
attention-intention-effort pathway to insomnia (Espie et al, 2006). Espie et al (2006) 
proposed that normal sleepers read in bed and attempt to stay awake (but they 
cannot), while poor sleepers read because they cannot fall asleep/cannot stay asleep. 
In other words, normal sleepers intend to read in bed but sleep takes over while poor 
sleepers unsuccessfully intend to fall asleep and because of wakefulness they start to 
read. Although this is a possibility, it was not tested in this study. 
The second prediction, that time spent in bed from waking up to getting out of bed 
would be greater in poor sleepers than in normal sleepers, was supported. This result 
highlights the importance of considering the period between waking up and getting 
up when calculating TIB. Whereas normal sleepers once they woke up tended to get 
out of their bed, poor sleepers seemed to lie there, presumably, in the hope of getting 
some more sleep. This finding is potentially important with regard to stimulus 
control theory at WASO. The poor sleeper, by staying in bed when awake in the 
morning, might weaken the association between the bed and sleep. 
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The finding that 70% of normal sleepers woke up during week-days because of an 
alarm clock replicate Monk et al's (2000) findings. They suggested that this finding 
coupled to the fact that normal sleepers tended to sleep longer at weekends (when 
they could wake up at leisure), was an indication of sleep debt. It could be argued 
that normal sleepers maintain a healthy tension between sleep drive and sleep 
behaviour, that is having a modicum of sleep debt helping to maintain sleep 
homeostasis. Poor sleepers, in contrast, reported waking up because of environmental 
noises or for no apparent reasons. However, this finding cannot be taken as an 
indication that they do not have a sleep debt. Indeed, they felt less rested and less 
alert in the morning than normal sleepers and they tried to satisfy their need for more 
sleep by staying in bed and `trying to fall back to sleep' once they woke up. 
3.5.3 Considerations for Study Two 
These findings inform the methodology for study two and three. 
First, the results indicated that a window of 15 minutes gives ample opportunity to 
fall asleep and may be the optimal cut-off when normalcy in sleep onset is 
considered desirable. It seems reasonable, therefore, to ask people complaining of 
insomnia to apply the stimulus control instruction `get out of your bed and go into 
another room if not asleep within a quarter of an hour'. Bearing in mind that the 
ultimate goal of therapy is reinstating the person with insomnia as a normal sleeper, 
by setting the limit of being in bed awake to quarter of an hour, the goal of sleep 
normalcy in the treatment programme is reinforced. It was decided to focus on a 
quarter of an hour rather than 15 minutes, so as to move away from the concept of 
`being absolutely precise'. 
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Second, the study highlighted the importance of including for analysis T2 (i. e. 
period between wake and rise) so as to capture early wakening. Importantly, with 
regard to stimulus control therapy, considering this period is important in order to 
make sure that the stimulus control instruction is applied every time the person is in 
bed but not asleep. Therefore, the sleep diary employed in study two and three 
explicitly asked `What time did you rise from bed this morning'. 
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Chapter Four: Study Two 
Could a Single Element of the Stimulus Control 
Package Improve Sleep? An Exploratory Study 
This chapter reports three single case studies, conducted to examine the 
feasibility of a single element therapy to improve sleep of people with insomnia, and 
data on adherence gathered subjectively and objectively. 
4.1 Rationale 
In the introduction it was reasoned that, despite CBT-I being consistently found to 
improve sleep of people with insomnia, its mechanisms of effect and whether all 
components are critical to positive outcomes are unclear. Furthermore, although 
stimulus control is central to diagnostic conceptualisation of psychophysiological 
insomnia (ICSD-R), a core component of CBT-I and, also, the best evidenced non- 
pharmacological intervention, whether re-conditioning is the mechanism responsible 
for sleep improvements is uncertain. In addition research findings highlighted that 
administering only some of the components of the stimulus control package 
produced outcomes equivalent to those obtained by the whole package. 
These findings highlighted the importance of de-constructing stimulus control. 
Following a detailed analysis of its components, one element (spending night-time 
wakeful periods out of the bedroom) was deemed to best epitomise the stimulus 
control essence and, therefore, merit of analysis in its own right. In study one a 
quarter of an hour was identified as the best amount of time to represent SOL of 
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normal sleepers, hence this single element therapy was named the quarter of an hour 
rule (QHR). The present exploratory study comprises three single cases and was 
conducted to assess the impact of the QHR on sleep of people with insomnia. 
The literature reviewed in chapter one also highlighted the need to measure 
stimulus control efficacy objectively because its efficacy in reducing insomnia has 
typically been measured only subjectively. Given that home PSG has the advantage 
of increasing ecological validity and that stimulus control hypotheses conditioning to 
the bedroom environment, PSGs were recorded in participants' homes. In particular, 
this study explored the feasibility of a novel program, (Biosleep), requiring recording 
EEG only at Fz and either Al or A2. If this program proved to be valid, then it could 
be readily used for home PSG studies because participants could set up EEG 
recording by themselves once trained to do so. 
Finally, given that adherence has been suggested to be an important factor in 
treatment outcomes but it has been rarely studied systematically, this study examined 
adherence by measuring it both subjectively and objectively. 
4.2 Aims and Hypotheses 
The first aim of the present study was to investigate the impact of the QHR on 
sleep parameters. In line with most research regarding the efficacy of cognitive and 
behavioural treatments for insomnia, this study employed subjective sleep measures 
in the form of sleep diary and the diagnostic tool PSQI (Buysse et al, 1989). 
Based on previous research showing that stimulus control improved sleep 
parameters (e. g. Bootzin, 1972,1975; Haynes et al, 1975; Puder at al, 1983) and 
produced clinically significant changes (e. g. Sanavio, 1990), it was predicted that: 
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i) Participants' subjective SOL and WASO would be reduced and S. E. would be 
increased following intervention; ii) The QHR would produce clinically significant 
improvements. 
In addition to diary data objective sleep continuity parameters were also 
recorded so as to explore if meaningful PSG data could be obtained by `Biosleep' a 
software package requiring recordings only at one site. 
Another aim of the present study was to assess daily adherence with the QHR and 
to gather comments related to its implementation. The feasibility of employing 
actigraphy to measure adherence objectively was explored. 
4.3 Methods 
4.3.1 Design 
The study comprised 3 single cases: P1, P2 and P3. Single case studies have been 
widely used by cognitive-behavioural researchers and this methodology is of great 
importance in the preliminary assessment of clinical techniques and innovations 
(Morley, 1987). Each single case was an A-B design (A=baseline of 21-22 days, B= 
treatment of 23 days). Treatment phase length was decided on the basis of previous 
findings that sleep improvements were observed within two to three weeks after 
stimulus control implementation (e. g. Bootzin, 1972; Espie, Brooks et al, 1989; 
Sloan, Hauri, Bootzin, Morin, Stevenson and Shapiro, 1993; Zwart and Lisman, 
1979). The data collected during baseline, via participants' responses to a nightly 
sleep diary, served as a point of comparison to evaluate i) changes in sleep patterns 
and ii) therapeutic gains following treatment. 
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4.3.2 Participants 
A campus e-mail recruitment procedure was introduced to identify individuals 
with sleep difficulties for an experimental study on insomnia. The researcher 
evaluated interested individuals' eligibility via a screening interview according to 
DSM-IV (APA, 1994) and ICSD-R (ASDA, 1997) diagnostic criteria. 
Inclusion criteria were: difficulty in initiating and/or maintaining sleep (SOI; 
and/or WASO greater than 30 minutes) occurring at least three nights per week for at 
least six months (consistent with Lichstein, Durrence, Taylor, Bush and Riedel, 
2003) and perceived as causing distress or deterioration in daytime functioning, and a 
PSQI (Buysse et al, 1989) score greater than 5. Exclusion criteria were a score 
greater than 14 on either of the two subscales of the HADS (Zigmond and Snaith, 
1983), major medical and/or psychiatric disorder (self reported), psychotropic drug 
use over the last year, sleep medication use during the last month, alcohol and/or 
drug abuse, report of symptoms suggestive of sleep apnoea, periodic leg movement 
(PLMS) or restless legs syndrome (RLS). 
Of an initial eighteen potential participants who were screened, 4 met all 
diagnostic criteria. However, one participant was excluded because diary baseline 
SOL, WASO, TST and S. E. values were in the normative range for good sleepers 
(flow chart as per Consort guidelines in fig. 17). The present study, therefore, 
includes 3 participants. 
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4.3.3 Materials and Apparatus 
4.3.3.1 Sleet) Diarv 
Subjective sleep continuity parameters were gathered by means of sleep diaries 
(adapted from Morin and Espie's (2003) sleep diary), which participants completed 
each morning upon arising during baseline and intervention phases. Via the sleep 
diary, daily information on SOL, WASO, bed-time, rising time, alcohol 
consumption, sleep medication and daytime napping were obtained (appendix 5). In 
addition information regarding quality of sleep, restfulness and alertness upon rising 
(5-point Likert scale) were collected. The variables retained from the sleep diaries 
were S. E., SOL and WASO. WASO was defined as the summation of the time spent 
awake after sleep onset and, therefore, comprised duration of all awakenings 
including early morning awakenings. 
4.3.3.2 Sleep Assessment and Anxiety and Depression Questionnaire 
4.3.3.2a The Pittsburgh Sleep Quality Index 
The Pittsburgh Sleep Quality Index (PSQI: Buysse, et al, 1989) was used as a 
global measure of sleep quality (section 3.3.3.2, appendix 4). In this study the global 
index was used in the analysis of treatment outcome as well as for individual 
assessment of clinical significance. 
4.3.3.2b The Screening Interview 
The screening interview was a standard protocol (Espie, 2000; Morin and Espie, 
2003) based on the ICSD-R and DSM-IV criteria for chronic insomnia. This was 
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completed during a face-to face interview and considered sleep complaints 
(chronicity, number of nights with sleep difficulties, SOL and WASO), daytime 
functioning, use of sleeping tablets, mood, sleep-disruptive medical conditions and 
other sleep disorders were assessed. 
4.3.3.2c The Hospital Anxiety and Depression Scale 
The Hospital Anxiety and Depression Scale (HADS: Zigmond and Snaith, 1983) 
is a self-report questionnaire measured on a4 point Likert scale (0-3): 7 items 
measure depression and 7 items measure anxiety (appendix 6). In particular a score 
between 0 and 7 is considered as normal, 8 to 10 as mild, 11 to 14 as moderate and 
15 to 21 as severe. Internal consistency and test-retest reliability were found to be 
good (Cronbach alpha= 0.89 for both sub-scales, test-retest correlation = 0.72, 
p<0.001) (Dunbar, Ford, Hunt and Der, 2000; ). 
4.3.3.3 Objective Measurement of Sleep 
4.3.3.3a Ambulatory Electroencephalogram/Polygraph Recording Device 
The Ambulatory EEG/PSG recording device employed in this study was Trackit 
(Lifelines Ltd, UK). It is a multi channel ambulatory electroencephalograph, 
comprising of 24-channel EEG amplifier and an 8-polychannel acquisition board. 
The device is powered by 3 batteries, it is the size of a small hand-bag and weighs 
approximately 750 grams (fig. 15a). The Patient Connection Unit is a block of 
moulded plastic with touch-proof sockets and a shielded cable, which connects the 
EEG recording electrodes attached to the individual to the Trackit unit. The Trackit 
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set up software is used to program the Trackit recorder for an ambulatory recording 
session. 
The EEG data are stored on an internal ATA flash card in the form of' an t: Utý 
(European Data Format) file, which enables subsequent review by any 1; )F- 
compatible EEG software package. 
4.3.3.3b Analysis of the Electroencephalographic Recording 
The EEG data in the fonn of EDF files were analysed by employing BioSleep 
software (Oxford Bio Signal Ltd). Biosleep is a computer program which uses a 
neural network (Roberts and Tarassenko, 1992; Pardey, Roberts, "I'arissenko and 
Stradling, 1996) to quantify sleep and wakefulness on a second-by second basis, 
using a single channel of recorded EEG. In particular the EOG signal is proposed to 
contain both eye movement and EEG signal. 
Biosleep first indirectly performs frequency analysis of the El'G, then it pre'ents 
this analysis as input to a neural network which has been trained to recognise 
combinations of three different types of EEG activity: wakefulness, REM or light 
sleep and deep sleep. Figure 15b shows an example of BioSleep Hypnogram. 
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For each one-second epoch, 
Biosleep assigns a probability value 
to each of these three processes so 
as to extract the probability that one 
particular process was dominant in 
the brain during a particular one- 
second epoch. 
Biosleep's analysis of the frequency content of the EEG uses a technique known 
as autoregressive modelling. It constructs its model using the kind of least-square 
technique employed in regression analysis. 
It is important to note that Biosleep is a simple and user friendly package, 
however it provides pseudo R&K. A study by McGrogan, Braithwaite and 
Tarassenko (2001) showed that over the nine nights recordings of sleep EEG the 
correlation between the pseudo- R&K obtained with Biosleep and R&K stages from 
a consensus of three human experts was 72.2%. 
4.3.3.4 Measures of Adherence 
Adherence was measured both subjectively via adherence diary and objectively via 
actigraphy. In particular, with regard to objective adherence, it was reasoned that 
implementation of the QHR required movement (e. g. going to another room, reading 
or having a juice) and therefore, actigraphy could be a useful tool. 
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4.3.3.4a Actigraphy 
The Actiwatch (Cambridge Neurotechnology Ltd) is a lightweight wristwatch-like 
electronic device that measures and records physical movements by the means of a 
piezo-electric accelerometer that is set up to record the intensity, amount and 
duration of movement (figure 16). The corresponding voltage produced is converted 
and stored as an activity count in the Actiwatch memory unit. The data collected are 
then analysed via a software package produced by Cambridge Neurotechnology Ltd. 
Fiji. 16: Actiwatch Given that the Ql-lR required 
participants to `get out of your bed ii 
,, )t aslcep within it quarter of an hour' 
one minute epochs recorded by the 
: \CTW were considered. It' there was 
L ontinued movement for at least 16 
minutes, the QHR should have been 
applied. 
4.3.3.66 Adherence Diary 
Adherence with the QHR was measured daily, from the first night of 
implementation, via a small 'intervention diary' devised by the researcher by 
adapting Lichstein's CBT adherence checklist (personal communication, 2003). This 
served to collect data regarding whether, for each night of intervention, the QI IR had 
to: a) be applied to fall asleep and/or during the night if awake, h) how many times, 
c) after how long it was applied (if at all) and d) how difficult it was to apply it 
(measured on a Likert type scale: 1-10 with 1=not difficult at all and 10= extremely 
difficult) (appendix 7). In order to minimise social desirability issues (e. g. pleasing 
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the researcher) participants were told that their responses would help the researcher 
to understand the extent to which people found it difficult to implement the QHR. 
4.3.3.6c Adherence Score 
An adherence score was calculated using the following formula: 
Number of Times QHR was adhered to 
Adherence Score= 
Number of Times Implementation was Required 
4.3.3.5 The Quarter of an Hour Rule Intervention 
The intervention was named The quarter of an hour rule'(QI-IR) and was extracted 
from the original protocol proposed by Bootzin in 1972. The QIIR stated: 
If you are NOT asleep within a quarter of an hour, 
Then get up and do the chosen activity in the chosen room. 
Go back to your bed when you feel ready to sleep again. 
The activity to perform and the room to go to were decided by the participant durin" 
the delivery of the QHR intervention. The words when you feel sleepy again' of the 
original protocol (Bootzin, 1972) were changed into when you feel ready to sleep 
again' to reduce the impact of the implicit instruction of monitoring an internal sta(c 
for sleep. 
Participants were requested to follow the instruction again if, once returned to their 
bed they were not asleep within a quarter of an hour or if they woke np during the 
night and could not fall to back to sleep within a quarter of an hour. 
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It was made clear that clock watching, so as to decide when a quarter of an hour 
had elapsed, was to be avoided as this might keep them awake and to get up if they 
felt that they had been lying in bed for about a quarter of an hour. The intervention 
was delivered individually, by the researcher, following a written protocol (appendix 
12) and it took only 30 minutes. A flow-chart instruction sheet was given to 
participants to help them follow the QHR when at home (appendix 8). 
4.3.4 Procedure 
People who replied to the recruitment email showing an interest in the study were 
sent an information pack (appendix 9) and they were invited to contact the researcher 
if they wanted to participate. 
Fig. 17 - Flow-chart of Participants to the study 
Screening interview (N=18) 
Not meeting criteria Meeting criteria. 
(N= 14) (N= 4) 
Baseline: 3 weeks 
3 weeks of Sleep Diary and 2 PSG measurements 
Sleep Diary data suggested) 
Normal sleep Treatment : Three weeks (N) 
Day 1: 
QHR delivered 
Sleep Continuity/quality: 
3 wks sleep diary 
Adherence to QHR: 
3 wks actigraphy 
3 wks adherence diary 
Telephone contacts: 
Day 3& Day 14 
PSG measurement: 
Last 2 nights of treatmcnt 
Questionnaires 
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Once potential participants replied, they were invited to meet with the researcher 
(on an individual basis) and sign a consent form. Eligibility was then assessed via 
structured interview (chapter 3 in Morin and Espie, 2003), the PSQI (Buysse et al, 
1989) and the HADS (Zigmond and Snaith, 1983). Assessment lasted around forty- 
five minutes. Participants not meeting criteria were debriefed and thanked for their 
interest and time but did not continue with the study. Participants meeting criteria 
were trained in the correct use of the EEG/PSG recording equipment (Trackit, 
section 4.3.3.3a), had a practice session and were handed in a written memo 
(appendix 11). The practice session ensured that participants had understood how to 
set up Trackit properly and that they felt comfortable using it. Participants were then 
provided with the sleep diary to be filled in each morning upon rising for three weeks 
and the EEG/PSG recording equipment. The training/practice session lasted around 
forty-five minutes. The researcher collected the EEG/PSG recording equipment three 
days after this meeting. 
Three weeks after baseline, participants met, on an individual basis, with the 
researcher who delivered the QHR intervention following a written version so as to 
avoid confounding in therapy outcome due to different wordings (appendix 12). 
Participants were given an easy to follow memo about the QHR (appendix 8), were 
instructed to keep completing the sleep diaries and, in addition, the `adherence with 
the QHR diary' (appendix 7) for a further three weeks. Finally, it was explained that 
the actiwatch detected movement and would provide the research with information 
regarding when they were active or resting. They were asked to wear the actiwatch 
all the time (unless they were getting in contact with water) during the three week 
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intervention and were given a memo about actiwatch use (appendix 13). The 
intervention session lasted around thirty minutes. 
During the three weeks intervention there were two informal contacts (the third 
and the fourteenth day of the intervention) over the phone, lasting no more than 10 
minutes each, during which the QHR was reinforced. Two days prior to the end of 
the intervention period the researcher gave participants the EEG recording equipment 
and reminded them how to use it. The morning after the second EEG night, 
participants met with the researcher and filled in the PSQI. The researcher collected 
comments (verbatim) about their sleep and how they felt about the intervention. 
Participants returned the EEG recording equipment, the sleep and adherence diary 
and the Actiwatch. They were fully debriefed and their sleep results were sent to 
them within a month. This session lasted around forty-five minutes. 
4.3.5 Data Analysis 
Efficacy of the QHR was explored via subjective (sleep diary) and objective 
(PSG recording) measures of SOL and WASO. Daily sleep diary data were first 
analysed by visual inspection of graphic representations, a standard method used in 
single case studies (Franklin, Gorman, Beasley and Allison, 1996). Thereafter 
Interrupted Time Series Analyses (ITSACORR, Crosbie, 1993) were conducted to 
determine whether visually observed changes between baseline and post intervention 
were statistically significant. Time series analysis permits identification, across 
adjacent (baseline and treatment) phases in an experimental design, of level change 
(abrupt change in the mean level of the data) and slope change (gradual change) once 
the treatment is introduced. 
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In accordance with Lichstein and Fischer's (1985) and Kazdin's (1980) proposal, 
the following indices of clinical significance of results (therapeutic gains obtained at 
outcome) were employed: i) SOL and WASO shorter than 31 minutes and SE greater 
than 85%, ii) PSQI global score equal to or less than 5 (which measure provided 
collateral validation of measures obtained via sleep diaries) and iii) individual subject 
variable effect sizes. These were calculated by dividing the pre-post treatment 
change by the pooled standard deviation. A positive effect size indicated a reduction 
in insomnia symptomology. 
No inferential statistics were calculated for objective sleep data or adherence. 
Objective sleep continuity data were compared to subjective data. As already 
mentioned, Biosleep provides pseudo R&K and sleep architecture values were 
reported. Adherence scores and participants' comments regarding applying the 
QHR were reported. 
4.4 Results 
4.4.1 Participants' Characteristics 
Participant P1 was a 25 years old male complaining of both sleep onset and sleep 
maintenance difficulties since the age of sixteen. He could not relate the onset of 
sleep difficulties to any particular event. He had a higher degree, was working full 
time, and shared a flat with two friends. He did not have a regular bed partner. 
Participant P2 was a female third year accountancy undergraduate student, 22 
years of age, who complained of having had sleep onset and sleep maintenance 
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difficulties for eighteen months (grandmother died). She was sharing a flat with two 
people and did not have a regular bed partner. 
Participant P3 was a 45 years old final year history undergraduate student, 
married and- with no children. His sleeping difficulties started in his mid-twenties 
probably due to shift work. His sleep difficulties had not disappeared despite having 
left the army (and shift work) for over 15 years. He complained of difficulties falling 
asleep. 
Participant P4 was a male support worker aged 32, who complained of both sleep 
onset and sleep maintenance difficulties and, particularly, of not feeling refreshed in 
the morning (non-restorative sleep). His sleep difficulties started when he was a 
teenager and his family moved from south of England to Scotland and he was teased 
at school for his accent. Criteria of psychophysiologic insomnia were met at intake, 
however, analysis of the three weeks baseline showed that all sleep parameters were 
within the norms for good sleepers (hence not confirming intake diagnosis). For this 
reason he was excluded from the study. He was fully debriefed, and the good 
sleeping guide prepared by Espie, together with a sleep relaxation tape, were given to 
the participant. 
4.4.2 Sleep Pattern Changes: Visual Inspection of Sleep Diary Data and ITSA 
4.4.2.1 Complaint of difficulty of fallin asleep (SOL) 
Figure 18 presents SOL data for P1, P2 and P3. Baseline values reflect typical 
sleep pattern variations inherent in insomnia with no indication of spontaneous 
improvement. Mean values for each phase are presented in table 8. 
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Following intervention with the QHR, Pl's mean SOL reduced by 24% (table 8) 
although visual inspection of figure 18a does not reveal a clear pattern of change. By 
contrast P2's SOL reduced by 35% and in particular only 3 out of the 23 treatment 
nights were in the clinical range (greater than 31 minutes) compared with 8 in the 22 
baseline nights. Visual inspection suggests reduced variability in sleep pattern. ITSA 
revealed a trend with regard to change in slope [t(39)= -1.75, p=0.08] from baseline 
to treatment for P1. With regard to P3, this participant never applied the QHR during 
the 21 intervention nights and it is not, therefore, surprising that no changes were 
observed between baseline and intervention periods. 
Fig. 18: Daily SOL at Baseline and Intervention 
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Fig. 18a: P1's dallySOL for baseline and Intervention 
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4.4.2.2 Complaint of difficulty of staying asleep (WASO) 
Figure 19 presents WASO data for P1, P2 and P3. Baseline values, again, reflect 
typical sleep pattern variations inherent in insomnia with no indication of 
spontaneous improvement. Mean values for each phase are presented in table 8. 
Fig 19: Daily WASO at Baseline and Intervention 
Fig. 11s: P1's daily WASO for baseline and Intervention 
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Visual inspection of fig. 19a suggests decrease in WASO for P1 confirmed by 
mean reduction of 28 minutes (67%, table 8), in particular 14 out of the 21 nights of 
baseline were in the clinical range (greater than 31 minutes), but none of the 23 post- 
intervention nights were. Reduction in WASO for P2 was less marked (37%) 
nonetheless 5 of the 23 post-intervention nights were in the clinical range compared 
with 9 out of the 22 baseline nights. It should be noted that she was camping at a 
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concert site during nights 10,11 and 12 of the intervention phase and people were 
coming and going all night. ITSA confirmed a significant overall change 
[F(2,39)=4.61, p=0.02] and a significant change in slope [t(39)= -2.06, p=0.05] from 
baseline to treatment for participant P1. 
4.4.3 Clinical Significance 
Clinical significance was evaluated on three indices: end state scores for SOL, 
WASO, S. E. and PSQI global score change and effect sizes. In particular clinical 
significance was measured on two criteria: a post-treatment change over baseline 
greater than 50% (Lichstein and Fischer, 1985) and/or the individual has moved from 
the dysfunctional to the functional range (Kazdin, 1977). 
As depicted in table 8, Pl's WASO and S. E. and P2's SOL and WASO returned 
within the normative average range following intervention. In addition, outcome 
measure on the PSQI showed a significant improvement following QHR intervention 
for both participants. Although their PSQI scores did not quite fall below the 
recognised threshold for sleep disturbance (55) scores were reduced by 50%: from 
13 to 6 (P1) and from 14 to 7 (P2) respectively. It is noteworthy that a significant 
improvement was found for the PSQI component score `subjective sleep quality', 
which changed, following intervention, to `fairly good' for both P1 and P2 (table 8). 
Finally, SOL effect sizes were in the small to medium range, and WASO and S. E. 
effect sizes in the medium to large range for both participants. With regard to P3, he 
did not show positive changes in the above mentioned values following treatment. 
His PSQI score changed from 9 to 8 and his PSQI component score 'subjective sleep 
quality' changed from `fairly bad' to `fairly good'. 
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la) Mean (SD) for SOL WASO and SE at baseline and post- intervention, 
post-treatment changes and effect sizes 
Baseline Post-Interv Pre to Post Change Treatment 
Value 17f EtTect Size 
PI 47.1(33.4) 35.6(25.3) - 11.5 24.4 0.39 
P2 45.0(50.3) 29.1(40.6) - 15.9 35.3 0.35 
P3 74.5( 8.3) 73.4( 4.0) - 1.1 1.5 0.17 
P1 42.9(19.0) 14.3(14.4) - 28.6 66.6 1.69 
P2 40.2(36.3) 25.2(35.4) - 15.0 37.3 0.42 
P3 4.5(6.5) 13.4(20.6) + 8.9* 66.4 *-0.58* 
WASO worsen ed in the intervention period 
S. E. (%) 
P1 75(11) 86(11) II 14.6 
P2 64(16) 74(14) 10 15.6 
P3 84(03) 82(05) - 2* 2.4* 
* this value shows a deterioration of sleep variables from baseline to F 
Ib) PSQI at 1'` day baseline and 23 `d day post-intervention 
O. y1) 
0.67 
- O. 75* 
t-trea(Illellt 
PSQI global score PSQI `subjective sleep quality' component 
Baseline Post-Interv Baseline Post-Interv 
P1 13 6 Fairly bad Fairly good 
P2 14 7 Very bad Fairly good 
P3 98 Fairly bad Fairly good 
4.4.4 Objective Sleep Continuity Data 
Table 9 presents the sleep continuity and sleep architecture data recorded during 
the second night of baseline and the last night of treatment. 
Inspection of table 9 shows that Participant Pi's objective SOL and WASO were 
shorter the last night of treatment than at baseline, participant P2's SQL decreased 
and participant P3's SOL and WASO increased. The objective and subjective data do 
not show any clear association. It is noteworthy that pseudo R&K values for REM 
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are extremely high as compared to those reported in the literature (p. 16) for hoth 
normal and poor sleepers. 
Table 9- Sleep Continuity Variables gathered by PSG at Baseline (night 2) 
and during the Last Night of Treatment Phase (and correspondent diary values) 
BASELINE END OF TREATMENT 
PSG Diary Pseudo R&K PSG Diary Pseudo R&K 
Participant Pl 
S. E. 0.92 0.61 0.98 0.97 
WASO 29 60 70 
SOL 9 40 1 15 
% REM 54.9% 85.2% 
% Stage 1 12.2% 12.6% 
% Stage 2 20.3% 22% 
% Stage 3&4 12.6% 0.0% 
Participant P2 
S. E. 0.95 0.88 0.92 0.97 
WASO 9 0 30 0 
SOL 10 30 1 20 
% REM 39.5% 40.2x% 
% Stage 1 3.8% 20.7% 
(/ Stage 2 11.1% 12.8% 
% Stage 3&4 45.6% 26.2(7( 
Participant P3 
S. E. 0.98 0.71 0.93 0.79 
WASO 4 35 25 15 
SOL 0 80 23 80 
% REM 54% 58% 
% Stage 1 13% 15% 
% Stage 2 20% 17% 
% Stage 3&4 13% 10% 
4.4.5 Adherence with the Quarter of an Hour Rule 
Participant P1 reported (daily adherence diary) applying the QHR at SOL 93%%c of' 
the times (14 of 15) he was not asleep within a quarter of an hour. Data gathered via 
actigraphy showed that there was movement on 13 occasions. With regard to WASO 
participant P1 stated that he never had to apply the rule. However, actigrahhv 
recorded seven periods of movements greater than 16 minutes suggesting that he 
should have applied the rule at least 7 times during the intervention phase. 
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P2 applied the QHR 70% of the times (12 of 17) she was not asleep within a 
quarter of an hour at SOL and data gathered via actigraphy confirmed that there was 
movement at SOL in 12 occasions. With regard to WASO, participant P2 applied the 
rule only 29% of the times (2 out of 7) she did not return to fall asleep within 15 
minutes and actigraphy detected movement on 7 occasions. 
Participant P3 never applied the rule. 
4.4.6 Adherence Comments 
PI commented that he wanted to "really give it a try", noticed the intervention 
helped his sleep and this, in turn, made him "more determined to follow the rule ". 
he enjoyed "reading my book" instead of "turning in my bed wondering whether I 
will fall asleep and thinking about everything until eventually I fall asleep ". 
P2 felt that by staying in bed, even if awake, she could not be blamed for her poor 
sleep "It shows I am really trying to sleep it is not my fault if I can not". For the 
same reason it was hard for her to stay up till she felt ready to sleep again "I feel 
obliged to go back and try hard to sleep". Having the QHR to apply enabled her to 
"get rid of the blame" and, therefore, to "stop trying harder and harder and getting 
more frustrated'. 
P3 did not apply the rule. When the researcher met the participant to debrief him, 
he said that he had realised that "family and friends know I don't sleep" and "I can 
get on with my study and things at my own pace". He told the researcher that not 
sleeping much at night and then having a nap actually suited him ok. 
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4.5 Discussion 
In this section results are discussed in relation of the feasibility of employing the 
QHR as a stand alone therapy and in relation to design improvements for the main 
study (study three). A more general discussion is provided when results of the main 
study are analysed and general issues raised. 
4.5.1 Summary of the Results 
The primary aim of this study was to explore if the QHR would reduce 
symptomatic sleep complaint at a meaningful clinical level. In addition, this study 
explored the possibility of acquiring meaningful PSG data by recording at one site 
only. Finally this study assessed daily adherence and participants' comments 
regarding the implementation of the QHR. The feasibility of actigraphy to measure 
adherence objectively was also explored. 
Two specific predictions were made. The first prediction was that, following the 
QHR, participants' estimates of SOL and WASO would be reduced and S. E. 
increased. This prediction was partially supported. Inspection of SOL and WASO 
mean and raw score values suggested that the QHR was associated with positive 
improvements in the two participants (P1 and P2) who applied the QHR. 
Conservative time series analyses evidenced statistically significant changes in 
WASO, and a trend toward significance for SOL for participant P1. Objective 
measures of sleep did not show a clear trend: P1's SOL and WASO and P2's SOL 
were reduced. 
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The second prediction was that the QHR would produce clinically significant 
improvements. This prediction was also supported. WASO of participants P1 and P2, 
P2's SOL and P1's S. E. fell within the normative range at post-treatment and their 
PSQI global scores were reduced by 50%, approaching normal range. 
Another aim of this study was to collect adherence information. Results 
suggested that better adherence (participant P1 reported following the QHR most of 
the time) was associated with more convincing data evidencing change (including 
ITSA). It is noteworthy that participant P2 obtained therapeutic gains despite partial 
adherence to the protocol. Importantly participant P3 never adhered to the QHR and, 
indeed, his sleep did not improve. 
With regard to objective measures of sleep acquired via Trackit and analysed via 
a novel program requiring EEG recording at one site only, no clear patterns were 
found. Importantly, sleep architecture data differed greatly from those reported in 
EEG literature for both normal and poor sleepers. 
4.5.2 Interpretation of the Results 
As reported in the previous section, following the QHR sleep difficulties were 
decreased in two out of three participants. With regard to the participant whose sleep 
did not improve, it is noteworthy that he never adhered to the QHR. Interestingly, 
these results are comparable to those obtained in previous studies of the full stimulus 
control treatment and of multicomponent CBT (Morin et al, 1994). 
Effect size calculations indicated that treatment gains were in the small to 
moderate range for SOL and in the moderate to large range for WASO. Previous 
studies have reported larger effect sizes for SOL (Morin et al, 1994; Morin et al, 
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1999; Murtagh and Greenwood, 1995) but initial insomnia severity in the present 
study was moderate thus limiting power. Indeed, a positive relationship between 
SOL and WASO reductions and initial insomnia severity in clinical samples has been 
found in previous studies (Espie et al, 2001; Lacks et al, 1983a). 
Importantly, for the two participants who applied the intervention, improvements 
were also clinically significant with sleep parameters and PSQI scores reduced by 
50% or returned to normalcy. Furthermore both participants PI and P2 reported 
greater satisfaction with their sleep. This is an important finding as perception that 
one's quality of sleep has improved, rather than insomnia symptoms simply being 
less, might be critical to reduce the psychological distress often accompanying 
insomnia (Morin et al, 1994). Subjective distress may be the primary motivation 
prompting people with insomnia to seek treatment (Stepanski, Koshorek, Zorick, 
Glinn, Rohers, and Roth 1989). 
In sum, three weeks after the delivery of the QHR (a single session intervention 
requiring 30 minutes to be delivered) positive effects, on both quality of sleep and 
sleep parameters, were obtained. 
Adherence data are important both from a clinical (adherence-response 
relationship) and theoretical (mechanisms of effect) point of view. An interesting 
finding, which highlights the need to research the issue systematically, regards the 
adherence-response relationship. Chambers (1992) proposed that adherence might be 
the most important factor in treatment success: indeed, better adherence (P1) was 
associated with more convincing data evidencing change (including ITSA). 
However, despite partial adherence to the protocol, therapeutic gains were also 
obtained by participant P2. This was an unexpected result: in light of Bootzin and 
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Epstein's (2000) suggestion that, for stimulus control to work, participants must 
follow the instructions `fastidiously' (p. 175), it was assumed that the QHR was to be 
followed consistently and rigorously to produce sleep changes. Perhaps factors other 
than adherence (e. g. feeling in control) played a role. 
Participant P1's comments suggest that the QHR might help the individual to feel 
differently about the time spent awake: rather than a frustrating period it becomes 
acceptable, even enjoyable. Speculatively, it could be argued that the QHR, by 
preventing the individual from using the time awake worrying, enabled him to reach 
the `right conditions' to fall asleep. On the other hand, it is possible that the QHR 
`broke' the association bedroom-wakefulness (i. e. sleep improvements were due to 
good stimulus control) but that the participant interpreted sleep improvement in a 
cognitive way. 
Participant P2 waited longer than fifteen minutes before applying the QHR most 
times (67%) and her comments, not only highlight one of the causes of non- 
adherence, but are also an example of `effortful sleep' typical of insomnia yet so 
atypical of `normal sleepers' (Espie, 2002). However, her sleep improved and it 
could be, tentatively, suggested that the QHR by removing her responsibility for not 
being able to sleep (she would have tried harder but the QHR did not allow her) 
enabled her to `do nothing' and hence fall asleep. As proposed by Espie (2002) good 
sleepers do not try or do something to fall asleep: they just seem to do it. 
Overall these comments are in line with Zwart and Lisman's (1979) proposal that 
stimulus control might work by disrupting cognitive activity at bedtime: be it 
thinking, planning, trying to sleep. Indeed, the six participants in Turner and 
Ascher's (1979a, b) studies pointed out that stimulus control provided them with a 
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means of'avoiding thinking while lying in bed. Although this is an interesting 
proposal further, direct testing, of this hypothesis should be devised. 
This study suggested that home PSG was well tolerated as participants 
commented on Trackit being easy to carry around (e. g. going to the bathroom, 
watching TV in the sitting room, making a cup of tea) and that the recording 
equipment minimally disrupted their usual sleep. However, Biosleep output 
displayed very high percentage of REM sleep and little percentage of Stg 2 sleep as 
compared to PSG scored according to R&K guidelines. This finding argues against 
recording EEG at only one site and analysing data employing Biosleep because 
output does not seem valid. 
In sum, this exploratory study highlighted that the QHR, requiring only 30 
minutes to be explained, might be a promising therapy for insomnia. In addition 
home PSG was well tolerated and participants reported that they were able to apply 
the QHR. 
4.5.3 Considerations for the main study 
As summarised and discussed in the previous section the results of this 
preliminary study are encouraging: one single session followed by a couple of 
telephone contact were sufficient to decrease sleep difficulties and outcomes were 
clinically significant. The two participants, who applied the QHR, responded quickly 
to treatment, reported good adherence and that home PSG was minimally intrusive. 
Furthermore this study highlighted changes to the methodology so as to better 
calibrate the main study. In particular the following points were noted. 
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First, the single case methodology permits assessment of an intervention fairly 
quickly and at modest cost and it is, therefore, well suited to test novel interventions. 
Indeed, the present single case study suggested that the QHR, a novel intervention 
requiring minimal contact with the therapist, decreases sleep difficulties. However, 
without a contrast intervention it is hard to assess whether any therapeutic gains are 
attributable to the QHR itself or to other factors such as passage of time or contacts 
with a therapist or the measurement process itself (i. e. monitoring one's sleep). The 
randomised controlled trials, which compare two or more treatments (one of which 
can be no-treatment) can help to address this issue. It seems, therefore, advisable, to 
carry out the next study employing this methodology. 
Second, although participants to the present study met criteria for 
psychophysiological insomnia, they were self-referred. In order to explore the 
generalisability of the QHR outcomes the main study involved GPs' and consultants' 
referred participants. 
Third, in order to shed light on whether the mechanisms of effects of the QHR are 
purely due to environmental conditioning and the re-establishment of good stimulus 
control, a counter control intervention (Zwart and Lisman, 1979) could be employed. 
For this reason a counter QHR instructing participants to apply the QHR in bed was 
devised and its outcomes contrasted to those of the canonical QHR. 
Fourth, although actigraphy may have a value in monitoring adherence, the 
present study highlighted that actigraphy can only indicate if the person is moving 
but does not evidence whether the QHR is actually adhered to. It was reasoned that if 
the QHR asked participants to read if not asleep, then actigraphy with the added 
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feature of a light detector would enable measurement of adherence to the rule. In the 
main study objective adherence was, therefore, measured with actigraphy plus light. 
Fifth, the pilot study highlighted that home PSG is feasible and well tolerated but 
that Biosleep has limited validation: it produces pseudo R&K and data seems 
implausible (note the REM for example). In the main study home PSG was carried 
out according to insomnia PSG recording criteria so as to enable traditional R&K 
scoring and interpretation of the collected EEG data. 
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Chapter 5 
Study Three 
Impact of the quarter of an hour rule intervention, implemented 
in bed and out of bed, on sleep parameters 
5.1 Rationale 
The results obtained with the single case studies in the preliminary study (study 
two, chapter 4) suggested that the QHR might be a promising therapy for insomnia 
and, therefore, worth exploring in a more systematic way. In addition, taking into 
account the methodological shortcomings highlighted by the preliminary study, a 
number of changes were made with regard to sleep measurements, objective 
measurement of adherence and procedure. Furthermore, sleep related questionnaires 
were introduced in order to shed light on the mechanism of effects of the QHR. The 
QHR was administered in two different formats and a control group was added. 
Briefly, this study comprised three groups (QHR in bed, QHR out of bed and 
Control). Similarly to the preliminary study sleep parameters were measured 
subjectively and objectively; however, unlike study two, home PSG measurements 
were performed employing traditional recording sites as per R&K (Rechtschaffen 
and Kales, 1968). As in study two objective and subjective measures of adherence 
were also collected; however the objective measure of adherence incorporated both 
detection of movement and light. Finally, a battery of sleep related questionnaires, 
tapping into sleep related cognitions, behaviours and arousability at bed time, was 
administered at baseline and at the end of the intervention. 
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5.2 Aims and Hypotheses 
The first aim of study three was to assess whether the QHR, proposed to capture 
the essence of the stimulus control therapy for insomnia, could be employed to 
reduce sleep difficulties in a clinical population. 
The second aim of the present research was to explore possible mechanisms of 
effect of the QHR. This exploration was carried out by devising two QHR 
interventions: one to be implemented out of bed (QHRout) and one to be 
implemented in bed (QHRin). Additionally, sleep related questionnaires measuring 
sleep behaviours and cognitive activity at bed time were employed. 
The third aim was to investigate the relationship between adherence and 
treatment response and to look into the feasibility of an objective measurement of 
adherence. 
Specifically the following predictions were made: 
. First, resting on the same bases discussed in the rationale of study two, it was 
predicted that participants' self reported SOL and WASO would be reduced and TST 
and S. E. increased following the QHRout intervention. 
The second prediction rested on evidence presented in the introduction (Alperson 
and Biglan, 1979; Zwart and Lisman, 1979; Davies et al, 1986) that a procedure 
named `countercontrol' improved sleep. Specifically, it was predicted that self- 
reported SOL and WASO would decrease and TST and S. E. would increase 
following the QHRin intervention. 
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Third, it was predicted that, differently from the QHRout and the QHRin 
interventions, the control group condition would not impact on SOL, WASO, S. E. or 
TST. 
Fourth, it was predicted that the outcome measure PSQI (Buysse et al, 1989) at 
the end of the intervention would be reduced, as compared to baseline, in both QHR 
groups. No changes in PSQI were expected for the control group. 
Fifth, improvements in reported qualitative measures of sleep (i. e. quality of 
sleep, restedness and alertness upon awakening in the morning) were expected 
following intervention only for the active treatment groups. 
Sixth, in view of evidence that stimulus control produces clinically significant 
changes (e. g. Bootzin, 1972; Sanavio et al, 1990) and the results of the pilot study, it 
was predicted that participants in the active treatment groups would meet criteria for 
clinically significant changes as compared to the control group. However, no 
predictions were made with regard to the differential magnitude of improvements 
obtained with the two different administrations of the QHR. 
No firm predictions were made with regard to sleep related cognitions (e. g. sleep 
effort, sleep beliefs) and arousability at bedtime measured via questionnaires. As 
discussed in the introduction a number of authors (e. g. Espie, 1991, Turner and 
Ascher, 1979a, b; Zwart and Lisman, 1979) have suggested that stimulus control 
reduced sleep difficulties not only by re-conditioning mechanisms but also by 
decreasing cognitive interference. If this was the case then a decrease in cognitive 
activity would be expected. In contrast, if the mechanisms of effect were solely 
related to re-conditioning then no differences in sleep related cognitions should be 
found. 
147 
Taking into account that previous research has produced mixed results with 
regard to objective changes following non-pharmacological insomnia interventions 
(Stepanski, 2000) no firm predictions were made with regard to changes in PSG 
defined sleep. 
Seventh, it was predicted that sleep continuity parameters measured via PSG and 
via sleep diary would be positively correlated. This prediction rests on evidence (e. g. 
Carskadon et at, 1976; Schramm et at, 1995) that sleep diary and PSG are correlated 
although sleep continuity parameters seem to be inflated as compared to objective 
ones. 
The eighth prediction rested on claims that adherence might be an important 
aspect of treatment response (section 1.81): specifically it was predicted that greater 
adherence to treatment would be associated with better outcomes. 
The third study set out to test these eight predictions and to shed light on the two 
research questions. 
5.3 Methods 
5.3.1 Design 
This was a randomised experimental controlled trial (Clinical Registration N. 
NCT00170391) investigating the efficacy of the QHR carried out in bed (QHRin) 
and out of bed (QHRout) as compared with a sleep self-monitoring group (control), 
using parallel measurements of objective and subjective sleep parameters, taken at 
baseline and post-treatment. The impact of the QHR interventions on a number of 
cognitive factors was investigated by employing six, well-validated questionnaires. 
They are commonly used in sleep research (section 5.3.3.2a provides a detailed 
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explanation of the questionnaires used). Finally, the impact of adherence was also 
investigated both subjectively (adherence diary) and objectively (actigraphy plus 
light). Randomisation was performed by the statistics department at Glasgow 
University: a random sequence, controlling for participants' gender, was generated 
by SPSS. 
This quasi-experiment with a mixed design had one between subject factor 
`Group' with three levels ('QHRout', 'QHRin' and `control') and one within subject 
factor `Time' with two levels ('baseline' and `end of treatment'). 
Table: 10 - Dependent Variables for PSQI, Sleep Continuity, Sleep Quality, 
Questionnaires and Adherence with the QHR 
Subjective Objective 
Diary Questionnaire PSG ACTW. L 
PSQI 
PSQI Total Score --  -- -- 
Sleep Continuity 
SOL (minutes)  --  -- 
WASO (minutes)  _  
S. E. (%)  _  -. 
TST (minutes)  --  
Number of Arousals -- --  
Sleep Quality 
Quality of Sleep (0-4)  _ -- 
Restedness (0-4)  -- -- 
Alertness (0-4)  _ _ -- 
Stage 1&2 (%) -- --  -- 
Stage 3&4 (%) -- -  
REM (%) -- --  -- 
Sleep related Cognitions 
Q1: Total Sleep Behaviour --  -- 
Q2: Glasgow Sleep Effort --  -- -- 
Q3a: Physical Tension --  -- -- 
Q3b: Sleep Pattern Problem -  -- -- 
Q3c: Cognitive Arousal --  -- 
Q3d: Sleep Effort --  -- -- 
Q4a: Problem Solving --  -- 
Q4b: Sleep & Wakefulness --  -- -- 
Q4c: Somatic & Sensory Engagement --  _ -- 
Q5a: Cognitive Arousal --  -- 
Q5b: Somatic Arousal --  -- -- 
Q6a: Immediate Consequence of Insomnia --  -- -- 
Q6b: Long-term Consequence of Insomnia --  _ -- 
Q6c: Need for Control over Insomnia -  -- -- 
Adherence with the QHR 
Adherence score at SOL (0-10)  -- --  
Adherence score at WASO (0-10)  -- --  
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Separate analyses were conducted for sleep data gathered subjectively (on the 
basis of participants' responses to a nightly sleep diary) and objectively (on the basis 
of PSG recordings). The sleep continuity dependent variables (DVs), sleep quality 
DVs, battery of questionnaires DVs, adherence with the QHR DVs and whether they 
were objectively or subjectively collected are listed in table 10. 
5.3.2 Participants 
Eighty-three individuals were screened. They were recruited via GP practices, a 
sleep clinic at the Southern General Hospital and via a media advertisement. People 
who responded to the media advertisement were invited to speak to their GP and ask 
to be referred. Participants' insomnia was assessed according to DSM-IV (APA, 
1994) and ICSD-R (ASDA, 1997) diagnostic guidelines first during a telephone 
interview and then during a face-to-face interview. 
Inclusion and exclusion criteria were identical to those applied in the preliminary 
study (study two, section 4.3.2). Thirty-nine possible participants were excluded, 
after assessment, due to the following: aged over 75 (n=4), drug use (n=1), alcohol 
use (n=5), suspected sleep apnoea (n=9), suspected PLMS/RLS (n=4), pain (n=4), 
shift-work (n=2), suspected sleep terrors (n=1), PTSD (n=2), physical illnesses (n=5) 
and nightmares (n=2). 
A cohort of 44 participants entered the study, however, one participant withdrew 
from the study after ten baseline days due to personal circumstances. The first PSG 
night confirmed that the 44 individuals included in the study did not present with 
sleep disorders other than insomnia. 
Six participants completed the study for all phases but the last PSG recordings (5 
participants informed the researcher that they could not undergo the two PSG nights 
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due to family circumstances, one was deemed to be distressed on the night of the 
recording and, therefore, the researcher decided not to perform PSG assessment). In 
addition, one participant did not complete the diary during the treatment phase and 
one participant's diary was lost in the post. Finally, four participants did not return 
the end of treatment battery of questionnaires. 
In summary baseline and treatment diary data and PSQI scores were gathered 
from 41 participants, baseline and end of treatment PSG data from 37 participants, 
complete sleep continuity and sleep quality data (diary and PSG) were obtained from 
35 participants. Baseline and end of treatment questionnaires were available for 39 
participants (flow chart as per Consort guidelines in fig. 25). 
Demographic and clinical characteristics of participants in each group are 
summarised in table 11. In brief, participants' mean age was 47.5 years, there were 
29 females and 15 males, 25 were living with a partner and 19 were living alone, 28 
were in full employment, 4 were in full time education and 12 were retired. They 
were all educated at college level or above. 
5.3.3 Materials and Apparatus 
5.3.3.1 Screening Interview 
The screening interview was identical to that used in study two (section 4.3.3.2b). 
Although reliance on self-report for screening out sleep disorders other than 
insomnia is prone to error (Hoffestein and Szalai, 1993) it provides a cost-effective 
way to initially screen each potential participant reducing, therefore, the number of 
(costly) PSGs to be carried out. 
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5.3.3.2 Subjective Measurements of Sleep and Sleep Related Questionnaires 
5.3.3.2a Sleep Diary 
The sleep diary was the same as that used in study two (section 4.3.3.1 and 
appendix 5). As in study two the variables retained from the sleep diaries were SOL, 
WASO, S. E. and, in addition, TST. 
5.3.3.2b Sleep Related Questionnaires 
As in study two the PSQI (Buysse, et al, 1989) and the HADS (Zigmond and 
Snaith, 1983) were administered (sections 4.3.3.2a and 4.3.3.2c and appendixes 4 
and 6 respectively). 
In addition psychological measures associated with sleep were collected by 
means of a battery comprising six, well validated, sleep related questionnaires that 
focus on symptoms, interpretation, cognitions and behaviour that may accompany 
sleep complaints. 
Sleep Behaviour Self Rating Scale - Revised (SBSRS-R Kohn and Espie, 2005) 
is an experimental measure of the behavioural pattern around bedtime and it is a 
revised form of the original one produced in 1979 (Kazarian, Howe and Csapo, 
1979). The revised version comprises 14 statements (appendix 14) rated on a5 point 
Likert scale (`Never', `Rarely', `Sometimes', `Often', `Very Often'). The total score 
ranges from 14 to 70. It was developed to assess sleep incompatible behaviour 
associated with a person's bed/bedroom and it is the only published scale to quantify 
the stimulus control paradigm. Test-retest correlation was r=0.88 indicating 
acceptable reliability; internal consistency and discriminant validity were also 
acceptable (Cronbach alpha=0.69, K-R 20 =0.70). 
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The Glasgow Sleep Effort Scale (GSES, Broomfield and Espie, 2005) is 
composed of 7 statements measured on a 3-point Likert scale (`Very Much', `To 
Some Extent', `Not at all') and the total score ranges from 0 to 14 (appendix 15). It 
measures elements of effortful preoccupation with sleep (e. g. worrying over sleep 
and failure to sleep, need to control one's sleep). It has acceptable internal 
consistency (Cronbach alpha=0.77). 
Sleep Disturbance Questionnaire (SDQ, Espie et al, 1989,2000) comprises 12 
statements (appendix 16). Using a5 point Likert scale (`Never True', `Seldom True', 
`Sometimes True', 'Often True', `Very often True') participants had to indicate what 
factors they perceived to be the sources of their sleep problem (e. g. `I get too "worked up" 
at not sleeping'). This questionnaire differentiates four sleep interfering factors. In 
particular items 1,5 and 9 give a total score for `physical tension', items 3,7 and 11 
for `sleep pattern problems', items 2,6 and 10 for `cognitive arousal' and items 4,8 
and 12 for `sleep effort'. Each of these 4 factors' total score ranges from 3 to 15. It 
has good internal consistency (Cronbach alpha=0.82). 
Glasgow Content of Thoughts Inventory (GCTI, Harvey and Espie, 2004) 
comprises 25 items scored on a4 point Likert scale ('Never', 'Sometimes, ', `Often' 
and `Always') (appendix 17). It measures the types of thoughts people have while 
trying to get to sleep and gathers a score for three different constructs: `cognitive 
intrusions relating to active problem solving' (items 1,3,8,12,14,15,19,21 and 23 
with a total score range from 9 to 36), `cognitive intrusions relating to sleep and 
wakefulness' (items 5,6,7,9,11,18,22,24 and 25 with a total score range from 9 
to 36) and `cognitive intrusions relating to somatic and sensory engagement' (items 
2,4,10,13,17 and 20 with a total score range from 7 to 28). Internal consistency is 
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good (Cronbach alpha=0.87) and test-retest reliability using the intra-class 
correlation coefficient was found to be highly satisfactory (ICC=0.87, p<0.001) 
Pre-Sleep Arousal Scale (PSAS, Nicassio et al, 1985). The PSAS is a sixteen 
item questionnaire using a 5-point rating scale (not at all, slightly, moderately, a lot, 
extremely) assessing the intensity of pre-sleep somatic and cognitive aspects of 
arousal (appendix 18). Higher scores indicate greater arousal. Eight items assess 
cognitive arousal (e. g. `thoughts keep running through your head') and eight assess 
somatic arousal (e. g. `a tight tense feeling in your muscles') that can be experienced 
in the pre-sleep period. Scores of the two sub-scales (each scale ranges from 8 to 40) 
are computed separately by summing across cognitive and somatic arousal items. 
This scale is a helpful screening measure to discriminate poor from good sleepers. 
Somatic and cognitive sub-scales were shown to be internally consistent and stable 
over time (Cronbach alphas ranged from 0.68 on the cognitive subscale to 0.88 on 
the somatic subscale; 3 week test-retest correlations ranged from 0.72 on the 
cognitive to 0.76 on the somatic subscales). Mean scores of people with insomnia 
were significantly higher than those of normal sleepers on scores for both subscales. 
On the cognitive subscales means for those with and without insomnia were 
M=15.2(5.3) and M=11.34(3.4), respectively. 
Dysfunctional Beliefs and Attitudes about Sleep -10 (DBAS-10, Espie, Inglis, 
Harvey and Tessier, 2000) is a 10 item scale rated on a visual analogue scale 
concerning sleep-related beliefs (e. g. needing 8 hours of sleep per night) (appendix 
19). It is based on the original 30 item scale (Morin et al, 1993) but limited to items 
shown to be sensitive to change after CBT. It has acceptable internal consistency 
(Cronbach alpha=0.69). It measures the types of beliefs people hold regarding 
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insomnia and yields a score for three different constructs: `beliefs about the 
immediate negative consequences of insomnia' (items 1,2,6,7 and 9 with a total 
score ranging from 0 to 50), `beliefs about the long term negative consequences of 
insomnia' (items 3,5 and 8 with a total score ranging from 0 to 30) and `beliefs 
about need for control over insomnia (items 4 and 10 with a total score ranging from 
0 to 20). Its validity has been recently supported (Edinger, Wohigemuth et al, 2001). 
Credibility/Expectancy Questionnaire (modified). The original questionnaire 
was developed by Devilly and Borkovec (2000) and comprised six items using a 9- 
point rating scale (not at all, .., very). It measures rationale credibility 
(items 1,2,3 
and 5) and treatment expectancy (items 4 and 6). The credibility factor was found to 
possess high internal consistency (Cronbach alphas ranged from 0.81 to 0.86), inter- 
item correlations across studies ranged between 0.62 and 0.78 and test-retest 
reliability was 0.75. In the present study only the four items of the credibility 
subscale were used. Furthermore the words' `trauma symptoms' were changed to 
`sleep difficulties'. In the present study the four items were measured on a 4-point 
scale (not at all, somewhat, quite, very) (appendix 20). 
5.3.3.3 Objectively Measured Sleek 
Data for objective sleep measures were obtained using PSG. These included data 
obtained from EEG, EOG and EMG (section 5.3.3.3a). The objective measures of 
sleep were acquired via an ambulatory recording device (section 5.3.3.3b) and 
downloaded to a proprietary software package (section 5.3.3.3c). They were then 
manually scored according to R&K manual (section 5.3.3.3c). 
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5.3.3.3a Objectively Measured Sleep 
EEG was recorded at 4 scalp sites (C3, C4, Ol , 02) according to the 10-20 
international electrode system (Jasper, 1958) (fig. 20) using an ambulatory 
EEG/polygraphy recorder referenced to Cz. 
Fig. 20 - The 10-20 Electrode Placement 
International System 
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(LOC, ROC). System reference (the 
mean amplitude between Cz and the 
recording sites) was used for recording. 
Neutral was taken from Ez. The data 
were later re-referenced off line to the 
opposite mastoid bone (Al. A2). 
The montage, therefore, included 2 EOG referenced to the left and right mastoid 
(LOC/A2 and ROC/A 1), 4 EEG referenced to both mastoids (C3/A2, C4/A 1, O1 /A2, 
02/AI) and a bipolar mentalis EMG. EOGs and EEGs were high pass filter at 0.3 1 lz 
and low pass filtered at 70Hz. EMGs were high pass filtered at 2 Hz and low pass 
filtered at 120 HZ. Electrode impedance was kept below 5k12. 
The researcher had been trained in correct electrode attachment and electrode 
removal by Mrs Popadopoulos the chief EEG technician of the department of 
Neurology at the Southern General Hospital in Glasgow. 
5.3.3.3b Ambulatory Electroencephalogrant/Polygrcrph Recording Device 
The ambulatory EEG/polygraphy recording device was, the Trackit (Lifcline. s, 
Ltd), the same as that employed in study two (4.3.3.3a). 
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5.3.3.3c Analysis of the Polygraphic Recording 
Stellate Sleep System (Stellate Ltd, Canada) is a software package enabling the 
acquisition and storage of EEG data in a central database. It offers tools facilitating 
manual scoring of the recorded EEG (e. g. spindle detector tool, autonnatised division 
of the EDF file in 30 second epochs). An example of the sleep hypnogram and sleep 
report produced by Stellate is depicted in figure 21. The EEG acquired via Trackit 
was stored in EDF format. The EDF file was, subsequently, uploaded in Stellate 
Reviewer and manually scored by an expert PSG technician according to R&K 
(Rechtschaffen and Kales. 1968) guidelines. Thereafter, Stellate summarised the 
scored file in sleep reports which contain, among others, SOL, WASO, 'I'ST, S. E?., 
sleep stages and micro/mini arousals data. 
Fig. 21 - An example of a PSG scored record and relative sleep report. The PSG recording is manually 
scored and staging for each epoch is memorised in Stellate and thereafter a Sleep Report is gcncraii d by 
the Stellate Software 
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5.3.3.3d Sleep Scoring 
The PSG recordings were blind scored in 30-second epochs from lights off to 
lights on according to R&K's (Rechtschaffen and Kales, 1968) standardised criteria 
by Ms Manon Lamy (Sleep Laboratory Coordinator, Universite' Laval, QC). Lights 
off and lights on were extracted by the `eventit' feature of Trackit: basically 
participants pressed a button on Trackit when they switched off the light and in the 
morning when they got up. The time of button pressing was recorded by Trackit and 
retrieved by the experimenter at a later stage. The C3, EMG and EOG areas were 
used for scoring. However, for correct detection of the waking stage (EEG alpha 
activities), the 02 area was used as well. If C3 and/or 02 recordings were difficult to 
score due to artifact contaminations, C4 and/or 01 were used as alternatives. TIB 
was calculated from lights off to lights on. EEG defined sleep onset was scored as 
the occurrence of 3 consecutives epochs of stage 1, or 1 epoch of stage 2,3,4, or 
REM. 
Thus sleep continuity variables were as follows: SOL was the amount of time 
elapsed in minutes from lights off to sleep onset, WASO was the sum of wake time 
in minutes from sleep onset to the last REM or NREM sleep episode, TST was the 
sum of NREM and REM sleep in minutes. The epochs contaminated by body 
movements for longer than half the epoch (i. e. 16-30 sec) were scored as movement 
time. Micro-and mini- arousals were computed visually according to the criteria of 
the American Sleep Disorders Associations (ASDA, 1992). 
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5.3.3.4 Subjective Measurement of Adherence 
As in study two, adherence to the QHR was measured daily. In particular 
measurement of adherence to the QHRout diary was identical to that employed in the 
pilot study and gathered information such as the need to apply the QHR and whether 
it was applied or not (section 4.3.3.6 and appendix 7). The only difference between 
the adherence diary for the QHRout and QHRin (appendix 21) concerned the 
location where the rule was to be applied (e. g. `Did you go to another room'? ' and 
`Did you sit up in bed? ' respectively). 
5.3.3.5 Objective Measurement of Adherence 
In the next two subsections actigraphy and the algorithm devised, by the 
researcher, to obtain an adherence score for objectively measured adherence are 
presented. 
5.3.3.5a Actigraphv 
The Actiwatch-Light (ACTW-L - Cambridge Neurotechnology Ltd) is similar tu 
the Actiwatch used in study two (section 4.3.3.4 and figure 17). However. as shown 
on the left (fig. 22), the event button is replaced by a 
light detector. In this way in addition to collecting 
movement information, the ACTW-L measures light 
intensity via a lux sensor. 
Data collected using the ACTW-L were analysed via a software package 
produced by Cambridge Neurotechnology Ltd (Actiwatch sleep 2002). As shown in 
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Fig. 22: ACT\V-I. 
figure 23, this software produces an automated measure of sleep continuity and light 
during the recorded period. A string of numbers represents the amount of movement 
and the amount of lux (light) for each one-minute- epoch. 
Fig. 23 - On the left side the Sleep analysis of the data gathered with ACTW-L is presented: the black 
lines represent movement and the yellow lines represent light. On the left side the epoch by epoch output 
with activity and light is presented. 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5.3.3.5b - Adherence Algorithm and Adherence Score 
Given the interest in adherence to the rule during the night, only the data gathered 
during the period from `switching off the light with the intention to sleep' - to `rising 
from bed' was considered. As depicted in fig. 23, Actiwatch Sleep produces 3 
columns for each epoch: one with time, one with movement data and one with light 
data. 
A rule-based algorithm was devised comprising binary digit notation to yield an 
index of movement and an index of light. These two indices were then linked to 
provide an overall adherence score. Specifically, each sixty-second epoch of the 
night was examined for movement and light sufficient to read (Iux>6). In order to 
determine adherence with the QHR the following steps were applied: 
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1. Three columns (M=movement, L--light and A=adherence) were created 
adjacently to those reporting movement and light values. 
2. In column M all epochs were given a score (0= no movement; 1= movement). 
3. If one or two epochs of no movement (M=0) were observed between two epochs 
of movement (M=1), they were considered as movement and given a score of 1. 
In this way a column with a mix of zeros and ones was produced for movement. 
4. In column L all light epochs were given a score (0= not enough light to read i. e. 
lux-<6; 1= enough light to read i. e. lux>6). 
5. For each period of more than 15 consecutive movement epoch (M=1 for 15 
consecutive epochs), the light scores (column L) were examined. If following 
movement only epochs (i. e. M=1, L=0) light was also detected (i. e. M=1 and 
L=1) then adherence with the QHR was successful; if no light was detected (i. e. 
M=1 and L=O) then the QHR was not implemented (i. e. no adherence). 
This rule based algorithm permitted the researcher to count objectively the 
number of times the behavioural intervention `QHR' should have been implemented, 
the number of times the QHR was actually adhered to and the length of time elapsed 
before the instruction was implemented. 
As in study two the adherence score was calculated using the following formula: 
Number of Times QHR was adhered to 
Adherence Score= 
Number of Times Implementation was Required 
Similarly to Riedel, Lichstein, Peterson, Epperson, Means and Aguillard' (1998) 
study if a participant fell asleep within a quarter of an hour (i. e. no need to apply the 
QHR) a score of 100% was given. 
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5.3.3.6 Material for the intervention 
5.3.3.6a The Single Component Interventions: QHR out of bed & QHR in bed 
The Single Component Intervention, named `the quarter of an hour rule' (QHR), 
was adapted from the situational component of stimulus control intervention 
(Bootzin, 1972) `if you are not asleep within reasonable time get up and do 
something in another room until you feel sleepy. Repeat the instruction as many 
times as it is necessary. ' In order to test the hypotheses, it varied regarding the 
location where it had to be applied (fig. 24). 
Fig. 24 - The QHR out of bed and The QHR in bed 
QHR out of bed - (QHRout) 
If you are not asleep within a 
QUARTER OF AN HOUR 
Get out of your bed, 
go to the designated room, 
read. 
Go back to bed when 
ready to sleep again / 
QHR in bed - (QHRin) 
If you are not asleep within a 
QUARTER OF AN HOUR 
Sit up in your bed, 
read 
lie down when 
ready to sleep again 
As shown in figure 24, if not asleep within a quarter of an hour then the QHRout 
asked participants to `get out of bed, go to the designated room and read. Return to 
bed when you feel ready to sleep'. The QHRin, in contrast, asked participants to `sit 
up in bed and read. Lie down when you are ready to sleep again'. The QHR 
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interventions were delivered individually by the researcher and, in order to enhance 
treatment fidelity, structured written protocols were followed. In this way it was 
ensured that delivery of the QHRout and QHRin interventions were consistent across 
participants (appendixes 22a and 22b respectively). A flow-chart type instruction 
sheet was handed to participants to help them follow the rule (appendixes 23a and 
23b respectively). 
5.3.3.6b Self-monitoring: the Control Group 
The control group self monitored their sleep by completing the sleep diary for the 
whole duration of the study (five weeks). In order to ensure that outcomes were due 
to specific therapeutic ingredients rather than the measurement process (sleep self- 
monitoring) or other non- specific factors (e. g. patient's expectations, therapist's 
attention) the number and length of contacts between the control group and the 
researcher were identical to those with participants randomised to the active 
intervention groups. Importantly, the control group was not given sleep hygiene 
instructions or any other insomnia treatment: during contacts the researcher asked 
general questions such as "how was your sleep yesterday? " or "did you remember to 
fill in the sleep diary? ". 
5.3.4 - Data Processing 
Preliminary calculations (e. g. TIB, S. E., global adherence score) were performed 
by inputting raw data in a spreadsheet (Microsoft Excel) and results were then used 
for statistical analyses. All data analyses (parametric and non-parametric tests of 
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differences and correlations) were performed employing the statistical software 
package SPSS 11.5 for Windows (Microsoft). 
In the mixed model ANOVAs, `Group' (QHRin vs. QHRout vs. Control) was the 
between subjects factor and time of measurement `Time' (Baseline vs. End of 
Treatment) was the repeated measure. The alpha level was set at 0.05 (Sterling, 
Rosenbaum and Weinkam, 1995) and a p-value between 0.051 and 1.0 was 
considered as a non-significant trend. In instances where non-significant results were 
obtained, the test power to detect significant difference was inspected and reported. 
A statistically significant main effect for `Group' was followed by pairwise 
Bonferroni corrected comparisons (p=0.05/3=0.017). Likewise a significant `Group' 
by `Time' interaction was followed by pairwise Bonferroni corrected comparisons 
(p= 0.05/6= 0.008) to examine the time effect within each group individually and the 
differences between groups at end of treatment. 
Bonferroni corrections for each set of analyses were employed to control for type 
I error. It is appreciated that the Bonferroni correction is conservative and, therefore, 
while controlling for type I error it inflates type II error. A less conservative post-hoc 
test, such as the Tukey HSD, would be more appropriate to balance type I and type II 
errors. However, this test assumes that each group has an equal number of cases 
(Urdan, 2001). The present study employed unequal sample size groups and, 
therefore, the Tukey HSD was not deemed to be the best post-hoc test to use. Fisher 
LSD, a post-hoc test less conservative and indeed often criticised for not sufficiently 
controlling for Type I error, also requires equal size samples (Keppel and Wickens, 
2004). It was decided, therefore, also to report uncorrected t-test values for those 
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pairwise comparisons that had obtained a p: 50.05 value but which were non- 
significant once Bonferroni correction was applied. 
Cohen's effect sizes (Cohen, 1988) were calculated using the formula (for an 
explanation of effect sizes see section 1.6.1): 
ES= 
Ml-M2 
(SD12+SD22)/2 M, (SDI)= Mean (SD) Group, 
M2 (SD2)= Mean (SD) Group2 
5.3.5 - Procedure 
As depicted in figure 25 participant recruitment utilised three avenues: General 
Practioners' (GPs) referral, sleep clinic referred patients and media advertisement. 
The researcher contacted, by letter, 42 surgeries in Greater Glasgow explaining the 
study and inviting GPs to refer suitable patients (appendix 24). This first contact was 
followed by a telephone contact within one month and, if requested, a visit to the 
surgery. The surgeries to be contacted were decided on the basis of number of GPs 
per surgery (N>2). GPs referred possible participants on the basis of a quick `fitting 
criteria for the study' checklist (appendix 25). With regard to recruitment via sleep 
clinic referrals, a letter asking permission to contact the referred patient was sent to 
the referrer (appendix 26). Individuals who responded to a media advertisement were 
asked to speak to their GP with a view to being referred to the study. There are no 
available data on number of people who responded to the advertisement and, when 
prompted to do so, asked their GPs to be referred to the study. 
Referred individuals were sent an information pack (appendix 27) by post and 
were asked to reply if interested in the study. Eighty-three individuals agreed to be 
contacted. 
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Fig. 25 - Flow-chart of Participants to the trial 
Sleep Clinic Referrals GPs Referrals Media Advert Responses 
(N= 15) (N= 43) (N= 50) 
Asked referee's permission Told to speak to their GPs ai 
Information pack and consent form sent 
to referred individuals 
Telephone Screening (30 min) 
N= 83 
Not meeting criteria, tfianked and Meeting first screening criteria. 
'Good Sleeping Guide' pamphlet forwarded Interview and Questionnaires (1 hr) 
(N= o (N= 53) 
into the study (N= 44)I 
( Not meeting criteria, 
(N= 9) 
Randomisation balanced for gender 
(performed by Stats Depart) 
Randomised to QHRin Randomised to QHRout 
11 Randomised to Control 
(N= 15) 
_ . 
(N= 17) (N= 12) 
Baseline: Two weeks 
2 weeks of Sleep Diary and 2 PSG measurements 
Treatment/Control: Three weeks 
Day 1: 
QHRin delivered (N= 14) 
Sleep Continuity/quality 
3 wks sleep diary (N= 14) 
Adherence to QHRin: 
1 wk actigraphy (N=13) 
3 wks adherence diary (N= 14) 
Telephone contacts: 
Day 2 
Day 4 
Day 9 
Day 15 
PSG measurement : 
Last 2 nights of treatment phase 
(N= 13) 
Questionnaires (N= 13) 1 
Day 1: 
QHRout delivered (N= 17) 
Sleep Continuity/quality 
3 wks sleep diary (N= 15) 
Adherence to QHRout: 
1 week actigraphy (N= 17) 
3 wks adherence diary (N= 17) 
Telephone contacts: 
Day 2 
Day 4 
Day 9 
Day 15 
PSG measurement : 
Last 2 nights of treatment phase 
(N= 16) 
Questionnaires (N= 17) 1 
Day 1: 
Control (N= 12) 
Questions regarding sleep 
Sleep Continuity/quality 
3 wks sleep diary (N= 12) 
Telephone contacts: 
Day 2 
Day 4 
Day 9 
Day 15 
PSG measurement : 
Last 2 nights of treatment phase 
(N= 8) 
Questionnaires (N= 9 
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The telephone screening interview lasted around thirty minutes. Those presenting 
with suspected sleep disorders other than primary insomnia or not meeting other 
criteria (e. g. age, medication used) were thanked for their interest, the `good sleep 
guide' (appendix 28) was forwarded to them but they did not participate further in 
the study. 
Individuals who, as per preliminary assessment, seemed to fit criteria were asked 
to come to the sleep research laboratory for an in depth face to face interview who 
lasted around one hour. Those meeting DSM-IV/ICSD-R diagnostic criteria for 
primary/psychophysiologic insomnia were advised of the study procedure in detail. If 
they agreed to participate, they were, once again, informed of their right to withdraw 
at any time without having to explain their decision and were asked to read and sign 
a consent form (appendix 29). They were reminded that, as stated in the information 
leaflet, they might not be assigned to a treatment group and that they would be 
informed by phone of whether they had been randomised to a treatment or control 
group. Participants, then, completed the battery of questionnaires and the PSQI and 
the date to start the baseline phase, commencing with two home PSG recordings, was 
agreed. The first night was an adaptation night, as routinely conducted in PSG 
studies (e. g. Bonnet and Arand, 1997), it provided objective screening information 
but the data collected were not utilised for outcome analyses. 
It is important to highlight that the researcher followed a 'safety procedure' 
during home visits (appendix 30). This was a revised form of the home visit 
procedure in place at that time at the Section of Psychological Medicine at the 
University of Glasgow. 
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On the first PSG night, the researcher went to the participant's house at the 
agreed time, explained how to fill in the sleep diaries, how the electrodes were going 
to be attached and removed and what to do with the ambulatory PSG recorder at 
bedtime and in the morning. Participants were provided with a mobile number to 
contact the researcher during the night should they have any question or problem. 
Thereafter the PSG was set up for the nightly measurement. This procedure lasted 
around 1%z hours. The following morning the researcher returned to the participant's 
house to remove electrodes. This contact lasted around half an hour. The second 
night and following morning procedures were identical to those of the first night and 
the associated morning. 
After the baseline period (2 weeks) the researcher met again with the participant. 
If the participant had been assigned to either the QHRout or the QHRin then the 
appropriate intervention was delivered and the researcher checked that the participant 
had clearly understood how to implement the intervention. An easy to follow QHR 
memo was provided (appendices 8 and 23). Use of Actiwatch and adherence diary 
(appendices 7 and 21) was explained and the participant was reminded to keep filling 
the sleep diary in. In order to avoid inflating adherence by making the participant 
aware of the purpose of actigraphy, they were told that the actiwatch monitored 
movement and rest and could give an indication of rest-wake patterns during day and 
night. This meeting lasted around 45 minutes and the delivery of the intervention 
took no more than 30 minutes. 
If the participant had been assigned to the control group the researcher met with 
them, collected the 2-week baseline diaries and asked a few general questions 
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regarding their sleep. They were then reminded to keep filling the sleep diary in for 
the next three weeks. 
Four, 5-10 minute, telephone contacts were made during the treatment period so 
as to ensure that the QHR was implemented correctly each night. The participants in 
the control group were also contacted four times, and the telephone conversation 
regarded correct completion of the sleep diary. Participants were contacted on the 
2n", 4th, 9th and 15th day of the intervention period (fig. 25). 
During the last two days of the treatment period PSG recordings were repeated. 
Participants were asked to fill in the PSQI and the battery of questionnaires on the 
morning after the last PSG recording. In instances where participants had to go to 
work early and did not have time to fill in the questionnaires, they completed them 
later in the day and posted them by the next morning. 
As already discussed in study 2 length of treatment phase was decided based on 
previous findings that sleep improvements were observed within two to three weeks 
after stimulus control implementation (e. g. Bootzin, 1972; Espie, Brooks et al, 1989; 
Sloan et al, 1993; Zwart and Lisman, 1979). 
5.4 Results 
This section comprises descriptive and inferential statistics, for subjective and 
objective data. First, participants' clinical and demographic characteristics are 
reported. Second, the results of analyses carried out on the subjective sleep 
continuity, sleep quality, clinical significance and sleep related cognitions 
questionnaires are provided. Third, the results of statistical analyses on the 
objectively gathered sleep quantity and sleep architecture data are reported. Fourth, 
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results of the comparison of the subjective and objective data are given. Finally, the 
results of the subjective and objective measurements of adherence and their 
associations to sleep parameters are presented. 
5.4.1- Participants' Characteristics 
Table 11 presents, for each of the 3 groups, information regarding the number of 
participants, their gender, if they were living with a partner or alone, their 
employment status and the type of insomnia they presented with [mixed, sleep onset 
(SOL) or sleep maintenance (WASO)]. All participants were educated at college 
level or above. In addition mean (SD) age of participants, PSQI total score, length of 
the insomnia complaint, HADS anxiety and depression scores are reported. 
Table 11: Summary Data for participants randomised to the 
QHRin, QHRout and Control (SD in brackets) 
Sociodemovayhic 
Age (yrs) Mean (SD) 
Age Range 
Gender (number of f/m) 
Living with Partner/Alone 
Employment Status 
Full Time/Student/Retired 
Steep 
QHRin (n=15) QHRout (n=17) 
48.3 (14.7) 45.5 (14.1) 
21-70 18-64 
11/4 11/6 
6/9 11/6 
10/1/4 12/2! 3 
Mean (SD) PSQI total score 12.8 (1.4) 
Mean (SD) Insomnia Duration (years) 11.5 (7.6) 
Insomnia Type: Mixed/SOU WASO 11/1/5 
Psycholozical 
Mean (SD) HADS Anxiety 8.1(2.8) 
Mean (SD) HADS Depression 4.6 (2.5) 
13.4(l. 9) 
10.2 (7.8) 
10/2/5 
9.5 (3.7) 
5.5 (2.9) 
Control (n=12) 
48.9 (14.9) 
24-72 
8/4 
8/4 
61/5 
12.0 (2.6) 
10.9 (9.2) 
610/6 
7.5 (4.0) 
5.7 (3.7) 
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One-way ANOVA revealed that there were no statistically significant between 
groups differences in age [F(2,41)=0.24, n. s. ], duration of insomnia [F(2,41)=0.11, 
n. s. ], PSQI total score [F(2,41)=1.79, n. s. ], HADS anxiety [F(2,41)=1.22, n. s. ] or 
HADS depression [F(2,41)=0.50, n. s. ] (all p, >0.1). 
5.4.2 - Subjective Sleep Continuity Data and PSQI total Score 
In this section sleep continuity parameters (SOL, WASO, TST and S. E. ) gathered 
via sleep diary and the PSQI total score are reported descriptively and then formally 
analysed. Before analysing each of these variables some points common to all 
variables are addressed. 
Diary entries for both baseline and intervention periods were completed by 41 
participants. The baseline mean values correspond to the mean of the two-week 
baseline daily data for each participant. In order to assess that there were no 
differences between the mean values of week 1 and those of week 2, mixed 
ANOVAs were carried out for each of the sleep continuity variables and no 
statistically significant differences were found (all ps>O. 1). The end of treatment 
mean values correspond to the mean values of the daily data for the third week of 
treatment. Inspection of sleep diary data suggested that they were not normally 
distributed and, indeed, the Shapiro-Wilk test of normality confirmed this. Therefore, 
logarithmic transformations (base 10) were performed on SOL, WASO, TST and 
S. E. data. For clarity, however, the reported means in tables and figures correspond 
to non-transformed data. 
One-way ANOVAs were performed on the baseline mean SOL, WASO, TST and 
S. E. values and the mean PSQI total score (table 12) to examine if there were 
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statistically significant differences in sleep continuity parameters among the groups 
prior to the treatment phase. No significant differences were found for SOL 
[F(2,38)=0.12, n. s. ], WASO [F(2,38)=2.60, n. s. ], TST [F(2,38)=0.58, n. s. ], S. E. 
[F(2,38)=0.36, n. s. ] or PSQI [F(2,38)= 2.56, n. s] (all p, >. 1). 
As already discussed in section 5.3.4, if the mixed ANOVAs showed significant 
main effects or interactions then pairwise t-tests, with Bonferroni correction, were 
carried out to assess where the differences were located. In particular, as the one-way 
ANOVAs showed no significant differences between the 3 groups at baseline, 
independent t-tests were carried out only on the end of treatment mean values. Paired 
t-tests (baseline vs. end of treatment) were applied for within subjects differences. 
Prior to reporting descriptive and inferential analyses it is important to provide 
data regarding the credibility of treatment. 
5.4.2.1 Credibility of the OHR Treatment 
Credibility questionnaires were completed by 13 participants in each of the 2 
treatment groups (QHRin and QHRout) to rule out the possibility that outcomes were 
influenced by a treatment being more plausible than the other. The mean credibility 
score for the QHRin was 2.88 (0.55) and for the QHRout was 2.98 (0.39). An 
independent t-test showed that the two groups' credibility scores were not 
statistically different [t(26)= -0.55, n. s. ). 
5.4.2.2 Descriptive Sleep Continuity Data gathered via Sleep Diary 
Table 12 presents mean (SD) data for sleep continuity variables (SOL, WASO, 
TST and S. E. ) and PSQI at baseline and the third week of treatment for the QHRin, 
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QHRout and Control groups. In order to assess if the differences, suggested by 
inspection of table 12, between and within groups were statistically significant, 
inferential statistics were computed. The next sub-sections report the results for each 
of the sleep continuity variables examined (ANOVAs results in appendix 33). 
Table 12: Mean and SD for Subjective Sleep Continuity Variables and PSQI 
at Baseline and End of Treat ment for the QH Rin, QHRout and Control Groups 
OHRin (N=14) OHRout (N=15) Control (N=12) 
SOL Baseline 61.5 (50.4) 58.2 (57.1)* 49.1 (31.0) 
SOL End Treatment 51.9 (58.7)* 30.1(34.3)* 64.1(52.7) 
WASO Baseline 113.5 (89.5) 98.4 (59.2)* 111.54 (57.3) 
WASO End Treatment 63.5 (54.1) 45.7 (36.9)* 113.0 (67.1) 
TST Baseline 314.6 (94.7) 342.6 (73.1) 321.3 (78.9) 
TST End Treatment " 383.0 (76.7) 408.7 (36.7) 324.1 (72.7)* 
S. E. Baseline 0.64 (0.18) 0.69 (0.14) 0.66 (0.15) 
S. E. End Treatment 0.77 (0.16) 0.83 (0.09)* 0.65 (0.13) 
PSQI (SD) Baseline 12.6 (1.3) 13.7 (1.8) 12.0 (2.7) 
PSQI (SD) End of Treatment 8.8 (2.9) 8.1(2.9) 12.0 (2.1) 
Note: * Shapiro-Wilk test of normalit y indicated that data are not normally distributed 
5.4.2.3 Sleep Onset Latency 
In figure 26 the mean SOL values for each group at baseline and end of treatment 
are presented graphically. A mixed model ANOVA was carried out on the log 
transformed mean SOL data. There was a significant main effect for time 
[F(1,38)=7.11, p=0.01] showing that the mean value at baseline [M= 56.16(47.5)] 
was statistically significantly higher than that at the end of treatment 
[M=47.56(50.0)]. No significant main effect for group [F(2,38)=0.81, n. s. ] was found 
but a significant interaction effect was found between group and time [F(2,38)=4.36, 
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pß. 02]. Employing the Bonferroni post-hoc correction (p=0.006), only the 
difference between baseline and end of treatment mean times for the QHRout group 
was significant [t(14)=3.99, p=0.001]. 
Fig. 26 - Mean SOL at Baseline and End of Treatment for the 
QHFän, QHRout and Control Groups 
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As depicted in figure 26 this result confirmed that following the QHR out of bed 
intervention the QHRout group's mean SOL was decreased. Regarding the 
uncorrected t-tests, the only significant result was that between the QHRout and the 
Control groups at end of treatment [t(25)=-2.14, p=0.041. 
5.4.2.4 Wake after Sleep Onset 
In figure 27 the mean WASO values for each group at baseline and end of 
treatment are presented graphically. A mixed ANOVA revealed no significant main 
effect for group but a significant main effect for time was found [F(1,38)=20.4, 
p<0.0005] showing that the mean value at baseline [M= 107.39(69.2)] was 
statistically significantly higher than that at the end of treatment [M=71.48(58.8)]. A 
significant interaction effect [F(2,38)=4.56, p=0.02] was explored with Bonferroni 
post-hoc correction. The difference between the baseline mean time and that at the 
end of treatment for the QHRout group was significant [t(14)=5.26, p<0.0005] as 
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was the difference between the mean time between the QHRout and the Control 
groups at the end of treatment [t(25)=3.63, p=0.001]. 
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These results indicate that following intervention WASO was decreased in the 
QHRout group and that it was significantly lower than that of the Control group at 
the end of the intervention. Regarding the uncorrected t-tests, statistically significant 
differences were found between baseline and end of treatment for the QHRin 
[t(13)=2.49, p=0.03] and between the QHRin and the Control groups at end of 
treatment [t(24)=-2.34, p=0.03]. 
5.4.2.5 Total Sleep Time 
In figure 28 the mean TST values for each group at baseline and end of treatment 
are presented graphically. A mixed ANOVA revealed no significant main effect for 
group but a significant main effect for time was found [F(1,38)=13.89, p=0.001] 
showing that the mean TST value at baseline [M= 328(81.6)] was statistically 
significantly lower than that at end of treatment [M=374(71.1)]. Probably because 
the power to detect significant differences was low (power=0.53), the interaction 
between group and time showed only a non-significant trend [F(2,38)=2.89, p=0.07]. 
Fig. 27 - Mean WASO at Baseline and End of Treatment for the OHFÜn, OHRout 
and Control Groups 
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Fig. 28- Mean TST at Baseline and End of Treatment for the OHFiin, OHRout and 
Control Groups 
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Inspection of figure 28 suggests that the QHRin and the QHRout groups slept 
longer following the intervention increased from baseline to treatment while the 
control group's TST did not change. 
5.4.2.6 Sleep Efficiency 
Figure 29 presents S. E. values for each group at baseline and end of treatment. 
No significant main effect of group was found but a main effect of time 
[F(1,38)=24.79, p<0.00051 was found. Mean S. E. value at baseline [M= 0.67(0.16)] 
was statistically significantly lower than that at the end of treatment [M=0.77(0.15)]. 
In addition, a significant interaction effect [F(2,38)=8.13, p=0.001] was explored 
employing the Bonferroni post-hoc test. This indicated differences between S. E. 
means at baseline and at end of treatment for the QHRout [t(14)=-5.52, p<0.0005] 
and for the QHRin [t(13)=-3.68, p=0.003] groups. Furthermore, the difference 
between the QHRout and the Control groups at the end of treatment [t(25)=3.27, 
p=0.003] was also significant. Regarding uncorrected t-tests, the only significant 
difference was between QHRin and Control groups at end of treatment [t(24)=2.51, 
p=0.02]. 
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Fig. 29- Mean S. E. at Baseline and End of Treatment for the QHRin, QHRout and 
Control Groups 
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These results indicate that S. E. increased following both QHR interventions and 
that the S. E. at the end of treatment was higher in QHRout than the Control group. 
5.4.2.7 Pittsburgh Sleep Quality Index Total Score 
In figure 30 the mean PSQI total score values for each group at baseline and end 
of treatment are presented graphically. 
Fig. 30 - Mean PSQI Total Score at Baseline and End of Intervention for the 
QHRin, QHRout and Control Croups 
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There was no significant main effect for group [F(2,38)=2.00, n. s. ] but a significant 
main effect for time [F(1,38)=46.04, p<0.0005] was found. This indicated that the 
PSQI at the end of treatment [M=9.54(3.1)] was lower than that at baseline 
[M=12.83(2.0)]. A significant interaction effect [F(2,38)=13.38, p<0.0005] was 
explored with Bonferroni correction. Pair-wise comparisons indicated that at end of 
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treatment the mean PSQI values of the QHRin and the QHRout groups were 
statistically significantly lower that that of the Control group [t(24)=-3.54, p=0.003 
and t(25)=-3.95, p=0.001 respectively]. In addition, the mean PSQI values at end of 
treatment as compared to baseline were lower for both the QHRin [t(13)=4.19, 
pß. 001] and the QHRout [t(14)=6.68, p<0.0005]. 
5.4.2.8 Summary of subjectively measured sleep continuity parameters 
The analyses reported in the sub-sections above suggest the QHR interventions 
produced statistically significant differences in some of the sleep parameters 
gathered via sleep diary while no changes were found between baseline and end of 
treatment for the Control group. In addition, while no statistically significant 
differences were found at baseline between the 3 groups, differences between the 
Control group and the QHRout and/or the QHRin were found at end of treatment. 
Furthermore, the QHR interventions produced highly statistically significant changes 
on the PSQI total scores within groups compared to the control group. However no 
differences were found between the two treatment groups QHRin and QHRout for 
any of the sleep continuity or PSQI mean values. These results will be critically 
examined in the discussion section. 
The aims of insomnia treatments are not only to improve sleep continuity but also 
to improve the perception of quality of sleep and feelings upon awakening. The next 
section is concerned with subjective estimates of sleep quality. 
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5.4.3 Sleep Quality Data 
In this section estimates of sleep quality factors are reported and analysed. Each 
morning participants reported the quality of the previous night's sleep, and their level 
of alertness and restedness upon awakening. First the descriptive data are presented 
and, thereafter, the results of separate mixed ANOVAs on each of these three 
dependent variables are reported. 
One-way ANOVAs on the baseline means of quality of sleep, alertness and 
restedness (table 16) revealed no significant differences for quality of sleep 
[F(2,38)=. 111, n. s. ], restedness [F(2,38)=. 79, n. s. ] or alertness. [F(2,38)=. 15, n. s. ] 
(all p, >O. 1) between the groups. 
5.4.3.1 Descriptive Sleep Quality Data 
The Mean Score and SD for each group during baseline and during the last week 
of treatment are reported in table 13. 
Table: 13- Mean (SD) scores for Quality of Sleep, Restedness and Alertness 
baseline and end of treatment for the QHRin, QHRout and 
QHRin N=14 
Q"a1: t of ciP Pp_, s1ertnesý RactnilnPSS 
Baseline 2.01(. 48) 2.09 (. 71) 1.93 (. 71) 
End of Treatment 2.48 (. 73) 2.25 (. 87) 2.26 (. 83) 
QHRout N=15 
Baseline 1.97 (. 62) 1.99 (. 79) 1.63 (. 64) 
End of Treatment 2.29 (. 47) 2.21(. 55) 2.12 (. 51) 
Control N=12 
Baseline 1.70 (. 57) 2.16 (. 98) 1.69 (. 67) 
End of Treatment 1.70 (. 68) 1.90 (1.0) 1.57 (. 76) 
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Inspection of table 13 suggests that there were differences between and within 
groups and inferential statistics were performed to assess if such differences were 
statistically significant. 
5.4.3.2 Sleep Quality 
In figure 31a the mean Sleep Quality values for each group at baseline and end of 
treatment are presented graphically. 
A significant main effect of group was found [F(2,38)=3.80, p=0.03]. The sleep 
quality means were M=2.25(0.6) for the QHRin, M=2.13(0.9) for QHRout and 
M=1.70(0.6) for the Control. Employing Bonferroni post-hoc pairwise comparisons 
no significant differences between the groups' means were found. There was also a 
significant main effect for time [F(1,38)=9.82, p<0.0005] indicating that quality of 
sleep at the end of treatment [M=2.18(0.7)] was higher than that at baseline 
[M=1.90(0.6)]. The group by time interaction was not significant perhaps because 
power was low (power=0.49). However, a trend [F(2,38)=2.60, p=0.09] suggested 
that at the end of treatment the QHRin and the QHRout groups reported that the 
quality of their sleep was better compared to baseline while the control group's score 
remained virtually the same. 
5.4.3.3 Restedness Upon Awakening 
In figure 31b the mean restedness values for each group at baseline and end of 
treatment are presented graphically. 
There was no significant main effect of group [F(2,38)=1.74, n. s] but a significant 
main effect of time [F(1,38)=6.95, p=0.01] was found indicating that the level of 
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restedness at the end of treatment [M=2.01(0.7)] was higher than that at baseline 
[M=1.75(0.7)]. In addition the group by time interaction was significant 
[F(2,38)=4.07, p=0.02]. However, employing the Bonferroni post-hoc test none of 
the pairwise comparisons was significant. Regarding uncorrected t-tests significant 
differences were detected for QHRin baseline vs. end of treatment [t(13)=-2.29, 
p=0.04], QHRout baseline vs. end of treatment [t(14)=-3.05, p=0.009], QHRin vs. 
Control at end of treatment [t(24)=2.16, p=0.04] and QHRout vs. Control at end of 
treatment [t(25)=2.16, p=0.04]. These differences indicate that both QHR 
interventions increased the level of restedness compared to baseline and that by the 
end of the intervention both QHR groups' estimate of restedness was higher than 
that of the Control group. 
5.4.3.4 Alertness Upon Awakening 
In figure 31c the mean alertness values for each group at baseline and end of 
treatment are presented graphically. 
No significant time effect [F(1,38)=. 24, n. s. ] or group effect [F(2,38)=. 10, n. s. ] 
were found. Perhaps due to low power (power=0.55), only a non-significant group 
by time interaction trend [F(2,38)=2.89, p=0.07] was found. It suggested that the 
QHRin and QHRout groups estimated greater alertness at the end of treatment as 
compared to baseline while the control group's estimate of alertness was lower at the 
end of treatment as compared to baseline. 
Interestingly, figure 31 shows almost parallel lines for the QHRin and QHRout 
suggesting that the intervention produced similar changes in direction and intensity 
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in the three sleep quality variables under examination. This raises the possibility that 
these questionnaires were measuring one single construct. 
Fig. 31 - Mean scores for the variables 'Quality of Sleep', 'Restedness' and 
`Alertness` at baseline and end of treatment for the three groups 
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In order to assess if this was the case a Pearson product correlation was Carried 
out on the first baseline week of participants in study three and on the week of 
participants in study one (total N=121). Significant positive correlations between 
'quality of sleep' and 'restedness' (r=. 875, p<. 0005), 'restedness' and 'alertness' 
(r=. 877, p<. 0005) and 'quality of sleep' and 'alertness' (r=. 809, p<. OOO5) were 
found. Squaring these values resulted in R2=7(/. IZ2=761/ and It'=65'% respecti%eIv 
indicating that there was substantial shared variance across this set OI' qualitative 
ratings. 
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5.4.3.5 Summary of the Sleep Quality Results 
The results presented above indicate that both QHR groups reported improved 
sleep quality, restedness and alertness following the intervention while the control 
group's estimates did not change. 
Having analysed the impact of the QHR interventions on both sleep continuity 
and sleep quality variables, which suggested that the QHR is efficacious in producing 
improvements, attention is now turned to the clinical significance of the QHRin and 
the QHRout. 
5.4.4 Clinical Changes Associated to the QHRin and the QHRout 
In this section the clinical significance of the QHR treatment is addressed. Kazdin 
(1977) regarded change in therapy as clinically significant when the individual 
moved from the dysfunctional to the functional range of normalcy. In addition, 
Lichstein and Fischer (1985) regarded a change over baseline greater than 50% as a 
useful clinical outcome measure. These two outcome measures were used to assess 
the clinical significance of the QHRin and QHRout interventions. They were applied 
to the sleep continuity variables SOL and WASO and to the PSQI total score. 
5.4.4.1 Clinical Significance 
Table 14 presents the percentage of participants in each group (QHRin, QHRout 
and Control) achieving a mean reduction of clinical significance (Kazdin, 1977, 
Lichstein et al, 1985) for SOL, WASO and PSQI and associated effect sizes. 
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Table: 14 - Percentage of Participants in Each Treatment Condition achieving 
Mean Reduction of Clinical Significance According to 2 Criteria'`' and Effect Sizes'`-]' 
5Vl Reduction Returned to Nurmatc} 
SOL 
QHRin 14 2I 'Y( 33% 0.2 
Q11kout 15 47(4 33% 0.6 
Control 12 17% 11% 0.3 
WASO 
QHRin 14 57% 33% 0.7 
QIlRout 15 53% 33% 1.1 
Control 12 0% 0% 0.0 
PSQI 
QHRin 14 29% 7% 1.7 
QHRout 15 33% 13%- 2.3 
Control 12 0% 0170 1). 1) 
'`'Criteria proposed by Kazdin, 1977: Lichst ein cl al, 1985 
»' Effect size c alculated base line to end of intervention 
As reported in table 14 the QHRin and the QHRout produced clinically significant 
changes in 30 to 50% of the participants. The effect sizes were in the small toi 
medium range for SOL, in the medium to large range for WASO and in the large 
range for the PSQI. The effect sizes for both TST (0.8 for QI Win, 1. I for OI Innut 
and 0.0 for Control) and S. E. (0.8 for QHRin, 0.8 for QllRout and t). O fror Control) 
were in the large range. Importantly 43% of' participants in the QIIRin, 0012(A f 
QHRout and only 8% of controls achieved a S. F.? 851/ . 
Interestingly, the magnitude of' change achieved with the QHRout was superior to 
that achieved with the QHRin as evidenced by effect sizes. 
5.4.4.2 Therapeutic effects at week one, two and three 
In order to explore when the QHR started to impact on slop. Ihc mcan chanrc 
scores over baseline at week 1, week 2 and week 3 were considered. Week I, week 2 
and week 3 represent the ºnean of the sleep diary data gathered during, thy' first, 
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second and third week of intervention respectively. In the following sections non- 
parametric analyses (Kruskal-Wallis) were carried out on the change score values to 
assess after how many intervention days statistically significant differences between 
groups emerged. 
5.4.4.2a Response Curve for Sleep Onset Latency 
In figure 32 the mean SOL changes over the baseline mean values at week 1,2, 
and 3 for each group are presented graphically. 
Fig. 32 - SOL Mean Change Values over the Baseline Mean Value at 
Intervention (week 1,2 and 3) for the 3 Groups 
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Statistically significant differences between the groups were found for SOL mean 
change values over baseline at week 1 [x2(2)= 9.700, p=0.008], week 2 [x2(2)= 
6.756, p=0.03] and week 3 [x2(2)= 9.213, p=0.01]. Bonferroni corrected Mann- 
Whitney comparisons between groups were performed for each week comparison. 
No statistically significant differences were found between the two treatment groups 
(QHRin and QHRout) at week 1, week 2 or week 3. With regard to week 1, 
statistically significant differences were found between the QHRin and the Control 
groups [U=36.00, N1=14, N3=12, p=0.01] and the QHRout and the control groups 
[U=31.00, N2=15, N3=12, p=0.003] indicating that already during the first week of 
intervention the two treatment groups took less time to fall asleep than the control 
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group. With regard to week 2 and 3, statistically significant differences were found 
between QHRout and the control [U=39.500, N2=15, N3=12, p=0.01 and U=26.000, 
N2=15, N3=12, p=0.001 respectively] showing that during the second and third 
weeks of intervention the QHRout took less time to fall asleep as compared to the 
control group. It is important to note that these results are due to the QHRout group 
reducing their SOL and the control group increasing theirs. 
5.4.4.2b Response Curve for Wake After Sleep Onset 
The graphic representation of the mean WASO changes over the baseline mean 
values at week 1,2, and 3 for each group (fig. 33) suggests no change for the control 
group but positive changes from the first week of intervention for the QHRin and the 
QHRout. 
Fig. 33 - WASO Mean Change Values over the Baseline Mean Value at 
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Statistically significant differences between the groups were found for WASO 
mean change scores over baseline at week 1 [X2(2)= 11.050, p=0.004], week 2 
[x2(2)= 9.678, p=0.008] and week 3 [x2(2)= 9.075, p=0.01]. Bonferroni corrected 
comparisons showed no statistically significant differences between the QHRin and 
the QHRout at week 1, week 2 or week 3. With regard to week 1, statistically 
significant differences were found between the QHRin and the Control groups 
[U=29.000, N1=14, N3=12, p=0.004] and the QHRout and the Control groups 
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[U=31.00, N2=15, N3=12, p=0.003] indicating that already during the first week of 
intervention the two treatment groups spent less time awake during the night as 
compared to the control group. These improvements were maintained during week 2 
and 3 [QHRout and the control group U=44.000, N2=15, N3=12, p=0.02 and 
U=24.000, N1=15, N3=12, p=0.001 respectively and QHRin and the control group 
U=26.000, N1=14, N3=12, p=0.002 and U=46.000, N2=14, N3=12, p=0.05 
respectively] (uncorrected t-tests for week 3). 
5.4.4.2c Response Curve for Total Sleep Time 
Inspection of figure 34 suggests that the mean TST over the baseline mean values 
at week 1,2, and 3 differed only for the QHRin and the QHRout. 
Fig. 34-TST Mean Change Values over the Baseline Mean Value at 
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Statistically significant differences between the groups were found for the TST 
mean change values over baseline at week 1 [X2(2)= 7.503, p=0.02], week 2 [x2(2)= 
10.000, p=0.07] and a non, significant trend at week 3 [x2(2)= 5.704, p=0.06]. 
Applying Bonferroni corrected comparisons no statistically significant differences 
were found between the QHRin and the QHRout at week 1,2 or 3. With regard to 
week 1, a statistically significant difference was found between the QHRout and the 
control groups [U=37.00, N2=15, N3=12, p=0.009] indicating that already during the 
first week of intervention the QHRout slept longer as compared to the control group. 
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The difference between the QHRin and the control group approached significant 
difference [U=42.000, N1=14, N3=12, p=0.03]. With regard to week 2, a statistically 
significant difference was found between the QHRout and the control group 
[U=28.000, N2=15, N3=12, p=0.002]. In addition the difference between the QHRin 
and the control groups approached significance [U=38.000, N1=14, N3=12, p=0.018]. 
With regard to week 3a non-significant trend was found and inspection of figure 34 
suggests that during the third week of intervention the QHRout and QHRin slept 
longer than the control group. 
5.4.4.2d Response Curve for Sleep Efficiency 
In figure 35 the mean S. E. changes over the baseline mean values at week 1,2, 
and 3 for each group are presented graphically. 
Fig. 35 - S. E. Mean Change Values over the Baseline Mean Value at 
Intervention (week 1,2 and 3) for the 3 Groups 
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Statistically significant differences between the groups were found for the S. E. 
mean change values over baseline at week 1 [X2(2)= 11.40, p=0.003], week 2 [X2(2)= 
14.40, p=0.001] and week 3 [x2(2)= 11.64, p=0.003]. Bonferroni corrected 
comparisons showed no statistically significant differences between the QHRin and 
the QHRout at week 1,2 or 3. With regard to week 1, statistically significant 
differences were found between the QHRin and the control group [U=35.000, N1=14, 
N3=12, p=0.01] and the QHRout and the control group [U=21.500, N2=15, N3=12, 
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p<0.0005] indicating that already during the first week of intervention S. E. mean 
change values of the QHRin and the QHRout were greater that that of the control 
group. With regard to week 2, a statistically significant difference was found 
between the QHRin and the control group [U=26.500, N1=14, N3=12, p=0.002] and 
the QHRout and the control group [U=18.000, N2=15, N3=12, p<0.0005] showing 
that during the second week of intervention the QHRout and the QHRin had higher 
mean S. E. values as compared to the control group. With regard to week 3, a trend 
between the QHRin and the control group [U=45.000, NI=14, N3=12, p=0.05] and a 
statistically significant difference between the QHRout and the control groups 
[U=14.500, N2=15, N3=12, p<0.0005] were found. 
5.4.4.2e Summary of the Response Curve Findings 
The response curve results obtained by performing statistical analyses on the 
mean change scores suggested that the QHR interventions produced statistically 
significant differences in most of the sleep parameters already during the first week 
of treatment as compared to the control group. These results are critically examined 
in the discussion section. 
Having shown that the QHR interventions improved subjectively estimated sleep 
continuity and quality, that it produced clinical significance changes and that these 
changes presented within the first week of treatment, attention is now turned to the 
possibility that the QHR intervention is associated to changes in sleep related 
cognitions and to arousability at bed time. 
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5.4.5 Sleep Related Questionnaires 
In this section sleep related cognition and physical and mental arousal at bedtime, 
gathered via a battery of six, well validated questionnaires, are reported descriptively 
and then formally analysed. This analysis can help to shed light on whether the QHR 
had an impact on cognition and arousal as well as sleep parameters. Before analysing 
each of the questionnaires some common points may be made. One-way ANOVAs 
were performed on the baseline mean scores for each scale, or questionnaire sub- 
scales where appropriate, to examine if there were statistically significant differences 
among the groups prior to the treatment phase. The only significant differences 
indicated that at baseline the somatic and sensory engagement of the QHRin was 
lesser than those of the QHRout and of the control group. The results of one-way 
ANOVAs are reported in appendix 31. 
5.4.5.1 Descriptive Data of sleep related cognitions and bed-time arousal 
The Mean Score and SD for each group at baseline and end of treatment are 
reported in table 15. The next subsections report results for each of the 
questionnaires completed by participants. 
5.4.5.2 01: Sleep Behaviour Self Rating Scale -R 
With regard to the SBSRS-R scale no significant main effects for time 
[F(1,36)=0.18, n. s. ] or group [F(2,36)=4.89, p=0.01] or significant interaction 
[F(2,36)=2.48, n. s] were found. It should be noted that power to detect differences 
was very low (power = 0.25) 
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Table 15 - Mean(SD) scores at baseline and end of treatment for the battery of 
questionnaires for the QHRin, QHRout and Control groups 
QHRin(N=13) QHRout (N=17) Control (N=9) 
Baseline Intervention Baseline Intervention Baseline Intervention 
Q1 29.8(6.8) 30.0(5.3) 29.8(5.5) 27.8(4.6) 31.3(5.9) 32.4(6.2) 
Q2 7.5(3.6) 5.3(2.8) 8.6(2.4) 6.5(2.4) 8.1((3.4) 7.9(2.8) 
Q3a 11.1(3.9) 9.9(4.1) 12.4(2.6) 11.7(2.6) 11.8(1.8) 12.1(1.3) 
Q3b 7.6(2.6) 6.1(2.2) 9.2(23) 8.5(4.1) 10.8(3.2) 9.7(2.8) 
Q3c 8.9(3.1) 5.1(1.8) 10.6(2.1) 7.9(2.2) 9.2(2.2) 7.1(2.2) 
Q3d 9.4(2.4) 6.2(1.7) 9.3(1.9) 6.3(1.8) 8.4(1.6) 8.2(2.2) 
Q4a 18.6(5.9) 17.9(6.5) 21.2(4.4) 18.6(5.3) 21.1(3.4) 22.1(2.9) 
Q4b 20.1(5.4) 18.7(6.2) 23.1(33) 19.5(5.0) 22.4(5.9) 245(4.2) 
Q4c 12.1(2.5) 12.0(3.1) 14.6(2.6) 11.6(2.3) 14.9(1.7) 15.7(3.3) 
Q5a 133(4.3) 11.6(3.8) 13.2(4.1) 113(3.7) 14.2(6.6) 14.1(5.8) 
Q5b 21.1(7.6) 19.1(7.9) 24.7(5.3) 21.8(6.7) 26.5(3.4) 25.2(4.7) 
Q6a 11.8(3.8) 11.1(3.9) 13.6(2.7) 12.9(2.4) 13.2(2.6) 11.6(3.7) 
Q6b 16.4(4.7) 16.8(4.2) 18.1(4.9) 18.7(3.2) 17.0(4.8) 16.4(4.5) 
Q6c 24.6(4.2) 23.6(6.9) 26.3(7.0) 24.6(5.9) 27.6(7.0) 26.7(8.0) 
Q1= SBSRS-R, 
Q2=GSES, 
Q3= SDQ. It comprises 4 subscales, measuring: 
Q3a= cognitive arousal. Q3b= physical tension, Q3c= sleep effort, Q3d- sleep pattern problems 
Q4= GCTI. It comprises 3 subscales measuring cognitive intrusions relating to 
Q4a= active problem solving, Q4b= sleep and wakefulness Q4c=somatic and sensory engagement 
Q5= PSAS. It comprises 2 subscales measuring Q5a= cognitive arousal, Q5b= somatic arousal 
Q6= DBAS-10. It comprises 3 subscales measuring beliefs about insomnia. In particular 
Q6a=need for control over insomnia Q6b= long term & Q6c= short term negative consequences 
5.4.5.3 02: Glasgow Sleep Effort Scale 
In figure 36 the mean total GSES scores for each group at baseline and end of 
treatment are presented graphically. 
Fig. 36 - Mean Total Score for f12 (GSI ) for the Three Groups at Baseline and 
End of Treatment 10 
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No main effects of group [F(2,36)=0.32, n. s. ] was found but a significant main 
effect of time [F(1,36)=12.93, p=0.001] was found showing that the total score was 
higher at baseline [M= 8.1(3.0)] than at end of treatment [M= 6.4(2.7)]. This result 
indicated a decrease in sleep effort at the end of treatment. No significant interaction 
[F(2,36)=2.00, n. s. ] was found but power to detect differences was low 
(power=0.38). 
5.4.5.4 03: Sleep Disturbance Questionnaire 
The SDQ comprises four sub-scales which were analysed separately as they 
measure different constructs. 
5.4.5.4a: Cognitive Arousal 
With regard to the dimension `cognitive arousal' of the SDQ no significant main 
effects of time [F(1,36)= 3.00, p=0.09] or group [F(2,36)=1.31, n. s. ] or significant 
interactions [F(2,36)=1.90, n. s. ] were found. The power to detect differences was low 
(power =0.39,0.26 and 0.37 for Time, Group and interaction respectively). 
5.4.5.4b: Physical Tension 
With regard to the dimension `physical tension' of the SDQ a significant main 
effect of group [F(2,36)=4.75, p=0.015] was found and post-hoc Bonferroni 
corrected pairwise comparisons indicated that physical tension of the QHRin 
[M=6.6(2.4)] was lower than that of the control group [M=10.2(2.9)] [t(20)=-3.01, 
p=0.007]. A significant time effect was also found [F(1,36)=4.50, p=0.04] showing 
that perception physical tension had decreased at the end of treatment [M= 8.0(3.4)] 
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as compared to baseline [M= 9.0(2.9)]. No significant interaction was found 
[F(2,36)= 0.22, n. s. ] however power to detect differences was low (power=0.08). 
5.4.5.4c: Sleep Effort 
With regard to the dimension `sleep effort' of the SDQ a significant group effect 
[F(2,36)=6.67, p=0.003] was found and post-hoc Bonferroni corrected pairwise 
comparisons [t(280=-3.76, p=0.001] indicated that the QHRin sleep effort was lower 
than that of the QHRout [M=7.0(2.4) and M=9.2(2.1)]. A main effect of time 
[F(1,36)=28.73, p<0.0005] indicated that the total score was higher at baseline [M= 
9.7(2.5)] than 3 weeks after intervention [M= 6.8(2.3)] (i. e. less sleep effort at the 
end of treatment). This result is similar to that obtained with the GSES (section 
5.4.5.3). No significant interaction [F(2,36)=. 805, n. s. ] was found but power was 
low (power=0.18). 
5.4.5.4d: Sleep Pattern Problems 
No significant main effect of group was found [F(2,36)=0.51, n. s. ] but a significant 
main effect of time [F(1,36)=22.18, p<0.0005] showing that the total score was 
higher at baseline [M= 9.1(2.0)] than at end of treatment [M= 6.7(1.9)] was found. A 
significant interaction effect [F(2,36)=3.78, p=0.03] was explored with post-hoc 
Bonferroni corrected comparisons. Results showed that sleep patterns problems were 
less at the end of treatment as compared to baseline for both the QHRout [t(16)=4.47, 
p=0.0005] and the QHRin [t(12)=4.58, p=0.001]. The uncorrected pairwise 
comparisons were: end of treatment QHRin vs. control [t(20)=-2.4, p=0.025] and 
QHRout vs. control [t924)=-2.4, p=0.024]. 
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Fig. 37 - Mean Total Score for Q3d (sleep pattern problems) for the 3 
Groups at Baseline and End of Intervention 
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As depicted in figure 37 these results indicated that hui Ii OIIIZ intorýýntiýýiýý 
decreased sleep pattern problems while the control condition diel not. 
5.4.5.5 Q4: Glasgow Content of Thoughts Inventory 
The GCTI comprises three sub-scales, which were analysed SCIMI- tel` as they 
measure different constructs. In figure 38 the mean total scores of ilir (i('"I'I Ior 11w 
three groups are presented graphically. 
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5.4.5.5a: Active Problem Solving 
There were no significant main effects of time [F(1,36)= 2.47, n. s] or of group 
[F(2,36)=1.27, n. s. ] but a significant interaction effect [F(2,36)=4.59, p=0.02] was 
found. Employing the Bonferroni post-hoc correction, only the difference between 
the baseline and end of treatment conditions for the QHRout group approached 
significant difference [t(16)=3.2, p=0.006] suggesting that the QHRout intervention 
decreased active problem solving (fig. 38-Q4a). All other comparisons did not differ 
(all p,, >0.05). 
5.4.5.5b: Sleep and Wakefulness 
There were no significant main effects of time [F(1,36)=1.59, n. s. ] or of group 
[F92,36)=2.18, n. s. ]. A significant interaction effect [F(2,36)=4.34, p=0.02] was 
explored employing the Bonferroni post-hoc tests which revealed no significant 
differences. The uncorrected t-tests indicated significant differences at the end of 
treatment between QHRin and control [t(20)=-2.43, p=0.02 and between QHRout 
and control [t(20)=-2.54, p=0.018]; the baseline vs. end of treatment difference for 
the QHRout was also significant[t(16)=-2.61, p=0.02]. These results suggest that the 
QHR conditions, compared to the control group, decreased sleep and wakefulness 
scores following intervention (fig. 38-4Qb). 
5.4.5.5c: Somatic and Sensory Engagement 
There was no significant main effect of time [F(1,36)=2.67, n. s. ] but a significant 
main effect of group [F(2,36)=5.73, p<0.007] was found. Post-hoc Bonferroni 
corrected pairwise comparisons revealed significant differences between the QHRin 
and control [t(20)=-2.88, p=0.009] and the QHRout and control [t(24)=-2.74, 
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p=0.011] indicating that the QHRin and the QHRout somatic and sensory 
engagement was lower than the control [M=12.1(2.8), M=13.0(2.4) and 
M=15.2(2.6)] respectively). A significant interaction effect [F(2,36)=6.54, p=0.04] 
was explored with Bonferroni post-hoc tests. Significant differences between 
baseline and end of treatment for the QHRout group [t(16)=3.42, p=0.003] and 
between the QHRout and Control group [t(24)=-3.63, p=0.001] were found, 
indicating that the QHRout group decreased their somatic and sensory engagement 
following intervention and it was lower than that of the control group at end of 
treatment (fig. 38-Q4c). The uncorrected pairwise comparison between QHRin and 
Control [t(20)=-2.6, p=0.017] was significant, however, this was due to the QHRin 
score being statistically significantly lower than the control group already at baseline 
rather than to a difference due to the intervention. 
5.4.5.6 05: Pre-Sleep Arousal Scale 
The PSAS comprises two sub-scales, which were analysed separately as they 
measure different constructs. 
5.4.5.6a: Cognitive Arousal 
With regard to `cognitive arousal' there was no significant main effect of group 
[F(2,36)=0.54, n. s. ] or interaction effect [F(2,36)=0.92, n. s. ] but a significant main 
effect of time [F(1,36)=5.18, p=0.03] was found indicating that cognitive arousal was 
higher at baseline [M=13.6(4.7)] than at end of treatment [M=12.1(4.3)]. 
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5.4.5.6b: Somatic Arousal 
With regard to `somatic arousal' a non significant trend for the main effect group 
was found [F(2,36)=2.65, p=0.08]. A significant main effect of time [F(1,36)=7.03, 
p=0.01] indicated that the somatic arousal at baseline was higher [M=24.0(6.1)] than 
at end of treatment [M=21.7(7.0)]. No significant interaction effect was found 
[F(2,36)= 0.34, n. s. ] but power was low (power=0.10). 
5.4.5.7 06: Dysfunctional Beliefs and Attitudes about Sleep-l0 
The DBAS-10 comprises 3 sub-scales, which were analysed separately as they 
measure different constructs. However none of the main effects or interaction effects 
for any of the three subscales was significant. This is probably due to the fact that 
power to detect differences was low ranging from 0.9 to 0.43. 
5.4.5.8 Summary of the Sleep Related Questionnaire Results 
The results presented above suggest that the QHR interventions decreased sleep 
cognitive activity at bedtime and improved sleep patterns while changes were not 
found in the control group. Inspection of the figures reveals that baseline to treatment 
changes evidenced by this battery of questionnaires were similar raising the 
possibility that these measures are not independent from each other. A correlation 
matrix (table 16) was calculated which confirmed the overlap across these scales. 
Consequently the results obtained may suggest changes in an underlying common 
construct (e. g. decreasing anxiety about sleep) rather than changes in 14 different 
constructs. 
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5.4.6 Objective Sleep Continuity Data 
In this section sleep continuity parameters gathered via PSG are reported and thin 
analysed. Before analysing each of these variables some points common toi all variahl("` 
should be made. As explained in section 5.2.5 PSG data for both haselirre and 
intervention periods were recorded in 37 of the 44 participants. One-way ANOVAs 
were performed on the baseline mean SOL, WASO TST and S. F. values and no 
significant differences were found for SOL I F(2,34)=. 067, n. s. I, WASO 1 I'(-'. 34 )_. 2 )8, 
n. s. 1, TST IF(2,34)=3.23, n. s. I or S. E. IF(2,38)=. 496, n. s. I (a 11 p, >I). 05). 
5.4.6.1 Sleep Continuity Data gathered via Polysomnogruphy 
Table 17 presents the means and SD for sleep continuity variablrs rrrunkdI during 
the second night of baseline and the last night of treatment for the Ql IRin, QI IRt it and 
Control groups. 
Table 17 - Mean and SD for Objectively Measured Sleep Continuity Variables 
at Baseline and End of Treatment for the 3 Groups 
QHRin (N=13) QHRout (N=16) Control (N=8) Total (N=37) 
SOL 
Base Iinc 27.73 (30.0) 24.03 (26.3) 
I? nd Treatment 33.92 (34.9) 17.35 (19.4) 
WASO 
Baseline 54.11 (45.4) 49.12 (38.8) 
Ind Treatment 70.6 (58.2) 61.62 (49.9) 
TST 
Baseline 421.73 (45.3) 430.03 (60.3) 
I: nd Treatment 393.23 (75.9) 411.84 (55.9) 
S. E. 
Baseline . 
83 (. 08) . 
84(. 08) 
End Treatment . 
78 (. 13) . 
83 (. 09) 
2h. Iý 2'1.9) 5. ( )o. 7 
18.87 (15.3) 23.5I (25.9) 
62.50 (32.2) 53.77 
62.18 (27.9) 0-1.90 (i . 
3) 
376.50 (27.2) -115.54 (52.8) 
40I. 56 (70.1) -I03.0 (65.2) 
. 
81 (. ()O) . 
83 i. ()()) 
. 82(. 06-) . 82 (. IO) 
Separate mixed model ANOVAs were carried out on each of' the sleep continuity 
variables but no statistically significant differences were found. 'T'hem' were no lime, 
OO 
group or interaction effects for SOL IF( I , 
34)=. 167, n. s., F(2,34)=. 513, n. s.; 
F(2.34)=1.12, n. s. ], WASO IF(I, 34)=1.130, n. s., IF(2,34)=. 264, n. s, F(2.34)=. 165, n. s. I, 
TST IF(1,34)=. 373, n. s., F(2,34)=1.595. n. s.. F(2.34)=1.121, n. s. 1 or S. F. IF( I, _ß4)=. 438, 
n. s.; F(2,34)=. 626, n. s.; F(2.34)=. 824, n. s. j. These results indicate that 1'S(; dcl'inrd 
sleep parameters were unchanged at end of treatment as compared tu ha. seline. The 
positive subjective outcomes regarding sleep continuity parameters were, therefore, not 
confirmed by outcomes obtained via PSG. It is, therefore, important to Consider \w heller 
or not sleep continuity variables measured subjectively were correlated with the saine 
variables measured objectively (section 5.3.7.3). First, however, slrrl) ; irrhiti'rturc 
parameters will be analysed 
5.4.6.2 Sleep Architecture Data 
Table 18 presents the means and SI) for sleep au-rhiteetum variables (Stg I, tilg, ?, 
Stg 3 &4 and REM) recorded during the second night of' baseline and the last night oI' 
treatment for the QHRin, QHRout and Control Groups. 
Table 18- Mean and SD for Objectively Measured Sleep ; lrchilectiu"e Variable', 
at Baseline and End of Treatment fror the 3 Groups 
QHRin (N=13) QIIRout (N=16) C ontrol (N=8) Total (N=37) 
Stg I 
Baseline ? 2.69(17. x)) 18.37(11.5) 17. ih(I2.1) 11) /1 i1-11) 
F. nd Treatment 21.65 (19.4) 20.78 (14.5) I0.00 (10.0) 20.06 (I 5A) ) 
Stg 2 
Baseline 255.03 (29.7) 247.19 (40.8) 242.50 (25.4) 248.11 (33.7) 
lind 't'reatment 226.26 (60.3) 241.35 (35.3) 25 1.00 (47.7) 238.1-1 (17.0) 
Stg3&4 
Baseline 31.96 (33.5) 39.15 (23.5) 18.50 (32.2) (2.10 (20.9) 
End "Treatment 34.07 (28.2) 33.68 (23.5) 17.06 (15.1) tO? 2 (24.3) 
REM 
Baseline 112.03 (25.7) 125.34 (33.8) 97.93 (19.4) 1 1-1.7.1) 9.7) 
End Treatment 111.23 (42.7) 116.03 (30.0) 117.68 (30.0)_ 
__] 
14.70 0.1. 
_i) 
Separate mixed model ANOVAs found no statistically Significant 
Specifically, there were no time IF(I, 34)=O. OOI, n. s. 1, group II (2,3-3)=(). 3(I, n. s. 1 or 
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interaction [F(2.34)=0.6.16, n. s. ] effects for Stg 1., no time [F(1,34)=1.102, n. s. ], group 
[F(2,34)=0.086, n. s. ] or interaction [F(2.34)=1.632, n. s. ] effects for Stg 2, no time 
[F(1,34)=0.367, n. s. ], main group [F(2,34)=1.661, n. s. ] or interaction [F(2.34)=0.876, 
n. s. ] effects for Stg 3&4 and no time [F(1,34)=0.342, n. s. ], no group [F(2,34)=0.699, 
n. s. ] or interaction [F(2.34)=2.200, n. s. ] effects for REM. 
These results indicated that sleep architecture values gathered via PSG at baseline 
remained unchanged following the intervention phase. 
These analyses and those reported in the previous section suggest that the QHR 
interventions had no impact on objective sleep continuity or sleep architecture variables. 
This is a net contrast with estimates of sleep continuity and sleep quality. It is, therefore, 
important to assess if the subjective and objective sleep parameters obtained in this 
study correlate. 
5.4.7 Subjective and Objective Sleep Continuity: Association 
In this section objective and subjective measures of sleep continuity are compared 
5.4.7.1 Descriptive Subjective and Objective Sleep Continuity 
To determine whether the subjective estimates of sleep on the recording nights were 
representative of the subjective sleep estimates of non-recording nights, the mean for 
self-report SOL, WASO, TST and S. E. on the recording nights were compared to the 
mean for self-report SOL, WASO, TST and S. E. for the baseline and end of 
intervention weeks for each group (Jacobs and Benson, 1993). As depicted in table 19 
the means did not differ significantly, suggesting that the sleep recording night was 
representative of sleep on non-recording nights . 
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Table 19 - Wilcoxon Signed Rank Test values and significances comparing sleep diary data of 
recording night and mean week values at baseline and end of' intervention 
Recording Night V alues Vs Weekly Mean Values 
Group Sleep Variable Baseline Intervention 
z N-ties p r. N-lies I) 
QHRin 
SOL (1. I5 13 ns 0.45 13 ns 
WASO 1.15 13 ns 0. S() 13 ns 
TST 0.31 13 ns 1.51) 13 ns 
S. E. 0.52 13 ns 0.53 II is 
QHRout 
SOL 0.85 14 ns 2.66 12 ns 
WASO 1.47 14 ns H) 1 (4 n> 
TST 1.22 (4 ns 1.218 14 nti 
S. E. 0.75 (4 ns L55 14 n. 
Control 
SOL 1.26 8 ns 1.18 7 ns 
WASO 0.42 8 ns 0.07 8 ns 
TST 0.28 8 ns 0.84 8 ns 
S. E. 0.14 8 ns 0.49 8 ns 
In table 20 means and standard deviations of snhjertivr ant) uhji"rtivi" slipp 
parameters collected during PSG nights are presented. As already discussed a Dull data 
set was available for 35 participants. 
Table 20 - Mean and SD for Objective and Subjective Sleep Continuity Variables 
at Baseline and End of Treatment for the 3 Groups 
QHRin (n=13) QHRout (n=14) Control (n=8) 
PSG 1)iarN PSG Diary P. M., Diary 
SOL 
Baseline 27.7(30) 63.1(95) 25.8(28) 83.1( 127) 'O z( 25) 21. ()(16) 
End Treatment 33.9(35) 40.5(65) 14.1(14) 15.2(15) 18.1)( 15) ; S. 5( 31) 
WASO 
Baseline 54.1(45) 105.9(107) 49.3(39) 70.4(68) 62.5(32) 103.7(45) 
End Treatment 70.6(58) 71.1(79) 57.9(42) 43.0(51) W. 2(28) tiO, Oo )) 
TST 
Baseline 421.7(45) 314.6(120) 431.1(65) 
-355.0(1.10) 
370.5(27) 
. 
32.5) 5I) 
End Treatment 393.2(76) 362.2(73) 416.3(58) 427.1(62) 401.5(70) 370.2(102) 
S. E. 
Baseline . 
83(. 08) 
. 
65(. 24) . 
84(. 09) 
. 69(23) . 
81(. 09) 
. 
73(. 11) 
End Treatment 
. 
79(. 13) . 
78(. 16) 
. 
85(. 08) 
. 88(. 10) . 82(. 07) . 
75(. 15) 
2O2 
Inspection of table 20 suggests that the discrepancy between subjectively rcpoiied 
and objectively measured sleep continuity (sub-ob discrepancy) is wider at haselirr Tian 
at end of treatment. 
Taking into consideration that, when only a few PSG nights were recorded, i'ST and 
S. E. showed less variability than SOL and WASO (Wohlg muth, Edinger, Fins and 
Sullivan; 1999) only TST and S. E. were formally analysed. 
Figures 39 and 40 illustrate such sub-ob discrepancies for the TST and S. F. values. 
The whole rectangle represents the mean PSG defined TST, the lighter (hutloni) portion 
represents the mean diary value. The darker (upper) polliun shows the discrepancy 
between PSG and estimate of TST. 
Fig. 39 Subjective and Objective TST at baseline (b) and End of Intervention (int) 
for the 3 Groups (darker portion indicates the sub-ob discrepancy) 
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For example, inspection of figure 39 shows that f 0r the QlIRin at hast-111c the 
discrepancy between PSG and estimate of TST (darker portion 01' ihC i, 
almost 4 times the discrepancy at the end of' the intervention. For the QIIRm l the 
discrepancy at baseline is almost 3 times the discrepancy at end of' intervention. 
Similar observations can be made for the QIIRin and the OIIRout data on S. I. ,. (fig. 
40): the sub-ob discrepancy at the end of the intervention is minimal for the Q1 Will and 
for the QHRout as compared to those at ha. si'linr. 'I'hr , uh-oh (liscici', ancv hr fIic 
control group remained, in contrast, unchanged. 
2()3 
FIG. 40 Subjective and Objective S. E at Baseline (b) and End of Intervention (int) 
for the 3 groups (darker portion indicates the sub-ob discrepancy) 
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Wilcoxon Matched Pairs Signed-Ranks Tests showed that there were significant 
differences between the TST sub-ob discrepancy at baseline and end of inlerventlon for 
the QHRin jz=2.34, N-ties=13, p=O. 0I91 and the QHRout Ir=3.04, N-tic`=I. 4, p-0.0021 
but not for the control group Jz=O. 50, N-ties=8, n. s. I. Similarly, statistically signilirant 
S. E. differences between the sub-ob discrepancies at baseline and end of intervention 
were found for the QHRin Iz=2.7, N-ties=12,1p=O. OO71 and the Qlllzout Ir=3. O7, N 
ties=14, p=0.002] but not for the control group Iz=0.42, N-tics=h, n. s. I. 
These results confirmed that, for the QHRin and the QIlk nit, the dlil'l'erenee 
between subjectively reported and objectively measured 'IST and S. I. values were 
smaller at the end of the intervention as compared to baseline. Wilh regard lo the control 
group no changes in the sub-ob discrepancy were detected. 
5.4.7.2 Associations between Objective and Subjective Me__isures_ 01' SILT I) ('0ntinuii1) 
Variables. 
As pointed out in the previous section subjective and objective sk'c p continuity 
outcomes contrast sharply and it is, therefore, important to assess il thew vari, ºhles 
correlate with each other. Spearman's rank order correlations Who) were carried out on 
U-4 
sleep diary and PSG data separately for each of the three groups but no significant 
correlations were found. 
In table 21 the correlation coefficients between objective and subjective measures of 
sleep are presented. 
Table 21: Correlations between objective and subjective measures of sleep at 
Baseline and End of Intervention for the OHRin, QHRout and Control 
(squared correlations (R2) are reported below each r) 
2"d Night Baseline Last Night of Intervention 
Diary - PSG Diary - PSG 
S. E. SOL WASO TST S. E. SOL WASO TST 
QHRin 
N=13 r 0.55 0.51 0.19 0.46 0.48 0.14 0.29 0.47 
R2 0.30 0.26 0.03 0.21 0.23 0.05 0.08 0.22 
QHRout 
N=14 r -0.10 0.30 -0.21 0.65 
It2 0.01 0.09 0.04 0.42 
Control 
N=8 r 0.56 0.50 0.50 0.40 
R2 0.31 0.25 0.25 0.16 
0.40 0.00 0.23 0.52 
0.16 0.00 0.05 0.27 
0.62 0.60 0.18 0.60 
0.38 0.36 0.03 0.36 
None of the above correlations was significant. The squared correlations show that 
the proportion of variance in common between the two variables is between 0% and 
42%. It should be noted that correlations appear to be variable and unstable; this is not 
surprising given that correlations are heavily dependent on power (i. e. sample sizes) and 
sample sizes were very small. 
5.4.8 Adherence with the Quarter of an Hour Rule 
In this section subjectively and objectively measured adherence with the QHR are 
reported descriptively. 
Subjective measures of adherence were collected during the three weeks of 
intervention. However, the weekly mean adherence scores were comparable and, 
therefore, only the first week was considered so as to have a mean of comparison with 
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objectively measured adherence (one week data) (fig. 41). It should he noted that thi' 
discrepancy between subjectively reported and objectively measured adherence is wider 
for the QHRout group than the QHRin. Paired t-tests revealed statistically significant 
differences between subjective and objective adherence It( 13)=5.09, p<0. (X)05I for the 
QHRout but not for the QHRin. 
Fig. 41 - Subjective and Objective Adherence Scores for 
the OHRin and QHRout Groups 
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The group SOL change scores from baseline to cud of treatment wen' 1) minutes for 
QHRin and 38 minutes for QHRout and the WASO change scores were SIl minutes for 
QHRin and 77 minutes for QHRout. These data give an indication that statistically 
significant improvements in sleep parameters are obtained even if adherence to the 
behavioural intervention is not complete. Indeed, the objective data stwoest that on 
average roughly 5O`: '( adherence to the rule is sufficient to produce si11nifirant ch, inges. 
It should he noted that inspection of the raw data on adherence indicated that 
participants either adhered or did not, making the data more categorical (i. e. adherril, 
not adhered) than linearly distributed (histograms in appendixes 32a and 32h). Own 
that correlation cannot be used for categorical data (e. g. render, ves/no) it w, i,, not 
deemed correct to correlate adherence data to sleep data. 
"0 
5.5 - Discussion 
Following an analysis of the biological, behavioural and cognitive perspectives of 
insomnia and related therapies it appeared that a closer examination of the single 
components of stimulus control was warranted and the present experiment was 
designed. It employed subjective and objective measures of sleep with the aim of 
investigating whether a simplified behavioural intervention for insomnia, namely the 
QHR, could be employed to improve sleep. Clinical significance and response curves 
were also examined. The target sample was composed of people presenting with 
insomnia in primary care and people recruited via media advertisements. 
A second aim of the present study was to explore mechanisms of effect of the QHR. 
In order to investigate this issue a group of participants was asked to implement the 
QHR out of bed (QHRout, canonical form of stimulus control) while another group 
implemented it in bed (QHRin, counter to stimulus control and potentially enhancing 
sleep incompatible associations). It was reasoned that should the QHR work because it 
re-establishes the connection between the bedroom environment and falling asleep then 
the QHRin condition would either not impact on sleep or impact negatively. In addition, 
sleep related questionnaires were administered to participants at baseline and end of 
treatment so as to assess if the QHR interventions were associated with changes in 
cognitive activity (e. g. sleep effort, planning) and arousability. 
Finally this study examined the relationship between adherence to treatment and 
treatment response. The feasibility of employing actigraphy with the added feature of 
light detection to measure adherence objectively to a behavioural treatment for insomnia 
was also explored. 
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5.5.1 - Summary of Results 
Seven specific predictions were made. These were based on theoretical 
considerations pertaining the link between insomnia and poor stimulus control, and the 
main findings reported in sleep literature. 
The first prediction that, following the QHRout, participants' estimates of SOL and 
WASO would decrease and S. E. would increase was supported. Furthermore, a trend 
suggesting TST increase was found. 
The second prediction was partly supported: the QHRin increased S. E. and trends 
suggesting an increase in TST and a decrease in WASO were found. However, SOL 
was not improved following the QHRin. 
The third prediction, that the QHR interventions would improve estimates of sleep as 
compared to the control group, was also partially supported. At the end of the 
intervention the QHRout group's WASO was shorter, S. E. was greater and trends 
suggesting longer TST and shorter SOL than those of the control group were found. 
With regard to the QHRin group trends suggesting longer TST, greater S. E. and shorter 
WASO than those of the control groups were found. 
The fourth prediction, that the QHR interventions would reduce the PSQI total score, 
was supported. As expected the control group's PSQI total score remained the same. 
The fifth prediction was that the QHR interventions would improve perception of 
sleep quality, restedness and alertness in the morning. Trends indicated that, following 
either the QHRin or the QHRout, participants considered their quality of sleep better 
and they felt more rested and alert than at baseline. The control group, in contrast, did 
not change their ratings of sleep quality, restedness or alertness. 
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The sixth prediction, that the QHR interventions would meet criteria for clinically 
significant changes as compared to the control group, was supported. Between 33 and 
57% of individuals assigned to the QHR interventions achieved clinically significant 
changes at post-treatment. Clinically significant improvements (SOL, WASO, TST and 
S. E. ) were evident from the first week of intervention and the magnitude of effect was 
bigger for the QHRout procedure than the QHRin. 
The seventh prediction, that subjective and objective measures of sleep would 
correlate, was not supported. 
The eighth prediction, that treatment response and adherence would be positively 
correlated could not be tested because adherence data tended to be categorical. 
With regard to the examination of sleep related cognitions and arousability, the 
detection of possible changes might have been hindered by low power. Nonetheless it 
was found that both QHR interventions resulted in reports of decreased sleep effort, 
fewer sleep pattern problems and less cognitive and somatic arousal. Additionally the 
QHRout decreased active problems solving and somatic and sensory engagement. In 
contrast no changes were found for the control group. 
Finally neither the QHR nor the control conditions produced changes in objective 
sleep continuity or sleep architecture variables. However, and importantly, the 
discrepancy between subjective and objective measures of sleep continuity diminished 
following the intervention in the QHR groups but not in the control group. 
These findings will be examined and interpreted in turn. 
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5.5.2 Interpretation of Results 
5.5.2.1 Subjective Sleep Continuity Data 
The prediction that following the QHR interventions SOL and WASO would 
decrease and TST and S. E. increase, was fully supported with regard to the QHRout but 
only partially so for the QHRin. Indeed, following the intervention, the QHRout group 
took less time to fall asleep, was awake for shorter periods during the night, showed a 
trend suggesting they slept for longer and increased the time actually asleep while in 
bed. In contrast, following the intervention, the QHRin took the same time to fall asleep 
as it did at baseline. Similar to the QHRout, the QHRin group increased the amount of 
time actually asleep when in bed and trends indicated that the QHRin was less awake 
during the night and slept longer. Importantly both QHRin and QHRout groups 
decreased their PSQI total score. The control group's baseline sleep estimates and PSQI 
total score remained unchanged at the end of treatment. 
An important point to make in interpreting these data relates to having detected 
trends rather than significant effects for TST (both QHRin and QHRout) and WASO 
(QHRin). Although these results might be due to the QHR interventions not impacting 
positively on sleep, it is plausible that statistical significance at a<0.05 was not 
achieved due to the Bonferroni correction being very conservative or to the low power 
to detect significance due to modest sample sizes. However, given the explorative 
nature of this study, it was felt important reporting trends suggesting that further 
research is worthwhile. 
The findings that the QHRout intervention produced significant changes in SOL and 
WASO corroborated Tokarz and Laurence's (1974) findings that delivering only the 
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situational components of the stimulus control package improved sleep. Furthermore, 
these results are not surprising taking into account that, in this research, the QHRout 
was posited to encapsulate the essence of the conditioning aspects of stimulus control. 
Indeed, as discussed in the introduction, stimulus control has consistently improved 
these two sleep parameters in students, GP recruited patients and older adults (Espie et 
al, 1989; Lacks et al, 1983a, 1983b, Morin et al, 1988; Puder et al 1983; Sanavio et al, 
1990). The present results, therefore, lend support to the idea that the QHRout 
epitomises stimulus control for insomnia. 
Similarly to Davies et al's (1986) report, that counter-stimulus control improved 
WASO, a trend suggesting that the QHRin improved WASO was found. However, 
unexpectedly and contrary to Zwart and Lisman's (1979) findings with counter-stimulus 
control, the QHRin did not impact on SOL. Obviously, the QHRin is only one of the six 
instructions of counter-stimulus control and, therefore, it is possible that the positive 
outcomes reported by those authors were not due specifically to the instruction `sit up in 
bed if unable to sleep' (QHRin). If this was the case, however, the QHRin should have 
resulted in no positive outcomes in both cases: at sleep onset and during the night. This 
would also have been consistent with stimulus control theory as the bedroom 
environment rather than becoming associated with sleep would signal wakefulness. 
It could be speculated that people enjoyed spending some time reading in bed and, 
therefore, retired to bed earlier than at baseline, with the intention of reading rather than 
sleeping. However, examination of TIB showed similar values at baseline and end of 
intervention (8hr & 7min vs. 8hr & 8min). Another possibility is that the 'cosiness' of 
reading in bed at the beginning of the night was a (positive) reinforcer for staying awake 
(elicited response). In the middle of the night, in contrast, having to read may have been 
unpleasant (negative reinforcer) which, in turn, elicited falling asleep quickly. In other 
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words, falling asleep quickly became a way to stop something unpleasant. Of course 
taking into account the sample size, it is possible that the power to detect differences 
was too low (Kazdin and Bass, 1989). 
The finding that S. E. increased following the QHR interventions, is consistent with 
results showing that significant changes in S. E. values were obtained in CBT trials (e. g. 
Backhaus, Hohagen, Voderholzer and Riemann, 2001, Morin et al, 1994). 
Unfortunately a direct comparison with stimulus control is difficult to make because 
during the 1970s and the 1980s (when most studies on single therapies were carried out) 
S. E. was not reported. Calculation of S. E. from Morin et al's (1994) stimulus control 
findings (S. E. = 0.69 at baseline and 0.84 at end of treatment), suggests that the present 
results are similar to those obtained in previous studies with the entire stimulus control 
package. It is noteworthy that S. E. depends on TIB and TST values and, as discussed 
above, following the QHR interventions TST increased while TIB remained unchanged: 
it is, therefore, unsurprising that S. E. increased accordingly. 
The present findings open the possibility that conditioning operates on two different, 
and perhaps additive, dimensions: an external environmental dimension and a 
cognitive/internal (to the individual) dimension. This possibility would help explain the 
findings that the QHRout is more efficacious than the QHRin: by getting out of bed 
faulty conditioning is broken on both levels and appropriate conditioning is re- 
established. It could be argued that the QHRout impacted positively on sleep for at least 
three reasons. First, it fosters the association between bedroom and sleep by making the 
bedroom an eliciting stimulus for falling asleep. Second, it helps breaking the 
association between being in bed and both negative (e. g. rumination about lack of sleep 
not sleeping) and/or constructive (planning the day ahead) cognitions. This possibility 
was suggested by Bootzin and colleagues as a possible explanation of findings that 
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counter stimulus control instructions resulted in sleep improvements (Bootzin et al, 
1991; 2000). Third, it makes falling asleep a behaviour that stops an aversive event (i. e. 
getting out of bed) from happening or continuing (Bootzin et al, 1972). The QHRin, 
however, may work only on two levels. For negative reinforcement reasons: falling 
asleep quickly if awake at night stops an aversive event (i. e. having to sit up in bed and 
read a book). This would help explaining why the QHRin worked during the night 
(when sitting up reading is most likely unpleasant) but not at bedtime (when reading a 
book in bed can be a pleasant activity). In addition, as in the case of the QHRout, 
having to read breaks the habit to lie in bed thinking and/or worrying. 
5.5.2.2 The PSOI Total Score 
One of the outcome measures of this study, the PSQI total score, decreased 
following the QHR interventions while the control group's PSQI did not indicating that 
individuals in the QHR groups, but not in the control group, had a more positive overall 
perception of their sleep quantity and quality following intervention. Admittedly, the 
PSQI at end of intervention did not indicate normal sleep (PSQI<=5). As already 
proposed in study two this could be because the PSQI at baseline was higher (13 for the 
QHRin and 14 for the QHRout) than the mean score (10.38) of the normative 
individuals with insomnia of the Pittsburgh study (Buysse et al, 1989). This difference 
is especially considerable if the fact that the individuals in this trial had to be sleep 
medication free is taken into consideration (hence PSQI score ranged from 0 to 18 
rather than 0 to 21). It is also important to consider that most treatment studies do not 
achieve a PSQI score below six and such an outcome might be a (strict) clinical end- 
point. 
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Importantly, this result provides further evidence to that gathered via sleep diaries that 
the QHR interventions were efficacious at improving sleep difficulties. 
5.5.2.3 Sleep Quality Data 
Following the QHR interventions, trends indicating improvements in perception of 
sleep quality, restedness and alertness emerged. Sleep continuity improvements were 
coupled to feeling more refreshed and alert in the morning and to considering the 
quality of sleep better as compared to baseline. In view of Vincent, Penner and 
Lewycky's (2006) findings that sleep quality and duration of sleep time were the most 
important predictors of a patient's perception of having 'improved a lot' after 
completion of CBT-I, these results are encouraging. Following the QHR interventions 
people rated their quality of sleep higher as compared to baseline and, as discussed in 
the previous section sleep duration was increased by about one hour: the two most 
important predictors of 'My sleep has improved a lot', as defined by Vincent et al's 
(2006) recent study, were both significantly improved. 
With regard to alertness and feeling rested the following comment is noteworthy. 
The ICSD-R diagnosis of insomnia includes a 'complaint of decreased functioning 
during wakefulness'. It is likely that the perceived degree of alertness and restedness 
impact on the overall sense of being able to function well during the day. Morin and 
Azrin (1988) found that stimulus control decreased self and significant others' ratings of 
sleep problems' interference with daily functioning. Unfortunately perception of daily 
functioning (e. g. ability to concentrate, fatigue, irritability) was not measured in this 
study. 
Alternatively, it could be that qualitative aspects of sleep were rated higher than at 
baseline because participants perceived fewer sleep difficulties (e. g. shorter SOL, longer 
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TST). Indeed, Neitzer-Semler and Harvey (2005) found that people who were told that 
actigraphy revealed they had had a bad night would report functioning less well during 
the day as compared to people told they had had a good night, independently of real 
sleep continuity. 
5.5.2.4 Clinical Changes Associated with the Quarter of an Hour Rule 
Clinically significant changes were observed in 33 to 57% of individuals assigned 
to the QHR interventions and about one third of them returned to normalcy. These 
results are consistent with Lacks and Powlishta's (1989) claim that about half of people 
with insomnia show reliable changes following insomnia treatment and that about one 
third return to normative level of functioning. The present results are also in line with 
findings from meta-analytic reviews that around 40 to 60% of individuals respond 
clinically to CBT treatments (Irwin et al, 2006; Morin et al, 1994; Murtagh and 
Greenwood 1995). 
Another important parameter for clinical significance of results is the magnitude of 
effect. Using Cohen's (1992) scheme, the effect sizes for WASO, TST, S. E. and PSQI 
for the control group were zero. These results suggest that self-monitoring per se has no 
impact on these sleep continuity parameters and on the PSQI. Interestingly, a small 
effect was found for SOL. It should be remembered that SOL deteriorated (increased) in 
the control group during the intervention phase. Unfortunately the design of the study 
does not allow exploration of this finding. It could be speculated that self-monitoring 
made participant focus on their inability to fall asleep and, in so doing, increased worry 
and sleep effort. These, in turn, impacted negatively on SOL. 
In contrast, large effect sizes for PSQI and S. E. and TST were found for both the 
QHRout (2.3,0.8 and 1.1 respectively) and the QHRin (1.7,0.8 and 0.8 respectively). 
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The TST effect sizes for both QHR interventions were in the large range while those 
typically reported at end of CBT interventions are in the medium range (Morin et al, 
1994=0.42; Murtagh et al, 1995=0.49, Smith et al, 2002=0.46). However, this result 
might not be surprising if the following is taken into consideration. Both sleep 
restriction and stimulus control, which are typically included in CBT packages, by 
curtailing sleep opportunity (amount of time the patient can be in bed) often result in 
modest TST increases during the treatment phase whereas the QHR does not limit the 
amount of time to be spent in bed (providing one is not in bed awake for more than a 
quarter of an hour). Following three weeks of QHR interventions TST was increased by 
around 60 minutes, in CBT trials, instead, TST is generally increased by only a modest 
20-30 minutes at the end of the insomnia treatment with further gains of around 30 
minutes at follow-up (Morin et al, 1994; Murtagh et al, 1995). 
With regard to WASO medium to large effects sizes, comparable to those reported 
by meta-analyses of the whole stimulus control package (Morin et al, 1994) and those of 
meta-analytic studies on behavioural treatment for insomnia (Irwin, et al, 2006; Morin, 
et al, 1994; Montgomery and Dennis, 2004; Murtagh and Greenwood 1995; Pallesen, et 
al, 1998; Smith, Perlis, et al, 2002) were found. 
Furthermore, the QHRout effect size for SOL was also consistent with meta-analytic 
findings (medium to large range); in contrast the QHRin effect size for SOL was small. 
This finding is not surprising given that the average SOL improvement was only 9 
minutes. 
An important finding was that the magnitude of effects obtained with the QHRout 
were bigger than those obtained with the QHRin. This result is not dissimilar to that 
obtained by Davies et al (1986). They found that counter-stimulus control was only 
moderately effective reducing SOL by only about 30%. Admittedly in their study there 
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was not a direct comparison between stimulus control and its counter but the magnitude 
of effects for counter-control was smaller that those typically obtained with stimulus 
control (Morin et al, 1994; Morin, Mimeault et al, 1999; Murtagh et al, 1995). In order 
to interpret the fording, that the magnitude of effect was larger for the QHRout, the 
learning theory perspective is useful. It could be argued that the QHRin, which requires 
sitting up in bed and reading, is not as effective at facilitating new associations between 
the bedroom and sleep as the QHRout. 
With regard to the response curve, these clinically significant changes were evident 
from the first week of intervention. It is important, however, to remember that the 
present study does not allow the assessment of the optimal dose needed to detect 
improvements, rather it suggests that one single dose of therapy is sufficient to improve 
sleep parameters. The few minimal telephone contacts following the intervention 
sessions might have been necessary to maintain improvements or superfluous but this 
was not tested. In addition the present design does not permit to determine if more 
sessions would have enabled a larger number of individuals to reach clinically 
significant changes. Nonetheless these findings give further evidence to Edinger, 
Wohlgemuth, Radtke and Marsh's (2004) findings that one CBT session had greater 
efficacy in decreasing WASO than either two or eight sessions . 
It is important to note that the present results represent response to the acute 
treatment phase and whether treatment gains would be maintained, enhanced or would 
disappear after last contact with the researcher is unknown. 
5.5.2.5 Sleep Related Questionnaires 
Several interesting findings derived from questionnaires responses. First, baseline 
endorsement of sleep disruptive behaviour score of the SBRS-R was unchanged at the 
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end of the intervention. This could be due to lack of power due to small samples. 
Nonetheless, this finding was not surprising with regard to the QHRin because it 
required 'remaining in bed when awake' (q. 11) and `reading in bed' (q. 1). Given that 
adherence data evidenced good adherence with the QHRin, scores on questions 11 and 8 
were likely to increase. Additionally, the QHRin did not require discontinuing 
behaviours such as watching T. V. (q. 2), taking naps (q. 8), or switching the light off as 
soon as entering the bed (q. 10). Although the QHRout did not comprise instructions 
regarding all sleep disruptive behaviours measured in the scale, it did require `getting 
out of bed if not asleep in 20 minutes (q. 12) and `not lying awake in bed if not asleep' 
(q. 11). It was, therefore, expected to find a change in score following intervention. 
Indeed inspections of mean values suggested a decrease in sleep disruptive behaviours 
(supported by repeated measure t-test). 
Interestingly, responses to the SDQ evidenced that sleep patterns of the QHRin and 
QHRout groups had improved following the intervention while those of the control 
group remained unchanged. These results suggest that despite the fact that QHR 
interventions did not directly attempt to regularise sleep schedules, participants started 
to do so themselves. It could be speculated that experiencing sleep improvements by 
having a routine to follow when not asleep, made participants seek more routine-like 
sleep habits. Alternatively, this could be the result of sleep monitoring; this 
interpretation is, however, unlikely because the control group did not show such change. 
Analyses of the GSES and SDQ questionnaires indicated that, following the 
intervention, sleep effort, cognitive arousal and somatic arousal were decreased in the 
QHRin and the QHRout. These findings are not surprising: having a specific activity to 
perform if not asleep might have reduced cognition regarding inability to sleep and 
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consequently effortfully trying to fall asleep (Espie et al, 2006). In turn, this enabled 
cognitive and somatic de-arousal. 
In order to interpret these results it is important to remember that although these 
questionnaires assess several distinct constructs (worries about not sleeping, sleep effort 
and sensory and somatic engagement), they are different aspects of a broader construct, 
that is cognitive activity. Indeed, the questionnaires were found to correlate. Although 
the QHR interventions did not challenge or address cognition directly, it is likely that 
they did so implicitly. After all, the QHR intervention implies that `it is ok giving up 
trying to sleep' (read if you cannot sleep). It could, therefore, be speculated that 
behavioural instructions per se, changed sleep cognitions. On the other hand, it is 
plausible that noticing sleep improvements changed attitudes toward sleep. 
It might seem surprising that a behavioural intervention, intending to establish a 
connection between the bedroom environment and falling asleep, influences such 
aspects of cognitive activity. However, the QHR requires performing and engaging with 
one simple, emotionally neutral, activity (i. e. reading something light) which may 
inhibit self-generated and sleep related and emotionally laden, mental activity. Indeed, 
previous research evidenced that under light cognitive load sleep onset was shortened 
(Ansfield, Wegner and Bowser, 1996; Haynes et al, 1981) in people with sleep 
problems. 
It is important to note that the design of this study does not permit to rule out that 
other generic psychological explanations such as self-efficacy, mastery, placebo effects 
or demand characteristics (e. g. social desirability, reactivity) might have been 
responsible for the changes evidenced by this battery of questionnaires. 
Before concluding this section, it is important to mention that improvement in sleep 
continuity was evidenced by subjective sleep diary, and that questionnaires are another 
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form of self-report. It is, therefore, likely that they follow a similar gradient: if the sleep 
diary evidences improvements sleep related questionnaires are also likely to depict 
improvement. 
5.5.2.6 Objective Sleep Continuity 
As discussed in the previous sections, subjective measures of sleep indicated sleep 
improvements following the QHR intervention. However, when sleep was measured 
objectively, no significant changes in sleep continuity and sleep architecture parameters 
were found. Another finding of the present study was that the discrepancy between 
subjectively reported and objectively measured sleep variables at baseline decreased in 
the QHR groups but not in the control group. These results are consistent with previous 
findings that insomnia treatment produces positive outcomes when sleep continuity is 
measured subjectively without necessarily resulting in changes in objective sleep (see 
Stepanski, 2000 for a review). In order to provide an interpretation of these findings 
several considerations must be made. 
First, the logical possibility that participants may have presented with paradoxical 
insomnia (SSM) can be ruled out by baseline PSG evidencing sleep maintenance and/or 
sleep onset difficulties in most participants. Estimates of sleep difficulties certainly 
suggested more severe insomnia than the PSG defined sleep implied, however, this is 
not an atypical finding in the insomnia literature (Stepanski, 2000). Importantly, no PSG 
improvements were detected at end of intervention. These findings could be interpreted 
as evidence that the QHR interventions were not actually efficacious in improving sleep 
i. e. PSG defined sleep did not change following intervention. 
Another explanation can be proposed by taking into account that the 
primary/psychophysiological insomnia diagnostic criteria characterise insomnia as a 
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difficulty in initiating /maintaining sleep at least three nights a week. These criteria 
suggest that insomnia does not necessarily occur every night and clinical evidence 
indicates that night-to-night variability and unpredictability of sleep are considered 
classic features of insomnia. Indeed, aetiological models of insomnia recognize these 
characteristics as central to the configuration of insomnia (Espie, 2002; Morin, 1993) 
and these characteristics have been corroborated by empirical findings (Coates et al, 
1981; Edinger et al, 1991,1997; Vallieres, Ivers, Bastien, Beaulieu-Bonneau and Morin, 
2005). It could be argued that the QHR interventions decreased sleep difficulties but did 
not eliminate completely the possibility of `bad' nights. Indeed, estimates of sleep 
suggested reduction of sleep problems following the QHR intervention, but only one 
third of individuals returned to normalcy: that is sleep difficulties were diminished but 
still present. Given nightly variability, recording PSG only one night at baseline and one 
at the end of the intervention might not have permitted detection of changes reliably. 
This possibility finds support in investigations of the stability of PSG measures in 
insomniacs and normal sleepers both at home and in laboratory settings. For example, 
one recording night resulted in inadequate stability (reliability) of measurement because 
of unpredictable nightly variations in both normal and poor sleepers (Wohlgemuth et al, 
1999; Bootzin, Bell, Halbisch, Kuo, Wyatt, et al, 1995). In view of these findings, 
Wohlgemuth et al (1999) suggested averaging multiple nights of recording with the 
number of recording nights varying depending on the sleep variable under examination: 
SOL and WASO being the most susceptible variables to nightly variations and TST the 
least. Similarly, Means et al (2003) found evidence of variability across nights for both 
poor and normal sleepers (the inter-night correlations ranged between 0.37 and 0.64 for 
the insomnia group and between 0.35 and 0.47 for normal sleepers). 
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The present findings, that following the QHR PSG sleep did not change, could, 
therefore, be due to the fact that one single night of PSG evaluation did not provide 
stability due to nightly variations. 
A third possible explanation is that the QHR interventions did not produce sleep 
changes. Rather, therapeutic outcomes evidenced by estimates of sleep were due to 
factors such as desire to please the experimenter or simply having the attention of a 
therapist or thinking that someone finally took the sleep problem seriously. 
It is also plausible that participants improved their time perception ability and this 
resulted in better estimates of time asleep and awake. This would explain the decrease 
in sub-ob discrepancies following the intervention. Harvey's (2002) model incorporates 
errors in time perception as an important feature in the experience and maintenance of 
insomnia. However, it is difficult to relate the QHR interventions to better perception of 
time passing. The self-monitoring process is, at face value, the best candidate to 
promote better time perception and Fichten, Creti, Amsel, Baffles and Libman (2005) 
suggested that self-monitoring could be of benefit by demonstrating that the sleep 
problem is not as severe as believed. Despite completing a sleep diary each morning for 
5 weeks, the control group did not change their estimates of sleep continuity and it 
seems, therefore, unlikely that self monitoring alone was the reason for a decrease in the 
sub-ob discrepancies in the active treatment groups. One way to enhance accuracy of 
time passing is provided by matching, several times, one's feeling of time elapsed with 
actual elapsed time. It could be argued the QHR interventions increased accuracy 
because every time participants got up to read they checked the time. However, 
participants were explicitly asked not to change their clock watching behaviour and to 
keep completing their diary in the way they did at baseline. Nonetheless, the present 
study could not directly control for clock monitoring and this remains a possible 
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explanation, although an unlikely one given that people with insomnia have a tendency 
to clock monitor and do not seem to benefit from it (Harvey and Schmidt, 2000). 
Another possibility is that participants in the QHR interventions knew they were being 
monitored via actigraphy. Although the rationale for wearing an actiwatch did not 
mention monitoring adherence or sleep, participants might have worked this out and, as 
a result, might have started to clock monitor so as to provide sleep estimates matching 
those detected by actigraphy. 
A further possibility, that the subjective experience of change is only moderately 
related to the physiological changes measured by PSG (Engle-Friedman et al, 1992), 
seems to provide a better alternative. 
Several studies have highlighted that patients with insomnia routinely report more 
severe sleep disturbance than evidenced by traditional PSG measures. In contrast, 
normal sleepers are generally more accurate in estimating their sleep latency (Bonnet 
and Arand, 1997; Edinger, Fins, et al, 2000; Means et al, 2003; Mercer et al, 2002; 
Schramm et al, 1995). For example, Schramm et al (1995) found that normal sleepers 
sub-ob discrepancies were significantly smaller than those displayed by people with 
insomnia when PSGs were recorded in a sleep laboratory setting. Similarly, Mercer et al 
(2002) found that people with insomnia showed a greater discrepancy than good 
sleepers between PSG-defined sleep and sleep diary reports during home recordings. 
In the present study: the sub-ob discrepancies for both TST and S. E. were 
statistically significantly smaller, for both the QHRin and the QHRout, at the end of the 
intervention than at baseline. In contrast the control group sub-ob discrepancy did not 
change. Taking into consideration previous research showing that the sub-ob 
discrepancies were greater for people with insomnia as compared to normal sleepers, 
the present results could be, tentatively, interpreted as a shift towards normalcy 
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following the QHR interventions. The next question, then, would be why the sub-ob 
discrepancy should be greater in people with insomnia as compared to normal sleepers. 
The sub-ob discrepancy, evidenced in people complaining of poor sleep, has been 
proposed to be due to an important feature of insomnia: elevated levels of fast EEG 
activity. Indeed, a number of studies employing EEG spectral analysis have reported 
evidence of elevated beta and gamma activity in people presenting with insomnia as 
compared to normal sleepers. For example, Merica and Gaillard (1992) performed EEG 
power spectral analysis of the PSGs of 26 people complaining of insomnia and 28 
normal controls. They found that fast EEG frequencies (14.7-30 Hz) dropped more 
slowly and to a lesser extent in people with insomnia as compared to controls. Similarly 
Merica et al (1998) found greater fast EEG activity in people with insomnia as 
compared to controls. Perlis, Merica et at (2001) found evidence of greater relative 
power (i. e. power within a frequency band divided by the sum of power of all bands) of 
activity in the 14-45 band in people with insomnia as contrasted to controls and people 
with depression. 
Furthermore, such fast EEG activity has been found to be correlated with subjective- 
objective TST discrepancies (Jacobs and Benson, 1993; Krystal, Edinger, Wohigemuth 
and Michaels, 2002; Merica et al. 1998; Nofzinger et al, 2000; Perlis, Merica et al, 
2001; Perlis, Smith, Andrews, Orff and Giles, 2001). For example Krystal et al (2002) 
found that greater fast EEG frequencies were related to greater TST, S. E. and WASO 
sub-ob discrepancies. Similarly, Perlis, Merica et al (2001) found that greater NREM 
fast frequencies correlated with sub-ob TST discrepancies and tended to correlate with 
sub-ob SOL discrepancies (Perlis, Smith et al, 2001). 
The next question is why fast EEG activity should impact on the perception of sleep 
and wakefulness. According to Perlis et al's (1997) model, cortical arousal (high 
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frequency EEG activity) enables elevated levels of sensory and information processing 
and increased formation of long term memory. Information processing, in turn, makes it 
more difficult to distinguish sleep from wakefulness. Enhanced long-term memory, may 
interfere with the person's perception of sleep onset. Normally, the mesograde amnesia 
related to sleep onset does not allow recall of information from periods immediately 
prior to sleep and this enables the individual to `know' they were asleep (Perlis, Smith 
et al, 2001). However, an enhanced recall and retrieval of information is likely to blur 
the ability to distinguish between sleep and wakefulness. 
A well construed study by Mercer et al (2002) lent support to this hypothesis. 
Normal sleepers and people with insomnia were presented with an auditory stimulus 
while they were asleep. Interestingly, during PSG defined sleep (stage 2) people with 
insomnia, differently to normal sleepers, reported that they were awake prior to hearing 
the stimulus. This finding suggests that they perceived stage 2 sleep as wakefulness. 
The investigators proposed that nocturnal mentation while awake might be similar to 
mentation during PSG defined sleep. Importantly, Mercer and colleagues also found 
that people with insomnia were as accurate as normal sleepers in estimating the time 
elapsed between presentations of 2 probes. However, unlike normal sleepers, they 
underestimated how much of such time they were asleep. This finding suggests that 
poor sleepers' overestimation of time awake was due to perceiving stage 2 sleep as 
wakefulness rather than to having a distorted time perception per se. 
Interestingly, Jacobs and Benson (1993) employed power spectral analysis of EEG 
activity in a treatment study. They found that, although beta activity remained higher 
than the matched normal sleepers control group, it decreased following CBT-I. It should 
be noted that in their study both diary and PSG defined SOL were improved following 
10-week intervention. More recently similar findings were obtained by Cervena and 
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colleagues following an 8-week CBT program (Cervena, Dauvilliers, Espa, Touchon, 
Matousek, Billiard, and Besset; 2004). 
It is important to note that the findings discussed above in relation to sub-ob 
discrepancies are not in contrast with Harvey's (2002) argument that insomnia is in part 
a disorder of interpretation. Indeed, the research above provides evidence of 
misinterpretation: misinterpretation of sleep and wakefulness rather than misperception 
of passage of time. People with insomnia may misperceive the amount of time they are 
awake because during PSG sleep defined they are still engaging with stimuli. 
The present research did not employ power spectral analysis. However, some 
indirect evidence for decreased arousal at bed time is provided by sleep related 
questionnaires: decreased sleep effort, problem solving, cognitive and somatic arousal 
and somatic and sensory engagement were evidenced at the end of the QHR 
interventions as compared to baseline. 
In sum, lack of changes in PSG defined sleep does not necessarily mean that the 
QHR intervention was not efficacious in improving sleep. The present results could be 
due to measurement unreliability (one night PSG recording) or to the fact that 
conventional sleep staging is not the best tool to measure sleep and sleep improvements. 
Importantly, the decrease in sub-ob discrepancy, following the QHR interventions, 
suggests that people may be better at distinguishing PSG defined sleep from 
wakefulness and it could be speculated that the QHR enabled extinction of classically 
conditioned cortical arousal (Perlis et al, 1997) i. e. decreased fast EEG activity. 
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5.5.2.7 Subjective and Objective Sleep Continuity: Association 
No significant correlations between sleep continuity data measured subjectively and 
objectively (i. e. estimated and PSG SOL, estimated and PSG WASO, etc. ) were found. 
This lack of association might be due to the small number of participants in each group 
which did not allow sufficient power to detect associations. However, very modest 
associations between PSG and sleep diary data are not uncommon in the literature. For 
example, Means et al (2003) looked at consistency in estimates of TST with PSG over 
four PSG nights. They found only a moderate degree of consistency between diary TST 
and PSG TST. In contrast, Bastien and colleagues found no significant associations 
between PSG defined SOL, WASO, TST and S. E. and those subjectively reported in 
either good sleepers or people with insomnia (Bastien, Fortier-Brochu, Rioux, LeBlanc, 
Daley and Morin, 2003). 
5.5.2.8 Adherence with the Quarter of an Hour Rule 
The finding that treatment response was not linearly correlated with adherence was 
unexpected. As discussed in the introduction, adherence to treatment has rarely been 
measured and, moreover, it has typically been measured only at the end of treatment or 
at follow up. Riedel and Lichstein (2001) measured adherence daily and found that 
greater adherence to a consistent `bed-time' and `wake-time' was associated with better 
outcome. However Vincent and Hameed (2003) failed to find a significant association 
between adherence to a consistent sleep schedule and outcome. Rather, in their study, 
therapist-rated adherence and spousal-rated adherence were significantly associated 
with outcome. Unfortunately their study did not permit the assessment of adherence to 
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components of CBT other than sleep schedule. Consequently outcome could have been 
associated to other components of CBT. 
In the present study, around 80% of participants in the QHRin and around 65% of 
those in the QHRout adhered to the rule between 60 and 100 % of times according to 
objective adherence data. Reported adherence was much higher: around 85% of 
participants in the QHRin and 95% of those in the QHRout reported applying the rule 
between 60 and 100% of the time. Both sets of data (objective and subjective) indicate 
that there was adequate adherence with the behavioural procedure and this contrasts 
with results from previous research (Chambers, 1992; Harvey, Inglis et al, 2002; 
Schramm et al, 1995). For example, Chambers (1992) found that only around 30% of 
patients consistently adhered to behavioural components. With regard to stimulus 
control, Harvey, Inglis et al (2002) found that, at one year follow-up, less than 50% of 
their sample adhered to sleep scheduling (that is sleep restriction and stimulus control) 
and in Schramm et al's (1995) study stimulus control was reported to be adhered to 
"very rarely". Although adherence rates were higher in the present study, this could be 
due to measurements being taken during the acute treatment phase and whether 
adherence rates would remain high at follow up is unknown. 
As already mentioned participants tended to adhere to the QHR most of the time or 
not to adhere at all. This dichotomy makes the adherence data more similar to a 
categorical (i. e. adhered/not adhered) than a linear model. A correlation coefficient, as a 
numerical measurement of linear association, becomes rather meaningless. Importantly, 
lack of variance in adherence score also makes it difficult to suggest what amount of 
adherence is necessary to obtain sleep improvements. On the other hand the finding that 
sleep improvements were achieved following the QHR interventions despite QHR not 
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being implemented 100% of the time suggests that complete adherence with the QHR 
intervention might not be necessary in order to achieve positive clinical outcomes. 
On the other hand the fact that people tended to adhere most of the times or not at all 
is interesting in its own right. Chambers (1992) pointed out, that people might not 
adhere to instructions because they are poorly understood and/or remembered. Perhaps 
good adherence was obtained in this study because of the simplicity of mastering and 
remembering the QHR. Participants had to follow only one instruction, they had a 
simple flow-chart showing how to correctly implement the QHR and, during the 4 
telephone contacts, the researcher checked that the QHR was implemented correctly. 
One comment made often by participants regarded the difficulty of applying the rule 
and that some times "it just seemed impossible to get up and read". This comment 
highlights that difficulty might not only relate to understanding but also to motivation 
and commitment to follow instructions. It, also, suggests that support and 
encouragement are important ingredients to `boost' treatment adherence. 
One possibility for the finding that some people did not adhere is that they were 
unmotivated to read. It would be incorrect to assume that all insomnia patients are 
literate to the extent that reading at bedtime would be an enjoyable experience. In 
addition, the QHRout condition might have been particularly aversive: for example fear 
of disturbing one's spouse (by getting up and returning to bed several times) or a cold 
sitting-room (although use of a blanket was suggested). 
The next chapter regards the theoretical and clinical implications deriving from the 
present research. In addition issues limiting the present research and informing future 
studies are presented. 
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Chapter Six 
General Issues and Future Research 
In the previous section tentative explanations for the obtained results were given. In 
this section first the theoretical and clinical considerations are extracted and then the 
issues limiting this piece of research considered. These considerations are, in turn, used 
to inform future research needs regarding the QHR. 
6.1 Theoretical Implications 
The QHR was proposed to epitomise the stimulus control package for insomnia 
devised by Bootzin (1972) by employing learning theory concepts. The present results 
evidenced that the QHR was as efficacious as the whole stimulus control in improving 
estimates of sleep and imply that the QHR may be an essential component of the whole 
package. 
Employing the QHR in two different locations (i. e. out of bed and in bed) permitted 
exploration of the mechanisms of effects of the QHR. First of all, the finding, that both 
the QHRout and, to a lesser extent, the QHRin improved sleep, suggest the mechanism 
of effects of the QHR cannot be attributed solely to falling asleep having returned under 
the stimulus control of the bed and bedroom environment. 
It could be, as suggested by Bootzin (1972) that the QHR interventions become a 
`punishment' for wakefulness in bed. This seems a plausible explanation as the majority 
of participants, when asked about implementing the QHR interventions, reported that 
sitting up in bed to read and having to get out of their bed during the night was 
unpleasant. This hypothesis may also help explain why the QHRout produced better 
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outcomes than the QHRin. Getting out of bed may be more unpleasant than sitting up in 
bed and, therefore, it might work better in eliciting a response to stop the occurrence of 
a negative event. In other words the person falls asleep more rapidly so as not to have to 
apply the rule (i. e. getting out of bed and reading, sitting up in bed with the light on and 
reading). 
Another possibility is that the faulty conditioning hypothesised to underpin insomnia 
is both to the bedroom itself and to cognitive activity in bed. The finding that following 
the QHR interventions aspects of cognitive activity decreased substantiates this 
possibility. Indeed, sleep effort, cognitive arousal, and engagement with external stimuli 
all decreased. It is noteworthy that stimulus control has previously been thought to 
operate by decreasing cognition at night (e. g. Hughes and Hughes, 1978; Turner and 
Ascher, 1979b; Zwart and Lisman, 1979). For example, Zwart and Lisman (1979) 
proposed that stimulus control and its counter disrupted the connection between the 
bedroom environment and arousability due to mentation and negative emotion (e. g. 
worry, frustration). The six participants in Turner and Ascher's study (1979) pointed out 
that stimulus control helped to break up lying in bed and thinking and that it gave them 
a means of asserting self-control over the bedtime cognitions by simply getting out of 
bed. However, this contention was speculative and had received no empirical 
confirmation. The results obtained by analysing the battery of questionnaires employed 
in the present study, in contrast, provided some support to this hypothesis. 
The present findings obviously fall short of demonstrating a cause effect 
relationship. While it is plausible that sleep effort and cognitive activity at night 
decrease in response to sleep improvements, it is also possible that putting effort into 
the process of falling asleep support and sustain sleep problems (Espie et al, 2006). The 
researcher speculated that the QHR, by providing participants with something to do that 
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was not cognitively taxing, decreased both worries about sleep and effort to fall asleep. 
Espie's (2002) psychobiological model of insomnia proposes that `letting go' of effort 
to fall asleep enables an optimal level of de-arousal, which, in turn, facilitates `letting go 
of wakefulness' typical of normal sleep. Likewise, Morin (1993) proposed that methods 
indirectly preventing/stopping emotional and cognitive load in bed were perhaps more 
efficient that methods drawing attention to mentation. Indeed, rumination theories 
suggest that one way of reducing negative and repetitive thinking, about a topic relevant 
to the individual, is distracting attention away from the recurrent thought (Martin and 
Tesser, 1996; Nolen-Hoeksema, 1991). It could be speculated that this is exactly what is 
at play in the QHR: the person disengages from attending to the sleep process and from 
effortfully trying to fall asleep. In addition the QHR faces the person with a paradox 
(similar to paradoxical intention: Fogle and Dyall, 1983; Broomfield and Espie, 2003) ): 
the person wants `desperately' to fall asleep and the QHR asks them to give up trying 
and, instead, read for as long as they need to. 
The findings that the magnitude of effect of the QHRout was greater than that of the 
QHRin could be indicating that the QHRout operates both at an external (e. g. overt 
activities in bed) and internal (i. e. thinking) level, thus breaking the connection between 
the bedroom and any sleep incompatible (behavioural and/or cognitive) activity. In 
contrast the QHRin disrupts only cognitive activity by giving something to do (reading) 
instead of thinking. Both conditions may facilitate breaking the connection between 
cognitive activity and the bedroom environment, and at a classical conditioning level 
break the pairing between the bedroom and anxiety and frustration (reduced cues 
associated with arousal). The finding that QHR interventions decreased the sub-ob 
discrepancy supports this possibility. As discussed in the previous chapter, the sub-ob 
discrepancy has been hypothesised to arise from being cortically alert during NREM 
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sleep. In addition, the QHRout may also remove the external stimuli (e. g. TV, book, 
mobile) signalling the presence of a pleasurable activity (e. g. watching a favourite soap 
opera) if wakefulness is maintained. 
Whereas each of these possibilities seems reasonable, further research is obviously 
needed to determine their relative merits. 
The present research highlighted the possibility of measuring adherence to a 
behavioural treatment objectively via actigraphy and light. This is an important design 
advance given that retrospective reports of adherence present problems of validity. It is 
common for participants to confuse adherence behaviour with outcome or for adherence 
reports to be influenced by degree of improvement (Kazantzis, Deane and Ronan, 
2000). 
6.2 Clinical Implications 
This was the first study showing that a simplified form of stimulus control for 
insomnia, which takes only 30 minutes to be delivered, produced clinically significant 
acute therapeutic gains. 
The finding that after a single session, lasting 30 minutes, participants improved 
their sleep is promising and opens a variety of possibilities: the QHR could be a 
promising first line intervention for insomnia. At present, sleep hygiene is a commonly 
utilized treatment option despite little evidence of its efficacy as a standalone therapy 
for insomnia (Stepanski and Wyatt, 2003). Its popularity is most probably due to the 
fact that it comprises a list of instructions that can be handed in to patients or talked 
through in a few minutes. The QHR could be delivered, for example, by health 
professionals in GP practices. Indeed, one study has already shown that GPs themselves 
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could and were favourable to deliver a stimulus control treatment requiring three 
sessions (Baillargeon, Demers and Ladoucer, 1998). 
Additionally, the fact that the QHR comprises only one instruction, easy to 
understand and remember, opens clinical applications targeting people who find it 
difficult to remember and/or to assimilate how to implement more complicated 
treatments such as multi component CBT, or find it difficult to adhere to elaborated 
packages due to lack of motivation (e. g. due to depression). 
The attrition in the present study was very low in comparison to that in other trials. 
Perlis, Alloia et al (2000) averaged attrition rates in 20 studies and the average drop out 
rate was 15.3% with some studies reaching as high as a 42% attrition rate. They 
suggested that attrition might be due to protocol demands as some individuals found the 
insomnia interventions too taxing. In the present study only one person dropped out 
during baseline and none of the people who started the intervention discontinued it. 
Admittedly 20% of individuals (half of them from the control group) did not undergo 
the end of intervention PSG. Such a low attrition rate might suggest that the QIIR 
intervention is not only easy to deliver but that is also well accepted and well tolerated 
by people with insomnia. This is a great strength of this insomnia intervention. Indeed it 
has been pointed out that notwithstanding the efficacy of a given treatment, if it is too 
time consuming, or too difficult and not acceptable to patients it is likely to be of little 
clinical use (Bell, 2001; Morin and Wooten, 1996). 
Importantly 26 of the 44 participants who completed the study were people who 
sought treatment (asking to their GPs) and this group appears to be more refractory to 
treatment than people actively recruited for clinical research (Stepanski et al, 1989). 
Although the severity of sleep disturbance is comparable, individuals seeking treatments 
display higher levels of psychological distress than those responding to recruitment 
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advertisements. Harvey and Tang (2003) pointed out that findings involving treatment 
seeking patients by GPs are likely to be the most generalizable to a real world sample 
followed by patients recruited via advertisements. 
Finally the finding that the QHR implemented in bed is efficacious may provide an 
insomnia intervention for people who have problems getting out of bed (for example 
elderly people with mobility problems) or patients who find it impossible to comply 
with getting out of bed. On the other hand, the QHRin was found to have only moderate 
effectiveness as compared to the QHRout. This finding corroborated Davies and 
colleagues' (1986) findings with counter-control and suggests that the QHR should 
require participants to go to another room if not asleep within a quarter of an hour. As 
proposed by Bootzin and Epstein (2000), only those individuals finding difficult to get 
out of bed for mobility or other issues (e. g. cold room, pain, fear of disturbing bed 
partner) should implement the QHR in bed. 
As already discussed, the present research evidenced an important application of 
actigraphy, with the added feature of light detection, as an objective measurement of 
adherence. Measuring adherence objectively could help a clinician understand if the 
therapy is not producing the expected effects because of poor adherence with the 
behavioural instructions. In addition, patients can be shown their nightly adherence, 
and reasons for non-adhering can be worked through together with the therapist. 
6.3 Limitations of the Present Study 
These sections discusses several methodological considerations which preclude 
drawing strong conclusions from this experimental trial. Future research addressing 
these issues is suggested in the next section (section 6.4). 
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First, from a clinical perspective, the biggest limitation is the absence of follow-up. 
Follow-ups are very important to ascertain if therapeutic gains are short lived or will be 
maintained over time. Although previous research has found that psychological and 
behavioural therapies for insomnia produced stable changes in sleep pattern over time, 
with gains maintained up to 12,24 and 36 months following end of treatment (e. g. 
Backhaus et al, 2001; Espie, Inglis Tessier and Harvey, 2001; Morin, Colecchi et al, 
1999; Sanavio et al, 1990), the lack of follow-up limits the conclusions of the present 
investigation to the time frame of the study, and thus prevents us from making any 
comments on sustained effects. However, this was an experimental trial, designed to test 
the feasibility of a simplified behavioural intervention for insomnia and to shed light on 
mechanisms of effect. 
It is important to remember that means and variability were influenced by the fact 
that some participants had only sleep onset insomnia, some had only sleep maintenance 
insomnia and some others met both sets of criteria (mixed insomnia). Although there 
were no statistical differences among the three groups on averaged measures of SOL 
and WASO during baseline, the groups did comprise different numbers of participants 
who had clinically defined mixed, onset or sleep maintenance insomnia. On the one 
hand, this suggests that positive results are especially meaningful because the sample, 
like so much of the clinical population was heterogeneous in their presentation of 
insomnia symptoms. On the other hand this might have had some influence on the 
treatment outcomes. 
With regard to generalisability, the trial included well-screened, healthy, reasonably 
well-educated and well functioning individuals. Additionally, only people who were not 
taking sleep medications and who did not present with concurrent psychopathologies 
(e. g. depression) were recruited. Although this may limit the generalisability to other 
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samples the experimental nature of the trial (which tested a novel therapy for insomnia) 
justifies setting more strict criteria. Obviously more studies are needed to determine if 
similar therapeutic outcomes can be obtained in other samples (e. g. people using 
hypnotic drugs, people with insomnia and depression). 
Another pitfall of the present research is the small sample size. Small sample size 
might have reduced the power of the statistical analyses to detect potential differences 
among the conditions. In order to avoid a type II error a sample size of minimum 27 
participants per group to detect a large treatment difference and minimum 70 per group 
to detect smaller differences have been recommended (Kazdin and Bass, 1989). 
Furthermore, a bigger sample size would permit analysis of the impact of the QHR on 
people presenting with one insomnia complaint (i. e. only SOL, only WASO, mixed). 
In addition, this study is limited by lack of a true control group that is equivalent to a 
pill placebo in pharmacological studies. However, this is a limitation common to most 
psychological research and one that is difficult to address. Nonetheless not having a 
`pure' placebo makes it difficult to determine what percentage of the variance in 
outcomes is due to specific therapeutic ingredients (i. e. stimulus control) the 
measurement process (self-monitoring), credibility of treatment rationales, or to non- 
specific factors (therapist's attention, patient's expectation). 
In the present study the impact of self-monitoring was controlled for, by having a 
control group whose only task was to monitor daily their sleep for the whole duration of 
the study. As already discussed in the introduction, credibility of the treatment rationale 
is a potentially powerful healing aspect of treatment (Baskin, Tierney, Minami and 
Wampold, 2003): if the rationales are not equivalent the credibility of the treatment and 
resulting expectations of participants might differ. However, the differential outcomes 
obtained with the QHRin and the QHRout are unlikely to be due to credibility of the 
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rationale: the treatment groups' responses to a credibility questionnaire showed no 
significant differences at pre-treatment regarding the credibility of the treatment. 
However, the control group was aware of not receiving treatment. 
With regard to structural equivalence (Howard, Kopta, Krause and Orlinsky, 1986), 
in the sense of dose of treatment, this was ensured by providing participants with equal 
number of therapist-patient contacts of equal length. Importantly both the QHR and 
control groups were given the same number, of equivalent length, contact. These 
features of experimental control reduced experimenter bias and controlled for 
differential therapist's attention. Nonetheless, it is appreciated that non-verbal behaviour 
might have played an important role in treatment outcomes. 
The possibility that differential therapist expectancies could account for the different 
magnitude of therapeutic outcomes should also be taken into account. Although the 
therapist was obviously aware of the participant treatment allocation, the experimental 
methodology followed a rigorous written protocol: the protocols used to deliver QHHRin 
and QHRout were identical apart from the instructions differentiating the QHRout ('go 
to another room and read') from the QHRin ('sit up in bed and read'). 
Another methodological flaw of the present research was that the researcher served 
both as the designer of the study, the therapist and the evaluator of the treatment 
outcomes: this could have given raise to biases. Although sleep diary, PSG and 
questionnaires were employed to assess treatment outcome, some judgement on the part 
of the scorer was still involved. In the present study, however, an independent 
technologist blind to treatment allocation scored the PSG data. With regard to diary 
data, questionnaires responses were inputted into a spreadsheet at the end of the study 
by the researcher who programmed the spreadsheet to calculate the total scores for each 
questionnaire. 
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Despite these methodological limitations, the positive outcomes obtained following 
the QHR intervention and magnitude of effects warrant further investigation. 
6.4 Future Research 
The present research suggested that the QHR is a promising intervention for 
insomnia warranting further research. However, the limitations (due to the exploratory 
experimental nature of the trial) discussed in the previous section do not permit firm 
conclusions and indicate that future research should address the following issues. 
First, this was the first trial involving only one simplified component of stimulus 
control and the present findings, although promising, need to be replicated by future 
investigations and in different centres. 
Second, due to its exploratory nature, the present study comprised only small 
samples and lack of significant differences between the QHRin and QHRout might have 
been due to power issues. Future research should endeavour to employ larger samples. 
Importantly, since the stability of results is essential for clinical appreciation of the 
validity of a psychological treatment for insomnia, future research should include a 
follow up so as to ascertain if improvements obtained with the QHR are maintained 
over time. 
Third, although the dose-response analyses suggested that therapeutic gains were 
achieved after only one week of QHR implementation, whether one session is sufficient 
to maintain such gains or some more contacts, even of a few minutes, are necessary to 
sustain and consolidate changes remain unclear. Future research with different doses 
(e. g. similar to Edinger et al's (2004) study) should be devised to determine the optimal 
number of sessions. 
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Fourth, research aimed at evaluating the incremental benefit of adding other 
components to the QHR treatment would help the understanding of the contributions of 
single components to total effectiveness of multicomponent CBT. 
Fifth, future research could investigate the feasibility of using the QHR to help to 
withdraw from medication. For example, Riedel, Lichstein et at (1998) investigated the 
efficacy of stimulus control in medicated and non-medicated people with insomnia and 
found that stimulus control was well received in medicated participants and resulted in 
better outcome as compared to the only medication group. Given the simplicity and 
limited time necessary to administer the QHR, it could be an important aid to 
withdrawal programs. 
Sixth, cross-sectional research has consistently evidenced that several areas (e. g. 
daytime functioning, mood and distress) of health related quality of life (IHRQoL) are 
poor among people with insomnia. It seems important to include measures of these 
domains because patients are generally seeking insomnia treatment because of the real 
(or perceived) negative effects of insomnia on their daily lives. In this regard, the most 
often used measurement of HRQoL in sleep research is the SF-36 (Ware, Gandek, et al, 
1994). Importantly the only study to date measuring changes in HRQoL following 
CBT-I showed that CBT-I improved both sleep quality and HRQoL in older adults 
(Dixon, Morgan, Mathers, Thompson and Tomeny, 2006). Their study also highlighted 
that the SF-36 is a valid instrument to measure such changes. 
Furthermore, participants randomised to the control group were aware that they 
were not receiving therapy and, therefore, this group did not represent a placebo 
condition. Future research, could, for example, simply ask participants to `sit up in bed 
if not asleep within a quarter of an hour' to explore if the QHR break the connection 
between wakefulness and cognitive activity. Alternatively it could ask participants to 
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`go to another room and sit on a chair' to explore if the mechanisms of effect of the 
QHR are to do purely with learning to associate the bedroom with falling asleep. Just 
sitting there, would presumably not alter internal states such as rumination. A counter 
demand condition could also represent a feasible control group. 
In addition, the present study highlighted the importance of recording PSG for 
multiple nights. In particular, Wohlgemuth et al's (1999) study suggested averaging 4-5 
nights to obtain reliable measures. Multiple PSG nights are seldom recorded due to the 
considerable cost, inconvenience and burden on participants but, the night-to-night 
variability questions the validity of results obtained by only one recording night. 
Finally, the findings that sub-ob discrepancies were reduced following the QFHR 
intervention confirmed the importance of carrying out power spectral analysis in 
addition to standard PSG. A few studies have found higher beta and gamma activity in 
people presenting with insomnia and that such activity was correlated with subjective- 
objective TST discrepancies (Perlis et al, 2001). Future research should consider 
exploring the impact of the QHR on fast EEG activity. Power spectral analysis will be 
performed on the PSG data collected in this research in the near future. 
6.5 Concluding Comments 
This study was, of course, preliminary and future research is required to replicate its 
positive findings and to address the limitations discussed in the previous section. 
Nonetheless, it provides the first evidence from a randomised controlled trial that the 
QHR, a simplified intervention extracted from the stimulus control package, is a 
promising insomnia treatment. Indeed, the QHR produced statistically and clinically 
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significant sleep changes, comparable to those obtained by more sophisticated and 
complex CBT packages, within the first week of implementation. 
Importantly, the QHR required only 30 minutes face-to face contact and a few 
telephone contacts lasting less than 10 minutes. It is quick to administer, participants 
found it easy to understand how to apply the QHR and adherence to the rule was high. 
These findings have important clinical implications for prevention. Recent meta- 
analyses (Cole and Dendukuri, 2003; Riemann and Voderholzer, 2003) have suggested 
that insomnia is a key risk factor for first episode of depression, and chronic insomnia is 
associated with increased utilisation of health services (Ford and Kamerow, 1989). 
Early intervention focussing directly on sleep disturbances which is easy to administer 
and to understand may prove particularly cost-effective. 
Furthermore, this study highlighted the importance of investigating critical 
components of CBT so as to understand whether multi-component programs are 
superior to mono-therapies. 
The QHR reduced cognition at bedtime in that sleep effort, engagement with 
sensory factors and worry were diminished following the 1intervention. Furthermore, 
both the canonical QHRout and its counter (QHRin) impacted positively on sleep. 
Theoretically these findings lend support to the hypothesis that the mechanisms of 
effect of the QHR are not solely due to poor situational stimulus control. Rather, 
classically conditioned cortical arousal might also play a role in insomnia and the QHR 
indirectly, by asking people to read, breaks the connection between the bed and 
cognitive engagement. 
Admittedly, following the QHR improvements were evidenced by participants' 
estimates of their sleep but not by PSGs. Obviously this could be due to the QIIR not 
impacting on sleep. However, by taking into account that sub-ob discrepancies 
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decreased following intervention, it can be argued that conventional PSG staging might 
not be the best tool to evidence changes. Indeed previous research suggested that beta, 
alpha and gamma activity (as measured by power spectral analyses) better correlate with 
estimates of sleep than PSG staging. 
The home-based portable polysomnograms were found to be an excellent alternative 
to laboratory polysomnograms. They were well tolerated by participants, involved 
minimal disruption to evening activities and the sleep environment, and allowed 
assessment of sleep naturally in the home environment. This might prove a good 
alternative to laboratory recordings if multiple nights are to be recorded. 
Very importantly this study also provided evidence of the feasibility of measuring 
adherence to a behavioural treatment objectively via actigraphy with the added feature 
of light detection. 
To conclude, this was the first randomised controlled trial in insomnia research 
employing one single element of stimulus control needing only thirty minutes to be 
delivered. The QHR produced statistically and clinically significant outcomes, it 
suggested that mono-therapies are worth investigating because they could provide a 
cost-effective alternative to more complex multi-component CBT-I. Theoretically the 
QHR suggested that stimulus control might operate both on operant and classical 
conditioning levels and might indirectly break the pattern of ruminating in bed. The 
QHR is, therefore, a line of research worth pursing on both theoretical and clinical 
grounds. 
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Appendix 1: Diagnostic criteria for psychophysiological insomnia (ICSD-II) 
Psychophysiological Insomnia - Diagnostic criteria 
a. The patient's symptoms meet the criteria for insomnia. 
b. The insomnia is present for at least one month. 
c. The patient has evidence of conditioned sleep difficulty and/or 
heightened arousal in bed as indicated by one or more of the following 
i. Excessive focus on and heightened anxiety about sleep 
ii. Difficulty faling asleep in bed at the desired bedtime or 
during planned naps, but no difficulty falling asleep during 
other monotonous activities when not intending to sleep 
iii. Ability to sleep better away from home than at home 
iv. Mental arousal in bed characterised either by intrusive 
thoughts or a perceived inability to volitionally cease sleep- 
preventing mental activity 
v. Heightened somatic tension in bed reflected by a perceived 
inability to relax the body sufficiently to allow the onset of 
sleep 
d. The sleep disturbance is not better explained by another sleep disorder, 
medical, or neurological disorder, mental disorder, medication use, or 
substance use disorder. 
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Appendix 3: Sleep Diary 
SLEEP DIARY: We are interested in finding out what normal sleepers do differently from poor 
sleepers both during a typical night and a night when sleep does not come that easily. Plese fill in the 
diary each morning upon awakening. Thanks very much!! Marina Malaffo 
If you want more information you can contact me on: 
01412113902 (University of Glasgow, Psychological Medicine, Gartnavel Royal Hospital) 
Please circle as appropriate: I am generally (last 6 months) a GOOD / POOR Sleeper 
I am: M/F My occupation: Student / Employed / Unemployed / Retired Age:......... 
Diary entries started: ...... J....... 2004 
What time did you rise from bed this 
morning? 
What time did you wake up this morning? 
Did you wake up because of. 
1: Alarm clock/asked to be waken up 
2: Noise or light 
3: Just woke up 
What time did you go to bed last night? 
What time did you switch off the light 
intending to sleep? 
How long did you take to fall asleep? 
If you had difficulties falling asleep, what did 
you do? 
(e. g. just lie in bed trying, read a book, 
listened to the radio, made myself a hot drink) 
How many times did you wake up during the 
night? 
How long were you awake, in total, during 
the night after you first fell asleep? 
What did you do when you woke up during 
the night if you could not fall asleep 
immediately? (e. g. just lie there, read a book, 
listened to the radio, made myself a hot drink) 
Did you take any nap yesterday? 
If yes for how long? 
How much units of alcohol did you take 
yesterday? 
Measuring the quality of your sleep: 
How was your sleep? 
0=very bad; 1=bad; 2=so so; 
3= good; 4= very good 
How rested do you feel this morning? 
0=not at all; 1=little; 2=so so; 
3= quite; 4=very rested 
How alert do you feel this morning? 
0=not at all; 1=little; 2=so so; 
3= quite; 4=very alert 
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Appendix 4: The PSQI 
Questionnaire A ID: 
The following questions relate to your sleep habits during the past month only. Your 
answers should indicate the most accurate reply for the majority of days and nights in 
the past month. Please answer all the questions. 
1. During the past month, when have you usually gone to bed at night? 
Usual bed time:...... . 
2. During the past month, how long (in minutes) has it usually taken you to fall asleep 
each night? Number of minutes:..... . 
3. During the past month, when have you usually got up in the morning? 
Usual getting up time:..... . 
4. During the past month, how many hours of actual sleep did you get at night? This 
may be different to the number of hours you spend in bed. 
Hours of sleep per night:..... . 
5. During the past month, how often have you had trouble sleeping because: you: 
Not during the 
past month 
Less than 
once a week 
Once or twice 
a week 
Three or more 
time a week 
a. Cannot get to sleep within 
30 minutes 
b. Wake up in the middle of 
the night or early morning 
c. Have to get up and use the 
bathroom 
d. Cannot breathe comfortabl 
e. Cough or snore loudly 
f. Feel too cold 
g. Feel too hot 
h. Had bad dreams 
i. have pain 
j. Other reasons, please describe them and how orten it nappenea :....................... . 
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6. During the past month, how would you rate your sleep quality overall? (Please circle your 
choice) 
Very Good Fairly good Fairly bad Very bad 
7. During the past month, how often have you taken medicines (prescribed or `over the 
counter') to help you sleep? (Please circle your choice) 
Not during the Less than Once or twice Three or more 
past month once a week a week time a week 
8. During the past month, how often have you had trouble staying awake while driving, eating 
meals, or engaging in social activities? (Please circle your choice) 
Not during the Less than Once or twice Three or more 
past month once a week a week time a week 
9. During the past month, how much of a problem has it been for you to keep up enough 
enthusiasm to get things done? (Please circle your choice) 
No problem Only a very Somewhat A very 
at all slight problem of a problem big problem 
10. Do you have a bed partner or a room mate? 
No bed partner Partner or room mate Partner or room mate in Partner in 
or room mate in other room same room but not same bed same bed 
If you have a room mate or bed/partner ask him/her how often in the past month you have: 
Not during the Less than Once or twice Three or more 
past month once a week a week time a week 
a. Loud snoring 
b. Long pauses between 
breaths while asleep 
c. Legs twitching or jerking 
while asleep 
d. Episodes of disorientation 
or confusion during sleep 
e. Other restless while you sleep: please describe and write down how often:.......... . 
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Appendix 5: The Sleep Diary (study 2 and 3) 
SLEEP DIARY: BASELINE / INTERVENTION ID: ............ 
This sleep diary helps both us and yourself to find out your sleep pattern and how you feel about 
your sleep. In order to get a precise picture of your night-by-night sleep and your feelings 
about it, it is essential that you fill the diary in every morning. Please, remember that there is 
not a right or wrong answer but just the way you slept each night. 
Diary entries started: DATE: 
What time did you rise from bed this 
morning? 
What time did you wake up this morning? 
What time did you go to bed last night? 
What time did you switch off the light 
intending to sleep? 
How long (rains) did you take to fall asleep? 
If you had difficulties falling asleep, what did 
you do? (for example: just lie in bed, read a 
book, think, ... ) How many times did you wake up during the 
night? 
How long were you awake, in total, during 
the night after you first fell asleep? 
What did you do when you woke up during 
the night if you could not fall asleep 
immediately? 
Did you take any nap yesterday? 
If yes for how long? 
How much units of alcohol did you take 
yesterday9 
Did you take an sleeping tablets? (Y / N) 
Measuring the quality of your sleep: 
How was your sleep? 
0=very bad; 1=bad; 2=so so; 
3= good; 4= very good 
How rested do you feel this morning? 
0=not at all; 1=little; 2=so so; 
3= quite; 4=very rested 
How alert do you feel this morning? 
0=not at all; 1=little; 2=so so; 
3= quite; 4=very alert 
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Appendix 6: The HADS 
ID: Date: ............. 
QUESTIONNAIRE B 
Please read each item below and circle the reply which comes closest to how you 
have been feeling in the past week. Don't take too long over your replies, your 
immediate reaction to each item will probably be more accurate than a long, thought- 
out response. 
1. I feel tense or 'wound up' 
Most of the time A lot of the time 
From time to time, occasionally Not at all 
2. I still enjoy the things I used to enjoy 
Definitely as much Not quite so much 
Only a little Hardly at all 
3. I get a sort of frightened feeling as if something awful is about to happen 
Very definitely and quite badly Yes, but not too badly 
A little, but it does not worry me Not at all 
4. I can laugh and see the funny side of things 
As much as I always could Not quite so much now 
Definitely not so much now Not at all 
5. Worrying thoughts go through my minds 
A great deal of the time A lot of the time 
Not too often Very little 
6.1 feel cheerful 
Never Not often 
Sometimes Most of the time 
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7. I can sit at ease and feel relaxed 
Definitely Usually 
Not often Not at all 
8. I feel as if I am slowed down 
Nearly all the time Very often 
Sometimes Not at all 
9. I get a sort of frightened feeling like `butterflies' in the stomach 
Not at all Occasionally 
Quite often Very often 
10. I have lost interest in my appearance 
Definitely I don't take as much care as I should 
I may not take quite as much care I take just as much care as ever 
11. I feel restless as if I have to be on the move 
Very much indeed Quite a lot 
Not very much Not at all 
12. I look forward with enjoyment to things 
As much as I ever did Rather less than I used to 
Definitely less than I used to Hardly at all 
13. I get sudden feelings of panic 
Very often indeed Quite often 
Not very often Not at all 
14. I can enjoy a good book or radio or television programme 
Often Sometimes 
Not often Very seldom 
Please check that you have answered all the questions. Thank you. 
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Appendix 7: Monitoring the use of the `Quarter of an hour rule': 
We want to evaluate hom difficult it is to follow this rule. Please fill out the following table. 
For each day put your answer in the box: 
a. If you followed the rule write 'Y', if you did not write `N'. 
b. If the question is not applicable to you write `N/A' 
c. When you are asked `How many tines..? ', write the number apply ing t(1 . uu. 
each night. 
Weeks: I/2/3 
RULE TODAY'S DATE 
1. Did you take less than a quarter of an hour to 
fall asleep once you switched off the light'? 
2. If not, did you go to another room? 
3. If you went to another room, 
after about how many minutes did you do so'? 
4. In order to follow the rule, how many times 
alingethor did )zoji have t( 
6 If ou had to more than once et u "d . y . g p 
after how lon ou do so'? did " g y 
After you fell asleep: 
7. II you awoke during the night, 
did you fall hack asleep within a quarter of an hour: ' 
8. If you did not fall back asleep within a quarter of 
an hour, did you go to another room? 
9. If you went to another room, 
after about how many minutes did you do so? 
10. In order to follow the rule, how many times 
altogether did you have to get up during the night'? 
-- - 
II If you had to get up more than once, 2' time 
--- ---- 
after how long did you do so? 3"1 time 
4" time 
12. Please describe how it was to follow the rule 
by circling the number that applies to you 
(I= not difficult at all. I I I I I 1 
2= a little difficult. 2 2 2 
3= difficult. 3 3 l l l 
4= very difficult. 4 4 4 1 t 
5= extremely difficult) 5 5 5 > .. > ti 
'7, i 
Appendix 8: Flowchart QHRout 
Preparation for The `QUARTER OF AN HOUR RULE' 
Decide which room you are going to ii' you I ºtoom 
cannot fall asleep within 15 minutes I .......... 
Think about a couple of activities you would wait 
to carry out in the chosen room if you don't Call asleep 
within 15 minutes 
Put the material needed for your chosen activities in 
the room where you are going to carry them out 
Make sure the room is prepared so that you will he 
comfortable enough in it if awake during the night 
(e. g. warm, with something to drink) 
LNG) 
Activities 
'till 
If you do not fall asleep within about 15 minutes 
Leave the bed 
Go to another room 
Do the chosen activity 
Do not nap or sleep in this room 
Return to bed when you want to sleep 
NO /ire you asleep within 
about 15 minutes 
YES 
you wake up during the 
N() 
NO Did you fall back to siech- YIDS 
within about 15 minutes 
/ 
Iý; NI) 
i 
Appendix 9: Participants' information sheet 
This information sheet will help you to understand why we are doing this research and what it 
will involve. Please take some time to read it and feel free to contact me if something is not clear 
(my contact numbers are listed below). 
What is the purpose of this study? 
The aim of this study is to explore how a sleep intervention called `the quarter of an hour rule' 
affects sleep. The study investigates how you feel about your sleep before, during and after the 
sleep intervention, but it also investigates your brain activity during the night. The equipment 
(called EEG) we have to measure brain activity is easy to use at home and is completely safe. 
What do I have to do if I take part in this study? 
If you decide to participate you would, first of all, be asked some questions about your sleep. In 
addition you will have one questionnaire to fill in. These would enable the researcher to find out if 
your sleep problems are the kind of problems we are investigating in this research study. This will 
take approximately 10 minutes. 
If your sleep difficulties are of the types studied in this research and you wanted to participate in 
the study, you would be involved in the research for 6 to 8 weeks. During this weeks you would 
have to: 
. meet with the researcher twice for about 45 minutes each, 
. meet another 5 times (for about 5 minutes each) so as to be given or return the EEG 
equipment 
. record your brain activity, using the EEG home recording equipment provided, for 6 nights 
. wear an `actiwatch' (very similar to a wrist watch), for the whole period of the study, so as 
to measure your body movements 
. fill in a sleep diary each morning for the whole duration of the study (about 5 minutes every 
day) 
During the first meeting with the researcher you will have the opportunity to ask any questions 
you wish to about the study, you will then be asked you to sign a consent form to participate in the 
study. The researcher will then tell you how to fill in the 'sleep diary', how to use the EEG 
recording equipment and how to use the actigraph. It might seem a lot of information to take in: for 
this reason you will be given a short and easy memo about what you are requested to do. 
During the second meeting, the researcher will explain to you the 'quarter of an hour rule' 
intervention for insomnia and you will be asked to start implementing it from that very first night. 
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., r5 
How much time will be required of me? 
All together to fill in the sleep diary each morning, meet with the researcher, use the EEG home 
recording equipment, you will be required to devote around 7 hours of your time over a period of 6 
to 8 weeks. 
Benefits to you in participating 
Participating in this study will help you to understand your sleep pattern better. In addition, it is 
hoped that the sleep intervention will help you to improve your sleep, although this cannot be 
guaranteed. Finally the information gathered with this research will be helpful to devise better 
treatment for insomnia. 
Will my answers be covered by confidentiality? 
All information about you collected during this research will be kept strictly confidential. The 
only people who will have access to your data are the researcher herself and her supervisor. Your 
name will not be kept together with your data (an ID number will be used instead). 
What if I chanee my mind? 
You can decide to withdraw from the study at any time without having to explain your decision. 
Thank you very much for taking the time to read this information. I would be very 
pleased if you decide to participate in this research study. 
If there is something you are not clear about, or if you wish more information, please do 
not hesitate to contact: 
- Ms Marina Malaffo, Department of Psychological Medicine, University of Glasgow 
Tel: 01412113902 or 07745811303, e-mail: 0219144m@student. gla. ac. uk 
If you would like to speak to an independent advisor about any concerns you may have 
regarding this study please contact: 
- Ms. Heidi-Louise Kelly (Research Fellow) The sleep clinic, Department of Psychological 
Medicine, University of Glasgow 
Tel: 01412113943, e-mail: Hk16b@clinmed. gla. ac. uk 
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Appendix 10: Consent Form 
An investigation of sleep patterns pre and post insomnia 
intervention 
CONSENT FORM 
1. I have read and understood the `Information Sheet' containing information 
regarding the study I am going to participate in. 
2. The researcher explained further any points I asked to. I have been given a 
contact telephone number so as to be able to discuss points at a later time 
should I wish to. 
3. In addition I had the opportunity to discuss any points and doubts with an 
independent source. 
4. I understand that I can decide to withdraw from this study at any moment 
without having to explain my reasons for wishing to do so. 
5. I have been assured that any information I provide is strictly confidential and 
that should the study be published the names of the participants to this study 
won't be available to third parties. 
I 
.................................. agree to participate 
in this study. 
(Name and Surname in print) 
Signature: ........................... Date:.............. 
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Appendix 11: EEG Recording INSTRUCTIONS 
Right ('rnire I 
.ý ft 
Step 3: Press the arrow ' 
(ý) (ý) 
I when you switch off the light (attennl)ting tO sIreelp) 
Step 4: Press the arrow '(l)' when you wake up in the morning (ue t Iv to get up) 
trackit 
©- 
Advanced Medical Solutions 
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APPENDIX 12: THE QHR 
PROTOCOL 'QUARTER OF AN HOUR INTERVENTION' 
Today we are going to learn a procedure which hopefully will help you sleep better 
and your task will be to implement and follow it from tonight. It is called the 'quarter 
of an hour rule' because you'll have to get up from your bed and do something in 
another room if you cannot fall asleep within around 15 minutes of trying to sleep. In 
addition you will have to get up and do something in another room if you wake tip 
during the night and cannot fall asleep again within 15 minutes. Although it might 
sound odd that you have to get up from your bed when all you want to do is to stay in 
bed and try to fall asleep, I am asking you to try to keep following this procedure. 
Please keep following it for the requested 3 weeks even if you do not feel it is 
working. As you have probably already experienced in other things in your life. it 
takes some time for changes to happen. 
What You might be thinking: 'Why 15 minutes? '. This time has been chosen 
because people who do not have sleep problems are generally asleep within 10/15 
minutes. In addition, although people without sleep problems do wake up during the 
night, they generally fall back to sleep within that time. You might also be sitting 
there thinking: 'why should I get up from my bed when what I want is to stay in bed 
and fall asleep? '. The idea is that if you have not fallen asleep within 15 minutes 
chances are you will be lying there awake for a pretty long time: getting up and then 
returning to bed when ready to sleep will make it easier to fall asleep quite quickly. If 
there is something you'd like to ask me . please feel free to interrupt me and I will 
answer to it at the end. 
The procedure is very simple and today we are going to learn and rehearse it till 
you feel comfortable about putting it into practice. In addition you will also have a 
memo at home with you if you want to go through it again. 
We can divide the 'quarter of an hour rule in 3 different steps: 
The first 2 steps are really to do with preparing things before going to bed. 
1. Decide which room you want to move to if you have to get because not asleep 
within 15 minutes and prepare it with the material needed for the activities. 
Also make sure you will be warm enough as it can be quite chilly during the 
night. You could also prepare something to drink (e. g. hot milky drink, herbal 
tea, a juice) but make sure it doesn't contain caffeine or alcohol. We can write 
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it on the memo with a pencil and if you realise you'd like to change to another 
room just make the change. 
2. Decide a couple of activities you might like (and is feasible) to carry out in 
another room if you cannot fall asleep within 15 minutes. Also think a couple 
of activities (they can be the same ones) you would like to do if you wake up 
in the middle of the night. We can write the activities on your memo and, 
again, if you'd like to change them just write down the new activities. 
You can do this preparation stage when you want to but at least an hour before 
going to sleep. When do you think it will a good time to prepare the room and 
material for you? 
3. Go to bed as usual. However if you are not asleep within 15 minutes from the 
moment when you have decided to sleep get up and go to the room chosen to 
carry out one of the activities. You do not need to keep looking at your clock 
to see if 15 minutes has passed as generally we have quite a good sense about 
this. In this other room carry out what you have chosen and when you feel 
ready to sleep again move back to your bedroom. If you are not asleep within 
15 minutes just repeat this step. Eventually you will be asleep within 15 
minutes. 
4. If during the night you wake up and cannot fall back to sleep within 15 
minutes get up and go to the room. 
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Appendix 13: Actigraghy instruction 
2. Movement recordine (AM-WATCH): INSTRUCTIONS 
a. You have to wear your acti-watch 24 hours a day for the duration of the experiment 
The only time when you should remove the watch is when you are performing 
`wet activities' (e. g. shower, bathing, swimming, washing-up). This is because 
the watch is not waterproof. Please remember to put your acti-watch back on as 
soon as you finish 'wet activities'. 
b. Press the event marker on the acti-watch face when you switch off the light (and 
attempt to sleep). Press it again when you wake up in the morning (ready to get up). 
c. If during the night you get up (e. g. to get a drink or go to the bathroom) please press 
the event marker again. Once you get back to bed and try to sleep again, please 
Event Marker to be pressed when attempting to 
sleep and again when getting up. 
I Sleep Diary : INSTRUCTIONS 
Please remember to fill in your daily sleep diary every morning, possibly when you 
wake up or while having breakfast, for the duration of the research. Remember to 
answer all questions. As agreed I will contact you during the morning to get your 
answers. 
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press the event marker again. 
Appendix 14: Q1- Sleep Behaviour Self Rating Scale-R 
Date: .................. ID:..... basel interv 
Questionnaire One 
Please indicate how often you have done the following things in your bed before falling 
asleep or while in your bedroom during the last week. Complete the questionnaire by 
considering what you would do in an average week. 
BEHAVIOUR NEVER RELY SOME 
TIMES 
OFTE VERY 
OFTEN 
Read a book or a magazine 
Watch TV 
Listen to the radio 
Have a conversation with someone 
Speak on the telephonelmobile 
Eat or drink 
Smoke 
Please also answer the following questions --------- --"--------- ----------- --------- --------- 
I take naps during the day or evening 
I feel sleepy when I go to bed 
I switch the light off as soon as I get into bed 
I spend a lot of time lying awake in bed at night 
If I cannot get to sleep within approximately 
20 minutes I get out of bed and move to another 
room until I feel sleepy again 
I set myself a regularly rising time each morning 
If I have a bad night's sleep I still get up at 
my usual time 
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Appendix 15: Q2 - The Glasgow sleep effort scale 
Questionnaire Two 
The following seven statements relate to your night-time sleep pattern in the past 
week. Please indicate by circlin once response only how true each of the statement is 
for you. 
1. I put too much effort into sleeping at night when it should come naturally 
Very much To some extent Not at all 
2. I feel I should be able to control my sleep at night 
Very much To some extent Not at all 
3. I put off going to bed at night for fear of not being able to sleep 
Very much To some extent Not at all 
4. I worry about not sleeping if I am in bed at night and cannot sleep 
Very much To some extent Not at all 
5. I am no good at sleeping at night 
Very much To some extent Not at all 
6. I get anxious about sleeping before I go to bed at night 
Very much To some extent Not at all 
7. I worry about the long term consequences of not sleeping at night 
Very much To some extent Not at all 
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Appendix 16: Q3- Sleep disturbance questionnaire 
Questionnaire Three 
On the nights when you didn't sleep well last week, the problem seemed to be: 
Never Seldom Sometimes Often Very often 
True true true true true 
1. I cannot get into a comfortable 
position in bed 
2. My mind keeps turning 
things over 
3. I cannot get my sleep pattern 
into a proper routine 
4. I get too 'worked up' at 
not sleeping 
5. I find it hard to physically 
'let go' and relax my body 
6. My thinking takes a long 
time to unwind 
7. I don't feel tired enough at 
bed time 
8. I try too hard to get to sleep 
9. My body is full of tension 
10. I am unable to unempty 
my mind 
11. I spend time reading/ 
watching TV in bed when 
I should be sleeping 
12. I worry that I won't cope 
tomorrow if I don't sleep well 
Which one of the above statement is most relavant to you? Item number:..... . 
Are there any other factors associated with your poor sleep pattern? If so, please write a 
short note in this space: ................................................... 
...................................................................... 
291 
Appendix 17: Q4- Glasgow Intrusive thoughts inventory 
Questionnaire Four 
Here are some thoughts that people have when they cannot sleep. Please indicate by 
placing a tick in the appropriate box how often over the past 7 nights the following 
thoughts have kept you awake. 
Never Sometimes Often Always 
1. Things in the future 
2. How tired/sleepy you feel 
3. Things that happened that day 
4. How nervouslanxious you feel 
5. How mentally awake you are 
6. Checking the time 
7. Trivial things 
8. How you cannot stop your mind from racing 
9. How long you have been awake 
10. Your health 
11. Ways you can get to sleep 
12. Things you have to do tomorrow 
13. How hot/cold you feel 
14. Your work/responsibilities 
15. How frustrated/annoyed you feel 
16. How light/dark the room is 
17. Noises you hear 
18. Being awake all night 
19. Pictures in your mind 
20. The effects of not sleeping well 
21. Your personal life 
22. How thinking too much is the problem 
23. Things in your past 
24. How bad you are at sleeping 
25. Things to do to help you sleep 
292 
Appendix 18: Q5- Pre-sleep arousal scale 
Questionnaire five 
Please describe how intensely you experienced each of the symptoms mentioned below 
as you attempted to sleep during the last week. 
Not at all Slightly Moderately A lot Extremely 
Heart racing, pounding or 
beating irregularly 
A jittery, nervous feeling in 
your body 
Shortness of breath or laboured 
breathing 
A tight, tense feeling in your 
muscles 
Cold feeling in your hands, feet or 
your body in general 
Have stomach upset (knot or 
nervous feeling in stomach, 
heartburn, nausea, gas, etc. ) 
Perspiration in palms of your hands 
or other parts of your body 
Dry feeling in mouth or throat 
Worry about falling asleep 
Review or ponder events of the day 
Depressing or anxious thoughts 
Worry about other problems other 
than sleep 
Being mentally alert or active 
Cannot shut off your thoughts 
Thoughts keep running through 
your head 
Being distracted by sounds, noise in 
the environment (e. g. ticking of clock, 
traffi c) 
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Appendix 19: Q6- DBAS-10 
Questionnaire 6 
Statements reflecting people's beliefs and attitudes about sleep are listed below. Please 
indicate to what extent you personally agree or disagree with each statement right now. 
There is no right or wrong answer. For each statement, place a mark (x) along the line 
wherever your personal rating falls. Try to use the whole scale, rather than placing 
your marks at one end of the line. 
Example: If I sleep too much I don't perform as well the next day 
Strongly Disagree Strongly Agree 
1.1 need 8 hours of sleep to feel refreshed and function well during the day 
Strongly Disagree Strongly Agree 
2. When I don't get the proper amount of sleep on a given night, I need to catch up on 
the next day by napping or on the next night by sleeping longer 
Strongly Disagree Strongly Agree 
3. After a poor night's sleep, I know that it will interfere with my daily activities on 
the next day 
Strongly Disagree Strongly Agree 
4. When I feel irritable, depressed or anxious during the day, it is mostly because I did 
not sleep the night before 
Strongly Disagree Strongly Agree 
5. When I feel tired, have no energy, or just seem not to function well during the day, 
it is generally because I did not sleep well the night before 
Strongly Disagree Strongly Agree 
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6.1 am concerned that chronic insomnia may have serious consequences on my 
physical health 
Strongly Disagree Strongly Agree 
7. I am worried that I may lose control over my abilities to sleep 
Strongly Disagree Strongly Agree 
8. When I sleep poorly on one night, I know it will disturb my week schedule for the 
whole week 
Strongly Disagree Strongly Agree 
9. When I have trouble getting to sleep, I should stay in bed and try harder 
Strongly Disagree Strongly Agree 
10. I get overwhelmed by my thoughts at night and often feel I have no control over 
this racing mind 
Strongly Disagree Strongly Agree 
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Appendix 20: Credibility - expectancy 
ID: Date: 
Please indicate how much you believe, RIGHT NOW, that the therapy will help you 
reduce your sleeping problems, by circling the voice relevant to you. There is not 
right or wrong answer, just the way you think and feel. 
Part A: - ANSWER IN TERMS OF WHAT YOU THINK RIGHT NOW 
1. How logical does the therapy offered to you seem? 
Not at all logical Somewhat logical Logical Very logical 
2. How successful do you think this treatment will be in reducing your sleep 
problems? 
Not at all useful Somewhat useful Useful Very useful 
3. How confident would you be in recommending this treatment to a friend who 
experiences sleep problems? 
Not at all confident Somewhat confident Confident Very confident 
Part B: - ANSWER IN TERMS OF WHAT YOU REALLY AND TRULY FEEL 
4. How much do you really feel that the therapy will help you to reduce your 
sleeping difficulties? 
Not at all A little Quite Very much 
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Appendix 21: Nlonitorini! the use of the 'Quarter of an hour rule' in bed: 
We ýýant to evaluate hovv difficult it is to follow this rule. Please fill out the following table. 
For each day put sour answer in the box: 
a. If you followed the rule write `Y', if you did not write `N'. 
b. If the question is not applicable to you write `N/A' 
c. When %ou are asked 'How mangy times..? ', write the number applying to you. 
Please remember that there is not a right or wrong answer but only what happened each night. 
Weeks: 11213 
RULE TODAY'S DATE 
I. Did Oil take lc,, than ,i quarter of an hour to 
tall asleep once you switched off the light? 
2. If not, did you '. it up in bed? 
3. If you did sit up in bed. 
after about how many minutes did you do so? 
4. In order to follow the rule, how many times 
illing . 
6 If more than once ou had to sit u 
f 
nd 
. y , p 
= 
after how lon did ou do , o: ' g 
After you fell asleep: 
7. It vuu awoke during the night, 
did you tall back asleep within a quarter of an hour? 
8. If you did not fall back asleep within a quarter of 
an hour. did you sit uin bed? 
9 If you did sit up in bed. 
after about how many minutes did you do so? 
10. In order to follow the rule, how many times 
altogether did you have to sit up during the night? 
1 If you had to sit up more than once, 20 time 
after how long did you do so" 3"' time 
3 time 
12. Please describe how it was to follow the rule 
by circling the number that applies to you 
(I= not difficult at all, I I 1 
2= a little difficult. 2 2 2 2 2 2 2 
3= difficult, 3 3 3 3 3 Z 3 
4= very difficult, 4 4 4 4 4 4 4 
5= extremely difficult) 5 5 5 5 5 5 5 
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Appendix 22: PROTOCOL'QHR out of bed INTERVENTION' 
PROTOCOL `QHR out of bed INTERVENTION' 
Today we are going to learn a procedure which hopefully will help you sleep better 
and your task will be to implement and follow it from tonight. It is called the `quarter 
of an hour rule' because you'll have to get out of your bed, go to another room and 
read the book I will give you today if you cannot fall asleep within around 15 minutes 
of trying to sleep. In addition you will have to get out of your bed and read the book if 
you wake up during the night and cannot fall asleep again within 15 minutes. 
Although it might sound odd that you have to get to another room when all you want 
to do is to lie in your bed and try to fall asleep, I am asking you to try to keep 
following this procedure. Please keep following it for the requested 3 weeks even if 
you do not feel it is working. As you have probably already experienced in other 
things in your life, it takes some time for changes to happen. 
What You might be thinking: `Why 15 minutes? '. This time has been chosen 
because people who do not have sleep problems are generally asleep within 10/15 
minutes. In addition, although people without sleep problems do wake up during the 
night, they generally fall back to sleep within that time. You might also be sitting 
there thinking: `why should I get out of my bed when what I want is to lie in bed and 
fall asleep? '. The idea is that if you have not fallen asleep within 15 minutes chances 
are you will be lying there awake for a pretty long time: going to another room and 
then returning to bed again when ready to sleep will make it easier to fall asleep quite 
quickly. If there is something you'd like to ask me, please feel free to interrupt me and 
I will answer to it at the end. 
The procedure is very simple and today we are going to learn and rehearse it till 
you feel comfortable about putting it into practice. In addition you will also have a 
memo at home with you if you want to go through it again. 
We can divide the `quarter of an hour rule in 2 different steps: 
The first step is really to do with preparing things before going to bed. 
1. Make sure the book you will have to read if not asleep in approximately a 
quarter of an hour is nearby your bed is in the room you will go if you cannot 
sleep. Also make sure you will be warm enough as it can be quite chilly during 
the night. For example have a cardigan or a little blanket to put round your 
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shoulder. Remember also to make sure that the actiwatch (during the week 
you will be wearing one) is not covered by your sleeve as it need to be able to 
pick up light from the lamp. 
2. Go to bed as usual. However if you are not asleep within 15 minutes from the 
moment when you have decided to sleep get out of your bed, go to the room 
you have chosen to go and start reading your book. You do not need to keep 
looking at your clock to see if 15 minutes has passed as generally we have 
quite a good sense about this. Keep reading until you feel ready to sleep 
again: when this time arrives go back to your bed, lie down and sleep. If you, 
are not asleep within 15 minutes just repeat this step. Eventually you will be 
asleep within 15 minutes. 
3. If during the night you wake up and cannot fall back to sleep within 15 
minutes sit up and read your book. 
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Appendix 22b: PROTOCOL `QHR in bed INTERVENTION' 
Today we are going to learn a procedure which hopefully will help you sleep better 
and your task will be to implement and follow it from tonight. It is called the 'quarter of 
an hour rule' because you'll have to sit up in your bed and read the book I will give you 
today if you cannot fall asleep within around 15 minutes of trying to sleep. In addition 
you will have to sit up in your bed and read the book if you wake up during the night 
and cannot fall asleep again within 15 minutes. Although it might sound odd that you 
have to sit up in your bed when all you want to do is to lie in your bed and try to fall 
asleep, I am asking you to try to keep following this procedure. Please keep following it 
for the requested 3 weeks even if you do not feel it is working. As you have probably 
already experienced in other things in your life, it takes some time for changes to 
happen. 
What You might be thinking: 'Why 15 minutes? '. This time has been chosen because 
people who do not have sleep problems are generally asleep within 10/15 minutes. In 
addition, although people without sleep problems do wake up during the night, they 
generally fall back to sleep within that time. You might also be sitting there thinking: 
`why should I sit up in my bed when what I want is to lie in bed and fall asleep? '. The 
idea is that if you have not fallen asleep within 15 minutes chances are you will be lying 
there awake for a pretty long time: sitting up and then lying down again when ready to 
sleep will make it easier to fall asleep quite quickly. If there is something you'd like to 
ask me, please feel free to interrupt me and I will answer to it at the end. 
The procedure is very simple and today we are going to learn and rehearse it till you 
feel comfortable about putting it into practice. In addition you will also have a memo at 
home with you if you want to go through it again. 
We can divide the `quarter of an hour rule in 2 different steps: 
The first step is really to do with preparing things before going to bed. 
1. Make sure the book you will have to read if not asleep in approximately a 
quarter of an hour is nearby your bed (possibly on your bed-side table). Also 
make sure you will be warm enough as it can be quite chilly during the night. 
For example have a cardigan or a little blanket to put round your shoulder. 
Remember also to make sure that the actiwatch (during the week you will be 
wearing one) is on the wrist on the side where the table lamp is. 
2. Go to bed as usual. However if you are not asleep within 15 minutes from the 
moment when you have decided to sleep sit up in your bed and start reading 
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your book. You do not need to keep looking at your clock to see if 15 minutes 
has passed as generally we have quite a good sense about this. Keep reading 
until you feel ready to sleep again: when this time arrives just switch on the light 
again, lie down and sleep. If you are not asleep within 15 minutes just repeat this 
step. Eventually you will be asleep within 15 minutes. 
3. If during the night you wake up and cannot fall back to sleep within 15 minutes 
sit up and read your book. 
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Appendix 23a 
Preparation for The `QUARTER OF AN HOUR RUDE; ' 
Decide which room you are going to if you 
cannot fall asleep within a quarter cif an hour 
Put the book in the room where you are going 
to go if you are not asleep within it quarter of an hour 
Make sure the room is prepared so that you will hr 
comfortable enough in it if awake during the night 
(e. g. warm, with something to drink) 
EIEEII:: 
Ioom 
; 02 
The `QUARTER OF AN HOUR RUM?. ' 
If you are not asleep in about a quarter of an hour 
Leave the bed 
Go to another room 
Read the hook 
Do not nap or sleep in this room 
Return to bed when you want to sleep 
NO /Ire you asleep in a 
Quarter of an hour 
YES 
you wake tip during the ni 
N() 
NO Did you fall hack to sleep- YES 
within about 15 minute' 
'ý. 
ir'ý 
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Appendix 23b: Flowchart the QHRin 
If you are not asleep within a quarter of an hour 
Light on 
Sit up in your bed 
Read (lie hook 
Do not nap or sleep while sitting 
Lie down when you want to sleep 
NO /Are you asleep 
quarter of an 
YES 
N() 
you wake up during the ni 
9 
NO Did you fall hack to sleep - YEAS 
within a cjuarter of gun 
9 
FN 1) 
; 04 
Appendix 24: Information GY NHS 
Greater 
Glasgow 
UNIVERSITY 
of r>LEEP Rf SF ARCH 
GLASGOW URou 
IO. lanuary 2004 
Dear Dr, 
TRIAL: BRIEF THERAPY FOR PERSISTENTINSOMNIA 
I am a 2°`1 year PhD student supervised by Prof Cohn N. spii' il I'syýhýýluýýiral 
Medicine. We are planning a randomised controlled trial (which will involve 5(1 
patients: 40 receiving active treatment and 10 controls) comparing the clinical 
effectiveness of a brief, behavioural therapy with a self-monitoring control group in 
the management of persistent insomnia. 
Patients participating in this trial will fill in a sleep diary and wear it light dclectur 
device (the size of a watch) for 5 weeks. Their FFG will he nwnilore(I hw -1 nights 
and they will meet with myself for the delivery of the intervention On _' occasion". 
We enclose a GP's information sheet containing details Of the Study, lVCF1111111CIll 
of patients, reimbursement and so on. NHS Greater Glasgow has granted ethical 
approval for the randomised controlled trial which will run for approximately for the 
18next months. 
We would he grateful it' you could discuss this opportunity' with your rullý; i lies. 
We do hope you will he interested in having your practice parlicipatink' in Ihis 
clinical trial on brief treatment for insomnia and propose to contact ýuur (practice 
manager in 2/ 3 weeks to find out if you are interested or otherwise. 
Yours sincerely, 
Marina M. II tIIO 
Tel 01412113902 
email: 02/9/ llnt<<ý'. citrdriit. gIa. ur. uk 
Department of Psychological Medicine, Academic ('entre, 
Gartnavel Royal Hospital, 1055 Great Western Road, Glasgow C 12 OXII 
; O5 
Trial: Simplified CBT for Insomnia 
A research project, funded by Greater Glasgow Primary Care NHS Trust, entitled 'Does a simplified 
treatment for insomnia improve polysomnographic sleep of patients treated in primary care? ' is 
currently being conducted by Marina Malaffo (PhD student), Department of Psychological Medicine, 
under the supervision of Prof Colin Espie. We are recruiting 50 patients with insomnia from GP 
practices. The study will run until September 2005 approximately. 
The intervention takes the form of 1 individual session where patients are given education and 
behavioural techniques to improve their sleep patterns. Patients' sleep will be assessed both 
via interviews and questionnaires and PSG (night EEG). Support is given by The Sleep 
Research Team at the University of Glasgow. This includes two Clinical Psychologists. 
What the GP has to do: 
Simply fill in a referral form and a reimbursement form and send it to the Sleep 
Clinic. We will send you a sleep assessment and intervention outcome of the referred patient 
in due course. 
Referred patients with insomnia will be randomly allocated to 1 of 2 groups (3: 1 ratio): 
- Active Treatment Group: will receive full assessment of their sleep (using PSG as 
well as interview and sleep diary) + simplified CBT for insomnia 
Control Group: will receive full assessment of their sleep (including PSG) 
What the patient is required to do: 
- Consent to participate in the study 
- Fill in a daily sleep questionnaire for 5 weeks 
-4 nights of EEG monitoring in their own house (the researcher will attach electrodes 
in the evening and go back in the morning to remove them) 
- If allocated to active treatment group, meet with the researcher 2 times for about 30 
minutes each to learn the intervention 
What the patient will gain from participating in the insomnia trial: 
-A full assessment of their sleep 
-A better understanding of their sleep patterns 
- If allocated to the active group, a good chance of learning to sleep better 
If you have any queries, contact: Marina Malaffo Tel: 0141 211 3902 e-mail: 
0219144m@student. gla. ac. uk 
Many thanks for your help. 
Marina Malaffo 
(Supervised by Professor Colin A. Espie) 
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Appendix 25: Referral Criteria for GP and Referral Form 
Simplified CBT for insomnia trial 
REFERRAL CRITERIA 
Patients must : 
be between 18 and 70 years of age in good general health 
Q have problems getting to sleep (at least 30 minutes) and/ or staying asleep (awakenings during 
the night) 
Q have sleep problems at least 4 nights per week 
Q having had sleep problems for at least 6 months 
Patients are unsuitable if they have one or more of the following characteristics: 
1. Depression and/ or psychotic illness and/ or dementia 
2. Be currently taking hypnotic medication for sleep disturbance 
IF UNSURE: Refer the patient. 
HOW ARE REFERRRALS MADE? 
Send a referral form to: Marina Malaffo, Southern General Hospital, Department of 
Neurosurgery, Sackler Foundation, 1345 Govan Rd, Glasgow G514TF 
We will then contact the referred patient informing him/her of the insomnia trial. 
If you have any queries, contact: Marina Malaffo Tel: 0141 232 7699 e-mail: 
0219144m@student. gla. ac. uk 
Many thanks for your help. 
Professor Colin A. Espie, University of Glasgow 
(on behalf of the Sleep research group) 
1t...,.. -............... ýw.. sý,.,. wý. w... ±w., -H.. ý... iý,. _.. _ý.. aa.... 
s ý ý"ý. 'si«s. ý. 
ý F( 
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SLEEP Research `Quarter of un Flour rule' REFERRAL FORM 
Patient's NAME: 
ADDRESS: 
Id. No. 
D. O. B. 
TEL: 
Brief description of problem (nature and duration): 
Known or possible contributory factors: 
(Confirmation that) the patient IS NOT currently prescribed sleeping niedicalion 
Il 
(Confirmation that) the patient IS NOT currently severely depressed 
Lj 
> (TICK TO 
('ONII I: M) 
GP's printed name 
GP's Signature 
Practice: 
Date 
Completed referral forms should be mailed to 
Marina Malapo, Southern General Hospital, Uepurtnirni of Nrurosurhrry, Nick Irr 
Foundation of Psychohiological Research, 134 Govan Road, (ila. tigti" (; 5I -I'I'I. 
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Appendix 26: Letter to consultant referring patient to sleep clinic 
26 `h May 2004 
Dear Dr , 
Name patient (DoB) 
As already communicated to you, Prof Colin Espie will not be able to see the 
above named patient whom you recently referred to the Sleep Clinic. 
However, our Sleep Research Group is currently running an insomnia clinical 
trial funded by Greater Glasgow Primary Care NHS Trust. We would, therefore, be 
happy to contact your patient to propose participating in the clinical trial. If the 
patient consents to it, his/her sleep will be fully assessed (including PSG) and a copy 
of the assessment result would be sent to you. In addition the patient might be 
randomised into an insomnia intervention. 
If we do not hear from you within the next three weeks, we will assume 
that you are satisfied for us to contact the above named patient directly. We will 
send him/her an information leaflet explaining the research trial and a consent form 
to be filled in and returned to us if the patient is willing to take part in the clinical 
trial. 
Please find here enclosed an information sheet regarding the clinical trial. 
Should you have any other patient whom you wish to refer for the study or would you 
like more information about the insomnia trial, please do not hesitate to contact us. 
Yours sincerely, 
Marina Malaffo 
(PhD Student supervised by Prof Colin Espie) 
Department of Psychological Medicine, 
Academic Centre, Gartnavel Royal Hospital, 1055 Great Western Rd, Glasgow G12 OXII 
Tel 01412113902 Email 0219144m@student. gla. ac. uk 
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Trial: Simplified CBT for Insomnia 
A research project, funded by Greater Glasgow Primary Care NHS Trust, entitled `Does a simplified 
treatment for insomnia improve polysomnographic sleep of patients treated in primary care? ' is currently 
being conducted by Marina Malaffo (PhD student), Department of Psychological Medicine, under the 
supervision of Prof Colin Espie. We are recruiting 50 patients with insomnia from GP practices. The 
study will run until September 2005 approximately. 
The intervention takes the form of 1 individual session where patients are given education and 
behavioural techniques to improve their sleep patterns. Patients' sleep will be assessed both 
via interviews and questionnaires and PSG (night EEG). Support is given by The Sleep 
Research Team at the University of Glasgow. This includes two Clinical Psychologists. 
What the GP has to do: 
Simply fill in a referral form and a reimbursement form and send it to the Sleep 
Clinic. We will send you a sleep assessment and intervention outcome of the referred patient 
in due course. 
Referred patients with insomnia will be randomly allocated to 1 of 2 groups (3: 1 ratio): 
- Active Treatment Group: will receive full assessment of their sleep (using PSG as 
well as interview and sleep diary) + simplified CBT for insomnia 
- Control Group: will receive full assessment of their sleep (including PSG) 
What the patient is required to do: 
- Consent to participate in the study 
- Fill in a daily sleep questionnaire for 5 weeks 
-4 nights of EEG monitoring in their own house (the researcher will attach electrodes 
in the evening and go back in the morning to remove them) 
. If allocated to active treatment group, meet with the researcher 2 times for about 30 
minutes each to learn the intervention 
What the patient will gain from participating in the insomnia trial: 
-A full assessment of their sleep 
-A better understanding of their sleep patterns 
- If allocated to the active group, a good chance of learning to sleep better 
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Appendix 27: Letter to participants for Information Pack 
Date 
Dear.., 
Your medical practice is participating in a study Into the assessment of and the non- 
pharmacological treatment of sleep difficulties being conducted here at the 
University of Glasgow. Your GP, Dr ... 1, referred you with a view to participate in the 
study as you have been troubled by sleeping difficulties for some time. 
The enclosed information sheet gives you details of the study and includes a 
consent form which, if you would like to be considered for this study, you should 
complete and return to us In the freepost envelope here enclosed. Two 
questionnaires are also enclosed: please fill them in and send them back with your 
consent form if you want to be considered. 
I will phone you in a couple of weeks to find out if you received the material and if 
you have any questions. 
We look forward to hearing from you. 
Yours sincerely, 
Marina Malaffo 
(supervised by Prof Colin Espie) 
Department of Psychological Medicine 
Based At 
Southern General Hospital, Department of Neurosurgery, Sackler Foundation of 
Psychobiological Research, 1345 Govan Road, Glasgow G51 4TF 
Tel 0141 - 232 7699 
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Appendix 28: THE GOOD SLEEP GUIDE 
DURING THE EVENING 
1. Daily exercise is a good way to encourage sleep. Try some light 
exercise early in the evening, such as walking or swimming, as this 
will make your body ready for sleep later on. 
2. Avoid drinking coffee or tea or eating chocolate in the evening 
because they all contain caffeine, which makes you more alert. A hot 
milky drink is it good alternative. Also don't drink alcohol it,, a 
nightcap -- it usually upsets sleep. 
3. Wind down during the course of the evening. Try not U() do 
anything that is mentally stimulating within 9() minutes or hrdltinu". 
Give yourself time to relax and prepare for sleep - try having; it warm 
bath or listening to some soothing music. 
4. Do not sleep or doze in the armchair because this can upset Your 
night time sleeping patterns. Keep all your sleep for bedtime. 
5. Feeling worried or anxious or just having an active mind can 
cause a sleepless night. Try to put the day tu rest. Take time to think 
it through and write down any worries or concerns or loose ends in a 
notebook. Say goodbye to them before you go to bed you can deal 
with them more effectively in the morning. 
6. Make sure your bed and bedroom are comfortable for sleep. Your 
room should he well ventilated, not too cold or too warne. 
AT BEDTIME 
1. Try to get up at the same time every day, even at weekends, use 
an alarm clock if' you need to. This helps estahlish your sleep Pattern 
to follow a regular routine. 
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2. Go to bed when you are "sleepy tired" and not before. Try to 
notice when you are ready to sleep. 
3. Try to avoid reading or watching TV in bed as this can stimulate the 
brain, sometimes making it difficult to relax. Keep these waking 
activities for another room. 
4. Put the light out when you get into bed and try to ensure your room 
is as dark as possible. This helps signal to your body that it's time for 
sleep. 
5. Let yourself relax. Tell yourself that "sleep will come when it's 
ready". Enjoy relaxing even if you don't at first fall asleep. If you are 
not good at relaxing, try to learn a relaxation method. 
6. Do not try to fall asleep - let sleep find you. Sleep is not something 
you can switch on automatically. Trying too hard can switch sleep off. 
IF YOU HAVE PROBLEMS GETTING TO SLEEP 
1. Remember that sleep difficulties are quite common, and are not as 
damaging as you might think. Most people cope quite well even after a 
disturbed night's sleep. 
. 2. Try not to get upset or frustrated or to think about the next day. Avoid watching the clock, as this will only make the time pass more 
slowly. 
3. Instead, if you are awake for more than 15 minutes, you just might 
not be ready for sleep. Try getting up, going into another room, and 
accepting it philosophically. 
4. Do something relaxing while you are up like listening to music or 
reading. 
5. Go back to bed again when you feel "sleepy tired". Remember you 
may have to repeat this rising and returning to bed several times a night 
at first. 
6. Whenever you experience difficulties sleeping try to follow these 
tips. A good sleeping pattern may take a number of weeks to establish. 
Be confident that you will achieve this by working through 
"The Good Sleep Guide"! 
This guide has been prepared by Professor Colin A. Espie, Director of the 
University of Glasgow Sleep Research Laboratory, Southern General Hospital, 
Glasgow 
httli: //www. jzla. ac. uk/sleepresearch 
The Good Sleep Guide is recommended by the British Sleep Sciety 
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Appendix 29: PARTICIPANT CONSENT FORM (study 3) 
`Does a simplified treatment for insomnia improve the polysomnographic 
sleep of patients treated in Primary Care? ' 
Name (Mr. / Mrs. / Miss/ Ms) 
Address 
Postcode 
Telephone Number (day) 
(evening) 
I confirm that I have read the information sheet for the above study, I 
understand its content and I have received my own copy. 
I have also had the opportunity to ask any questions about taking part to the 
study (and what it will involve) with the research worker. 
I understand that I am free to withdraw from the study at any time, without 
having to give a reason. I also understand that if I withdraw, my care and treatment will 
be not affected in any way. 
I understand that all information collected during the study, including 
questionnaires, sleep diaries and sleep data from the actiwatch and the EEG recorder, 
will be treated confidentially. 
I hereby consent to participate in the above study. 
Signed Date 
GP Name 
GP Address 
Department of Psychological Medicine 
Academic Centre, Gartnavel Royal Hospital, 1055 Great Western Road, Glasgow G12 
OXH 
Based at Southern general hospital, department of Neurosurgery, Sackler Foundation 
of Psychobiological Research, 1345 Govan Rd, Glasgow 
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Appendix 30: Home visit Protocol 
HOME VISIT SAFETY PROTOCOL FOR PSG STUDIES 
(01/09/2004) 
Home based PSG research projects require researchers to undertake home visits. 
Health, safety and welfare of research and clinical staff are regulated by the Health 
and Safety at Work etc Act 1974 which also requires workers themselves to take 
reasonable care of their own safety. 
This procedure has been formulated in order to remind researchers to adopt a 
common sense approach to each situation so as to take reasonable care of 
themselves and to be responsible for their own safety. 
You and your supervisor should discuss this protocol and adapt it to your specific 
project in order to make sure that it is conducted as safely as possible. Remember 
also that 'Management of Aggression (Breakaway) courses' are made available on a 
regular basis within the Trust. 
WHAT to do before offering a home visit appointment 
" 1. Before agreeing with a participant a home visit, it is important to check within 
yourself whether you feel comfortable with that particular participant (e. g. mannerism, 
GPs notes, means of recruitment). Inform your supervisor of participants you do not 
feel comfortable with. 
" 2. It is also important to find out if there is anything unsafe about the 
neighbourhood the person lives 
o If the person or the neighbourhood could pose risks, it is 
important to attend the visit accompanied by another person (e. g. 
a friend, a colleague) 
When an appointment is offered (irrespectively of whether one or two 
people go to the participant's home) the following must be in place: 
1. You must have a mobile phone with you and ensure it is switched on. If you 
do not have one, ask your supervisor to be provided with one. Remember to 
check that it is charged and has calling credit. 
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2. Inform a nominated person (family member, partner, friend, colleague), where 
you are going (full address/name and telephone of the person being visited) 
and when (day/date/time and approximately when the visit should finish). 
3. Contact the nominated person prior to entering the premises and again 
immediately after leaving the participant's home. Obviously your contact must 
be available for the time period you are paying the home visit and must 
understand the importance of hearing back from you. Make sure your contact 
person has your mobile phone number. 
4. You should carry a personal attack alarm - one will be available from your 
supervisor. 
5. Do not forget that you might be at risk also while walking to the participant's 
home or entering the close, especially if not well lit. 
WHAT THE NOMINATED PERSON SHOULD DO IF YOU DON'T CONTACT 
HIM/HER WITHIN 15 MINUTES FROM THE TIME AGREED 
" Phone you on your mobile phone and/or at the patient's home number. 
" If he/she is unable to speak to you, they should inform the Police and your 
supervisor 
" If you answer the phone and are in a threatening situation, please state 
"My phone does not have battery left, cannot speak just now". 
This will act as an alert signal. In this case the nominated person 
should inform 
the Police and your supervisor. 
During the home visit: 
1. Ensure that your phone and attack alarm are within easy reach. 
2. If you feel threatened in any way even before you enter the building, you 
should leave. Make your excuses and leave if anything worries you. 
3. If you are asked to leave by your participant you should go without hesitation. 
4. All significant incidents, in particular those of violence or aggression both 
physical and verbal including inappropriate behaviour must be recorded in line 
with the Trust and University's incident reporting procedure. 
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Appendix 31 : Results of one-way ANOVA on the baseline scores of the battery 
of questionnaires 
Results of One-way ANOVA on the baseline scores of sleep related 
questionnaires for the QHR1n, QHRout and Control Groups 
Mean Scores F (2,36) p Bonferroni corrected t-tests 
Sleep Behaviour Self Rating Scale-R 1.9 n. s. 
The Glasgow Sleep Effort Scale 0.5 n. s 
Sleep Disturbance Questionnaire. 
physical tension 3.7 0.04 U. S. 
sleep pattern problems 0.7 n. s. 
cognitive arousal 0.8 as. 
sleep effort 1.9 n. s. 
Glasgow Content of Thoughts Inventory 
active problem solving 12 n. s. 
sleep and wakefulness 1.4 n. s. 
somatic and sensory engagement 5.3 0.01 QHR. in a QHRout pr 0.01 
Pre-Sleep Arousal Scale QHRin y Control p- 0.009 
cognitive arousal 0.1 n. s. 
somatic arousal 2S n. s. 
DBAS-10 
immediate negative consequences 0.7 n_s. 
long term negative consequences 0.4 n. s. 
need for control 1.2 n. s. 
318 
Annendix 12 - 
Hktnnrams: AdhereneeRaw Data 
Appendix 32a- Number of Participants in the QHRin group according to 
SOL and WASO adherence score measured objectively and subjectively 
OHRin objective adherence score at SOL QHRin srbieclive adtnrerr: e score at SOI 
OHRin objective adherence score at WASO 
r s a 
Appendix 32b - Number o( Participants in the QHRout group according to SOL and WASO 
adherence score measured objectively and subjectively 
_JI 
OHRuut objective adheres e score at SOL OHROuI subjective edt reue o score at 
SOL 
T 
ü 
z 
OHRin sWlecM adhoronco score at WASO 
s a 
,: 
ýEt 
i 
r 
;ý"ý 
OHRour objective adluorerre score at WASO QHRoin srbIoolivo adhorork 0 -)rv at WASO 
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Appendix 33: Results of Mixed ANOVAs for subjective sleep continuity 
variables and PSQI on baseline and post-treatment scores for the QHRin, 
QHRout and Control Groups 
Results of Mixed ANOVAs for subjective sleep continuity variables and PSQI 
on baseline and post-treatment scores for the QHRin, QHRout and Control 
Groups 
Time Effect p Group Effect p Interaction p 
F(1,38) F(2,38) F(2,38) 
SOL 7.11 0.01 0.81 n. s. 4.36 0.02(0 
WASO 20.41 0.0005 1.36 n. s. 4.56 0.02(2) 
TST 13.89 0.001 2.32 n. s. 2.89 0.07 
S. E. '24.79 0.0005 1.78 n. s 8.13 0.0013) 
PSQI 46.04 0.0005 2.00 n. s. 13.38 0.0005(4) 
Post-Hoc Corrections 
(1)Bonferroni Corrected: QHRout Baseline vs Post-Treatment t(14)=3.99, p=0.001 
Uncorrected t-test: QHRout vs Control at Post-Treatment t(25)=2.14, p=0.04 
(2) Bonferroni Corrected: QHRout Baseline vs Post-Treatment t(14)=5.26, p<0.0005 
QHRout vs Control at Post-Treatment t(25)=3.63, p=0.001 
Uncorrected t-test: QHRin vs Control at Post-Treatment t(24)=2.34, p=0.03 
(3) Bonferroni Corrected: QHRout Baseline vs Post-Treatment t(14)=5.52, p<0.0005 
QHRout vs Control at Post-Treatment t(25)=3.27, p=0.003 
QHRin Baseline vs Post-Treatment t(13)=3.68, p=0.003 
Uncorrected t-test: QHRin vs Control at Post-Treatment t(24)=2.51, p=0.02 
(4) Bonferroni Corrected: QHRout Baseline vs Post-Treatment t(14)=6.68, p<0.0005 
QHRout vs Control at Post-Treatment t(25)=3.95, p=0.001 
QHRin Baseline vs Post-Treatment t(13)=4.19, p=0.001 
QHRin vs Control at Post-Treatment t(24)=3.54, p=0.003 
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